"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL1403281";"ERGOCRYPTINE";"None";"575.71";"1";"2.43";"ALPHA-ERGOCRYPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1572";"NETILMICIN";"4.0";"475.59";"2";"-3.20";"NETILMICIN";"CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL423192";"ANISOMYCIN";"None";"265.31";"0";"0.50";"Anisomycin";"COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL351285";"";"None";"388.39";"0";"3.22";"14";"Cc1ccc(NC(=O)Nc2nc3nn(C)cc3c3nc(-c4ccco4)nn23)cc1";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644485";"Inhibition of IB-MECA agonist-mediated cAMP production in CHO cell membranes expressing human Adenosine A3 receptor; range 2.7-7.8";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL27769";"STANOLONE";"2.0";"290.45";"0";"3.96";"SID50086823";"C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800861";"";"None";"328.33";"0";"1.65";"44";"C=CCN1C(=O)N2CC(C)N=C2c2[nH]c(-c3cc(OC)no3)nc21";"IC50";"'='";"24.2";"nM";"7.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800863";"";"None";"378.39";"0";"2.66";"46";"COc1cc(-c2nc3c([nH]2)C2=NC(C)CN2C(=O)N3Cc2ccccc2)on1";"IC50";"'='";"20.4";"nM";"7.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL3736156";"";"None";"260.15";"None";"None";"3";"CB1C=Cc2c(cccc2OCC(O)CN(C)C)N1";"IC50";"'>'";"5011.87";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3738125";"Antagonist activity at human wild-type A3 receptor expressed in CHO-K1 cells assessed as IB MECA-induced cAMP by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734721";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307512";"";"";""
"CHEMBL1741";"CLARITHROMYCIN";"4.0";"747.96";"2";"2.44";"CLARITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3350037";"";"None";"1019.26";"None";"None";"OCTREOTIDE";"C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL302765";"";"None";"432.44";"0";"3.80";"7";"CCCn1cc2c(nc(NC(=O)Nc3ccc(OC)cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644509";"Inhibitory concentration as antagonistic activity against cAMP generation inhibited by IB-MECA in CHO cell membranes transfected with human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132457";"1";"Scientific Literature";"J Med Chem";"1999";"CHEMBL3308072";"";"";""
"CHEMBL445067";"";"None";"501.55";"1";"4.81";"12";"COc1ccc(-n2nc3c(NC(=O)C(c4ccccc4)c4ccccc4)nc4ccccc4n3c2=O)cc1";"IC50";"'='";"215.0";"nM";"6.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL867251";"Antagonist activity against Cl-IB-MECA inhibited cAMP level in CHO cells transfected with human A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138044";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL190";"THEOPHYLLINE";"4.0";"180.17";"0";"-1.04";"THEOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL37858";"SARAFLOXACIN";"-1.0";"385.37";"0";"2.38";"SARAFLOXACIN";"O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL464040";"";"None";"388.81";"1";"5.07";"14";"O=C(Nc1nc2ccccc2c2cn(-c3ccc(Cl)cc3)nc12)c1ccco1";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1013711";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of CI-IB-MECA-mediated inhibition of cAMP accumulation by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152204";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL471";"SOTALOL";"4.0";"272.37";"0";"1.09";"SOTALOL";"CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL642";"ACEBUTOLOL";"4.0";"336.43";"0";"2.37";"ACEBUTOLOL";"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200396";"BUPIVACAINE HYDROCHLORIDE";"4.0";"324.90";"0";"3.90";"BUPIVACAINE HYDROCHLORIDE";"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL16068";"BROMOBENZENE";"None";"157.01";"0";"2.45";"BROMOBENZENE";"Brc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL125288";"";"None";"370.38";"1";"5.31";"9c-3";"CCCCc1nc2ccccc2c2nc(-c3ccc(C(F)(F)F)cc3)nn12";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"17.04";"0.32";"1.00";"14.65";"0";"CHEMBL644555";"Binding affinity for human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL94";"PHYSOSTIGMINE";"4.0";"275.35";"0";"1.77";"PHYSOSTIGMINE";"CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL934";"METYRAPONE";"4.0";"226.28";"0";"2.64";"METYRAPONE";"CC(C)(C(=O)c1cccnc1)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL717";"MEDROXYPROGESTERONE ACETATE";"4.0";"386.53";"0";"4.66";"MEDROXYPROGESTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL480";"LANSOPRAZOLE";"4.0";"369.37";"0";"3.52";"LANSOPRAZOLE";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL16073";"PHENACETIN";"4.0";"179.22";"0";"2.04";"PHENACETIN";"CCOc1ccc(NC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL210456";"";"None";"441.47";"0";"1.44";"5";"COc1ccc(NS(=O)(=O)c2ccc(-c3cc4c([nH]3)c(=O)n(C)c(=O)n4C)cc2)cn1";"IC50";"'='";"1525.0";"nM";"5.82";"";"";"UO_0000065";"13.18";"0.26";"4.38";"4.54";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"22.91";"nM";"7.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322687";"Agonist activity at wild type human A3 receptor M177'5.38A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"M177A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL1419";"SIBUTRAMINE";"4.0";"279.86";"0";"4.74";"SIBUTRAMINE";"CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL141154";"";"None";"422.84";"0";"4.05";"20";"CCn1cc2c(nc(NC(=O)Nc3cccc(Cl)c3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"14.8";"nM";"7.83";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL644494";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 10.8-21.5";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL422820";"";"None";"494.52";"0";"4.63";"31";"COc1ccc(NC(=O)Nc2nc3nn(CCc4ccccc4)cc3c3nc(-c4ccco4)nn23)cc1";"IC50";"'='";"13.9";"nM";"7.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644491";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL123346";"";"None";"368.44";"0";"4.68";"1d";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(-c4ccccc4)cc3)nn12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"22.53";"0.40";"3.62";"11.57";"1";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL124897";"";"None";"366.85";"0";"4.95";"3r";"CCCCc1nc2ccc(Cl)cc2c2nc(-c3ccc(OC)cc3)nn12";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"20.39";"0.39";"2.53";"14.30";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL12948";"SEMUSTINE";"3.0";"247.73";"0";"2.50";"SEMUSTINE";"CC1CCC(NC(=O)N(CCCl)N=O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL203266";"TRIMETAZIDINE";"4.0";"266.34";"0";"1.12";"TRIMETAZIDINE";"COc1ccc(CN2CCNCC2)c(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL850";"SPARFLOXACIN";"4.0";"392.41";"0";"2.08";"SPARFLOXACIN";"C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL142562";"";"None";"394.78";"0";"3.56";"17";"O=C(Nc1cccc(Cl)c1)Nc1nc2n[nH]cc2c2nc(-c3ccco3)nn12";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644490";"Inhibition of cAMP accumulation in CHO cells expressing human A3 adenosine receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL177756";"FLUORESCEIN";"None";"332.31";"0";"3.97";"FLUORESCEIN";"O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1560";"CAPTOPRIL";"4.0";"217.29";"0";"0.63";"CAPTOPRIL";"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1619";"CLADRIBINE";"4.0";"285.69";"0";"-0.30";"CLADRIBINE";"Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL563";"FLURBIPROFEN";"4.0";"244.26";"0";"3.68";"FLURBIPROFEN";"CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL124725";"";"None";"306.37";"0";"3.32";"2i";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(C)cc3)nn12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"27.41";"0.50";"5.08";"11.70";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL122230";"";"None";"292.34";"0";"3.88";"3b";"CCCCc1nc2ccccc2c2nc(-c3ccco3)nn12";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"23.67";"0.43";"3.04";"12.31";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL423934";"";"None";"450.89";"0";"4.83";"24";"CCCCn1cc2c(nc(NC(=O)Nc3cccc(Cl)c3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644498";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 3.0-6.9";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL583747";"";"None";"793.35";"3";"1.21";"17a";"CNC(=O)[C@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(Cl)c4)nc(C#CCCC(=O)NCCNC(=O)CCCC[C@H]4SC[C@H]5NC(=O)N[C@H]54)nc31)[C@H](O)[C@@H]2O";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1053707";"Agonist activity at human recombinant adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production treated 45 mins before forskolin challenge measured after 15 mins by radioimmunoassay relative to NECA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154768";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL167753";"";"None";"408.81";"0";"3.57";"21";"Cn1cc2c(nc(NC(=O)Nc3ccc(Cl)cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL646731";"Inhibition of IB-MECA agonist-mediated cAMP production in membranes of CHO cells expressing human Adenosine A3 receptor; range 1.2-4.9";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL341376";"";"None";"373.38";"0";"2.45";"55";"Cn1cc2c(nc(NC(=O)Cc3ccccc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"6.4";"nM";"8.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644557";"Inhibition of IB-MECA agonist-mediated cAMP production in membranes of CHO cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL339556";"";"None";"336.83";"0";"4.94";"3o";"CCCCc1nc2ccc(Cl)cc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"21.81";"0.42";"2.41";"17.05";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL124900";"";"None";"326.79";"0";"3.66";"2e";"CCCCc1nc2[nH]ncc2c2nc(-c3cccc(Cl)c3)nn12";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL145767";"";"None";"390.36";"0";"2.91";"16";"COc1ccc(NC(=O)Nc2nc3n[nH]cc3c3nc(-c4ccco4)nn23)cc1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644490";"Inhibition of cAMP accumulation in CHO cells expressing human A3 adenosine receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL302765";"";"None";"432.44";"0";"3.80";"2";"CCCn1cc2c(nc(NC(=O)Nc3ccc(OC)cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"5.2";"nM";"8.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644501";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 4.4-6.5";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL437309";"";"None";"572.49";"1";"2.50";"16";"Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccc(Br)cc5)CC4)cc3)cc2n(C)c1=O";"IC50";"'='";"12260.0";"nM";"4.91";"";"";"UO_0000065";"8.58";"0.19";"2.41";"4.89";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL209019";"";"None";"493.59";"0";"1.74";"11";"Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccccc5)CC4)cc3)cc2n(C)c1=O";"IC50";"'='";"3169.0";"nM";"5.50";"";"";"UO_0000065";"11.14";"0.21";"3.76";"5.48";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL211762";"";"None";"439.50";"0";"1.15";"7";"Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCc4ccccn4)cc3)cc2n(C)c1=O";"IC50";"'='";"2085.0";"nM";"5.68";"";"";"UO_0000065";"12.93";"0.25";"4.53";"4.78";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL1200431";"GADOPENTETATE DIMEGLUMINE";"4.0";"742.79";"None";"None";"GADOPENTETATE DIMEGLUMINE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL62350";"8-PHENYL THEOPHYLLINE";"None";"256.26";"0";"0.63";"1";"Cn1c(=O)c2nc(-c3ccccc3)[nH]c2n(C)c1=O";"IC50";"'='";"1250.0";"nM";"5.90";"";"";"UO_0000065";"23.04";"0.42";"5.27";"8.12";"0";"CHEMBL644505";"Inhibitory activity against cyclic AMP production in human adenosine A3 receptor assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134604";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL1105";"6-METHOXY-2-NAPHTHYLACETIC ACID";"-1.0";"216.24";"0";"2.48";"6-METHOXY-2-NAPHTHYLACETIC ACID";"COc1ccc2cc(CC(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL164686";"";"None";"442.36";"0";"3.93";"17";"Cn1cc2c(nc(NC(=O)Nc3ccc(C(F)(F)F)cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"6.6";"nM";"8.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644487";"Inhibition of IB-MECA agonist-mediated cAMP production in CHO cell membranes expressing human Adenosine A3 receptor; range 3.7-117";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL124724";"";"None";"320.40";"0";"3.57";"2j";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(CC)cc3)nn12";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"24.72";"0.45";"4.35";"11.04";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL917";"FLOXURIDINE";"4.0";"246.19";"0";"-1.68";"FdU";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL122632";"";"None";"348.45";"0";"4.31";"22";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(C(C)(C)C)cc3)nn12";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"25.60";"0.47";"4.61";"12.43";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL122819";"";"None";"336.40";"0";"3.41";"28";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(OCC)cc3)nn12";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"28.77";"0.53";"6.27";"11.95";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL165224";"";"None";"418.37";"0";"2.64";"12";"Cn1cc2c(nc(NC(=O)Nc3ccc4c(c3)OCO4)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL646732";"Inhibition of IB-MECA agonist-mediated cAMP production in CHO cell membranes expressing human Adenosine A3 receptor; range 1.8-5.6";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL1390";"";"None";"344.50";"0";"4.08";"MEDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL429131";"";"None";"331.44";"0";"3.56";"5p";"CCCSc1nc(NC(C)=O)cc(OCCc2ccccc2)n1";"IC50";"'='";"1.25";"nM";"8.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL951866";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as reversal of NECA-mediated inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143166";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL410746";"";"None";"306.28";"0";"-1.82";"11";"CNC(=O)[C@@]12CO[C@@H]([C@H](n3cnc4c(N)ncnc43)O1)[C@@H]2O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL211449";"";"None";"485.50";"0";"4.52";"19";"O=C(c1ccccc1)N(C(=O)c1ccccc1)c1nc2ccccc2n2c(=O)n(-c3ccccc3)nc12";"IC50";"'='";"28.3";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL867251";"Antagonist activity against Cl-IB-MECA inhibited cAMP level in CHO cells transfected with human A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138044";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL209122";"";"None";"426.44";"0";"2.88";"11";"COc1ccc(-n2nc3c(NC(=O)c4ccccc4)nc4c(N)cccc4n3c2=O)cc1";"IC50";"'='";"8.6";"nM";"8.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL867251";"Antagonist activity against Cl-IB-MECA inhibited cAMP level in CHO cells transfected with human A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138044";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL85";"RISPERIDONE";"4.0";"410.49";"0";"3.59";"RISPERIDONE";"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL374478";"RIFAMPIN";"4.0";"822.95";"3";"4.34";"RIFAMPIN";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2367892";"TEICOPLANIN";"None";"1767.46";"None";"None";"TEICOPLANIN";"CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL332742";"";"None";"306.37";"0";"3.32";"21";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(C)cc3)nn12";"IC50";"'='";"0.33";"nM";"9.48";"";"";"UO_0000065";"30.95";"0.56";"6.16";"13.21";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL9";"NORFLOXACIN";"4.0";"319.34";"0";"1.27";"Norfloxacin";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL43882";"TRICHLOROETHANE";"None";"133.41";"0";"2.03";"TRICHLOROETHANE";"ClCC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1458880";"CADMIUM DICHLORIDE";"None";"183.32";"None";"None";"CADMIUM CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1417172";"";"None";"282.30";"0";"3.48";"17";"COc1ccc(-c2cc3cccc(OC)c3oc2=O)cc1";"IC50";"'='";"25300.0";"nM";"4.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4379763";"Antagonist activity at human adenosine receptor A3 expressed in CHO cells assessed as suppression of NECA-induced decrease of cAMP accumulation by Glo-sensor cAMP assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376839";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL1777844";"";"None";"296.32";"0";"3.87";"5";"CCOc1cccc2cc(-c3ccc(OC)cc3)c(=O)oc12";"IC50";"'='";"29500.0";"nM";"4.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4379763";"Antagonist activity at human adenosine receptor A3 expressed in CHO cells assessed as suppression of NECA-induced decrease of cAMP accumulation by Glo-sensor cAMP assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376839";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL597";"PHENTOLAMINE";"4.0";"281.36";"0";"2.84";"PHENTOLAMINE";"Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909072";"PIPAMAZINE";"4.0";"401.96";"0";"4.53";"PIPAMAZINE";"NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL76904";"TYRPHOSTIN 23";"None";"186.17";"0";"1.53";"TYRPHOSTIN A23";"N#CC(C#N)=Cc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL434639";"";"None";"320.37";"0";"4.43";"3d";"CCCCc1nc2ccccc2c2nc(-c3ccc(F)cc3)nn12";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"23.58";"0.43";"3.12";"17.53";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL1148";"TORSEMIDE";"4.0";"348.43";"0";"2.53";"TORSEMIDE";"Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157548";"DANOFLOXACIN";"-1.0";"357.39";"0";"2.07";"DANOFLOXACIN";"CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL384467";"DEXAMETHASONE";"4.0";"392.47";"0";"1.90";"dexamethasone";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1753";"CLINDAMYCIN";"4.0";"424.99";"0";"0.39";"CLINDAMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL205596";"CHOLIC ACID";"4.0";"408.58";"0";"3.45";"CHOLIC ACID";"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL923";"RISEDRONIC ACID";"4.0";"283.11";"0";"-0.37";"RISEDRONIC ACID";"O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1411979";"METHAPYRILENE";"4.0";"261.39";"0";"2.71";"METHAPYRILENE";"CN(C)CCN(Cc1cccs1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL509";"MECLOFENAMIC ACID";"4.0";"296.15";"0";"4.74";"MECLOFENAMIC ACID";"Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL281129";"";"None";"301.34";"0";"1.58";"41";"CSc1c2c(nc(N)n3nc(-c4ccco4)nc23)nn1C";"IC50";"'='";"188.0";"nM";"6.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644554";"Antagonist activity as inhibition of cAMP generation after agonist-modulation of Adenosine A3 receptor with 100 nM CI-IB-MECA";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136743";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL878";"METOLAZONE";"4.0";"365.84";"0";"2.71";"METOLAZONE";"Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL54440";"MEVASTATIN";"2.0";"390.52";"0";"3.95";"MEVASTATIN";"CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL625";"THIABENDAZOLE";"4.0";"201.25";"0";"2.69";"thiabendazole";"c1ccc2[nH]c(-c3cscn3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1258284";"";"None";"449.51";"1";"5.85";"17";"Cc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL452861";"(-)-PROPANOLOL ";"2.0";"259.35";"0";"2.58";"S-(-)-PROPRANOLOL";"CC(C)NC[C@H](O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1935765";"";"None";"432.44";"0";"3.80";"45b";"CCCn1cc2nc(NC(=O)Nc3ccc(OC)cc3)n3nc(-c4ccco4)nc3c2n1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1936208";"Antagonist activity at human adenosine A3 receptor expressed in forskolin-stimulated CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1932966";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"IB-MECA";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"18.07";"0.43";"8.81";"6.86";"1";"CHEMBL3876338";"Displacement of [125I]AB-MECA from human recombinant adenosine receptor A3 expressed in HEK293 cells measured after 120 mins by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875185";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3307715";"";"";""
"CHEMBL1094132";"";"None";"420.48";"1";"5.19";"2j";"O=C(Nc1ccccc1)Nc1nc(-c2ccccc2)nc2nn(Cc3ccccc3)cc12";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120804";"Antagonist activity human recombinant adenosine A3 receptor expressed in CHO cells assessed as blockade of NECA-mediated inhibition of forskolin-stimulated [3H]cAMP production treated 15 mins before NECA challenge measured after 30 mins by liquid scintillation spectrometry";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157749";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1096078";"";"None";"450.50";"1";"5.19";"2k";"COc1ccc(NC(=O)Nc2nc(-c3ccccc3)nc3nn(Cc4ccccc4)cc23)cc1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120804";"Antagonist activity human recombinant adenosine A3 receptor expressed in CHO cells assessed as blockade of NECA-mediated inhibition of forskolin-stimulated [3H]cAMP production treated 15 mins before NECA challenge measured after 30 mins by liquid scintillation spectrometry";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157749";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL123195";"";"None";"293.33";"0";"2.41";"13";"CCCCc1nc2[nH]cnc2c2nc(-c3cccnc3)nn12";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"30.41";"0.55";"6.51";"10.54";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL817";"TOLAZAMIDE";"4.0";"311.41";"0";"1.77";"TOLAZAMIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL28079";"ZAPRINAST";"2.0";"271.28";"0";"1.50";"ZAPRINAST";"CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL541";"BENZOIC ACID";"4.0";"122.12";"0";"1.38";"BENZOIC ACID";"O=C(O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL26260";"BETA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"BETA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL319244";"CAFFEIC ACID PHENETHYL ESTER";"None";"284.31";"0";"2.90";"CAFFEIC ACID PHENETHYL ESTER";"O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL141154";"";"None";"422.84";"0";"4.05";"6";"CCn1cc2c(nc(NC(=O)Nc3cccc(Cl)c3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"15.1";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644509";"Inhibitory concentration as antagonistic activity against cAMP generation inhibited by IB-MECA in CHO cell membranes transfected with human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132457";"1";"Scientific Literature";"J Med Chem";"1999";"CHEMBL3308072";"";"";""
"CHEMBL340580";"";"None";"302.38";"0";"4.29";"9c-1";"CCCCc1nc2ccccc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"21.78";"0.39";"2.30";"15.29";"0";"CHEMBL644555";"Binding affinity for human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL357663";"";"None";"446.47";"0";"4.14";"25";"COc1ccc(NC(=O)Nc2nc3nn(C(C)(C)C)cc3c3nc(-c4ccco4)nn23)cc1";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644502";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 5.1-8.9";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL344706";"";"None";"283.30";"0";"1.73";"31";"CCCn1cc2c(nc(N)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"40.2";"nM";"7.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644509";"Inhibitory concentration as antagonistic activity against cAMP generation inhibited by IB-MECA in CHO cell membranes transfected with human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132457";"1";"Scientific Literature";"J Med Chem";"1999";"CHEMBL3308072";"";"";""
"CHEMBL122163";"";"None";"378.48";"1";"5.95";"3h";"CCCCc1nc2ccccc2c2nc(-c3ccc(-c4ccccc4)cc3)nn12";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"18.11";"0.32";"0.90";"15.91";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL465946";"";"None";"378.44";"1";"5.13";"20";"Cc1cccc(C(=O)Nc2nc3ccccc3c3cn(-c4ccccc4)nc23)c1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1013711";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of CI-IB-MECA-mediated inhibition of cAMP accumulation by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152204";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1258170";"";"None";"465.51";"1";"5.55";"15";"COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258396";"";"None";"435.49";"1";"5.54";"18";"Cc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258505";"";"None";"457.53";"1";"5.76";"20";"COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2C2CCCCC2)c(C(=O)O)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258506";"";"None";"485.93";"1";"5.89";"21";"COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2Cl)c(C(=O)O)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258622";"";"None";"489.46";"1";"6.25";"23";"Cc1ccccc1-n1nc(C(F)(F)F)c(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL123144";"";"None";"371.24";"0";"3.77";"19";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(Br)cc3)nn12";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"23.49";"0.52";"4.95";"12.15";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL331111";"";"None";"322.37";"0";"3.02";"9a-2(6)";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(OC)cc3)nn12";"IC50";"'<'";"0.1";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL644555";"Binding affinity for human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL126061";"";"None";"322.37";"0";"3.02";"9b-2";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(OC)cc3)nn12";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644555";"Binding affinity for human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL121339";"";"None";"326.79";"0";"3.66";"17";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(Cl)cc3)nn12";"IC50";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"28.73";"0.56";"5.73";"13.08";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL414804";"OXALIPLATIN";"4.0";"395.27";"None";"None";"OXALIPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL428880";"CROMOLYN";"4.0";"468.37";"0";"2.11";"CROMOLYN";"O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL61";"PODOFILOX";"4.0";"414.41";"0";"2.41";"PODOPHYLLOTOXIN";"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL472";"GLYBURIDE";"4.0";"494.01";"0";"3.64";"GLYBURIDE";"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200993";"GALLAMINE TRIETHIODIDE";"4.0";"891.54";"2";"5.45";"GALLAMINE TRIETHIODIDE";"CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119443";"ERGONOVINE";"4.0";"325.41";"0";"1.53";"ERGONOVINE";"C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL808";"ECONAZOLE";"4.0";"381.69";"1";"5.80";"ECONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"'='";"3249.0";"nM";"5.49";"";"";"UO_0000065";"14.38";"0.31";"-0.31";"20.29";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1162";"NORETHINDRONE";"4.0";"298.43";"0";"3.49";"NORETHINDRONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL92401";"IPRONIAZID";"4.0";"179.22";"0";"0.72";"IPRONIAZID";"CC(C)NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1428";"NIMODIPINE";"4.0";"418.45";"0";"2.97";"NIMODIPINE";"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL210383";"";"None";"511.58";"1";"1.88";"13";"Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5cccc(F)c5)CC4)cc3)cc2n(C)c1=O";"IC50";"'='";"8888.0";"nM";"5.05";"";"";"UO_0000065";"9.87";"0.19";"3.17";"5.03";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL643";"PROMETHAZINE";"4.0";"284.43";"0";"4.24";"PROMETHAZINE";"CC(CN1c2ccccc2Sc2ccccc21)N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL487894";"DIPYRONE SODIUM";"None";"333.35";"0";"0.77";"DIPYRONE";"Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL86304";"MOCLOBEMIDE";"4.0";"268.74";"0";"1.40";"MOCLOBEMIDE";"O=C(NCCN1CCOCC1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909071";"";"None";"None";"None";"None";"NOVARTIS P-38 INHIBITOR";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201203";"BENZTROPINE";"4.0";"307.44";"0";"4.42";"BENZTROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL564201";"6-AZAURIDINE";"None";"245.19";"0";"-3.46";"AZAURIDINE";"O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1370";"BUDESONIDE";"4.0";"430.54";"0";"2.72";"BUDESONIDE";"CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL526";"PROPOFOL";"4.0";"178.27";"0";"3.64";"PROPOFOL";"CC(C)c1cccc(C(C)C)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1601669";"ALFACALCIDOL";"4.0";"400.65";"1";"6.59";"ALFACALCIDOL";"C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL940";"GABAPENTIN";"4.0";"171.24";"0";"1.37";"GABAPENTIN";"NCC1(CC(=O)O)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200845";"HALCINONIDE";"4.0";"454.97";"0";"3.89";"HALCINONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1730";"CEFOTAXIME";"4.0";"455.47";"1";"-0.62";"CEFOTAXIME";"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL768";"ESMOLOL";"4.0";"295.38";"0";"1.53";"ESMOLOL";"COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL954";"ENCLOMIPHENE";"3.0";"405.97";"1";"6.56";"CLOMIPHENE";"CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1";"IC50";"'='";"5350.0";"nM";"5.27";"";"";"UO_0000065";"12.99";"0.25";"-1.29";"42.27";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL914";"FEXOFENADINE";"4.0";"501.67";"2";"5.51";"FEXOFENADINE";"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL44657";"ETOPOSIDE";"4.0";"588.56";"2";"1.34";"Etoposide";"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1650";"CORTISONE ACETATE";"4.0";"402.49";"0";"2.56";"CORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL49";"BUSPIRONE";"4.0";"385.51";"0";"2.09";"BUSPIRONE";"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1230813";"ALFADEX";"2.0";"972.85";"3";"-13.05";"ALPHA-CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL23";"DILTIAZEM";"4.0";"414.53";"0";"3.37";"DILTIAZEM";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1319362";"HOMATROPINE HYDROBROMIDE";"4.0";"356.26";"0";"1.89";"HOMATROPINE HYDROBROMIDE";"Br.CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL502620";"ACLARUBICIN";"3.0";"811.88";"2";"3.16";"ACLARUBICIN";"CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL500";"PINDOLOL";"4.0";"248.33";"0";"1.91";"PINDOLOL";"CC(C)NCC(O)COc1cccc2[nH]ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL131";"PREDNISOLONE";"4.0";"360.45";"0";"1.56";"Prednisolone";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL444633";"RIFABUTIN";"4.0";"847.02";"2";"4.62";"RIFABUTIN";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL506247";"TANNIC ACID";"4.0";"1701.21";"None";"None";"TANNIC ACID";"O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200545";"DIFLORASONE DIACETATE";"4.0";"494.53";"0";"2.99";"DIFLORASONE DIACETATE";"CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1586";"BECLOMETHASONE";"2.0";"408.92";"0";"2.17";"BECLOMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL972";"SELEGILINE";"4.0";"187.29";"0";"2.18";"SELEGILINE";"C#CCN(C)[C@H](C)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"SULFADIAZINE";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267345";"AMPHOTERICIN B";"4.0";"924.09";"3";"0.71";"AMPHOTERICIN B";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL305660";"EBASTINE";"4.0";"469.67";"1";"7.22";"EBASTINE";"CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"3195.3";"nM";"5.50";"";"";"UO_0000065";"11.70";"0.21";"-1.72";"18.60";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL13209";"NITRAZEPAM";"4.0";"281.27";"0";"2.38";"NITRAZEPAM";"O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1276308";"MIFEPRISTONE";"4.0";"429.60";"1";"5.41";"MIFEPRISTONE";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL24944";"TRIBROMSALAN";"4.0";"449.92";"0";"4.93";"TRIBROMSALAN";"O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL27577";"SALICYLAMIDE";"2.0";"137.14";"0";"0.49";"SALICYLAMIDE";"NC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL165790";"IPRIFLAVONE";"2.0";"280.32";"0";"4.25";"IPRIFLAVONE";"CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL559147";"Y-27632";"None";"247.34";"0";"2.17";"Y-27632";"C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL116903";"";"None";"351.36";"0";"-1.24";"7";"OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"27.54";"nM";"7.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3772952";"Agonist activity at human Adenosine A3 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769381";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307512";"";"";""
"CHEMBL3770310";"";"None";"392.42";"0";"-1.09";"21";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"2.291";"nM";"8.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3772952";"Agonist activity at human Adenosine A3 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769381";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307512";"";"";""
"CHEMBL125647";"";"None";"282.31";"0";"2.60";"14";"CCCCc1nc2[nH]cnc2c2nc(-c3ccco3)nn12";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"29.15";"0.54";"5.63";"9.69";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL326538";"";"None";"457.53";"0";"4.54";"22";"O=C(OCc1cccc(Oc2ccccc2)c1)N1CCC2(CC1)C(=O)NCN2c1ccccc1";"IC50";"'='";"1510.0";"nM";"5.82";"";"";"UO_0000065";"12.72";"0.23";"1.28";"8.19";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL326263";"";"None";"503.59";"2";"5.75";"2";"N#Cc1ccc(CCOC(=O)N2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1";"IC50";"'='";"3480.0";"nM";"5.46";"";"";"UO_0000065";"10.84";"0.20";"-0.29";"9.65";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL428377";"";"None";"497.29";"0";"1.31";"20";"CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NCc3cccc(I)c3)ncnc21";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL1258850";"";"None";"453.48";"1";"5.68";"26";"Cc1ccccc1-n1nc(C)c(-c2cc(F)c3nccnc3c2)c1Nc1ccccc1C(=O)O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL72613";"";"None";"593.62";"2";"2.32";"4";"CO/C(=C\c1ccc(O)cc1)C(=O)O[C@@H]1[C@H](OC(=O)/C=C/c2c[nH]cn2)[C@@H](CSC)O[C@H]1n1cnc2c(N)ncnc21";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644503";"Inhibition of forskolin-stimulated cAMP accumulation in chinese hamster ovary cell membranes expressing human adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"ovary";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148450";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL212528";"";"None";"483.55";"0";"1.99";"25";"CCCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCc4ccc(OC)cn4)cc3)cc2n(C)c1=O";"IC50";"'='";"7600.0";"nM";"5.12";"";"";"UO_0000065";"10.59";"0.21";"3.13";"4.00";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL83668";"TOLNAFTATE";"4.0";"307.42";"0";"4.95";"TOLNAFTATE";"Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL468";"THALIDOMIDE";"4.0";"258.23";"0";"0.09";"THALIDOMIDE";"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL324735";"";"None";"374.36";"0";"2.92";"1";"Cn1cc2c(nc(NC(=O)Nc3ccccc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"23.18";"0.42";"5.76";"7.53";"0";"CHEMBL644504";"Inhibitory activity against Human Adenosine A3 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135541";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL599";"MELOXICAM";"4.0";"351.41";"0";"1.95";"MELOXICAM";"Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL406";"INDAPAMIDE";"4.0";"365.84";"0";"2.08";"INDAPAMIDE";"CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1068";"OXCARBAZEPINE";"4.0";"252.27";"0";"2.64";"OXCARBAZEPINE";"NC(=O)N1c2ccccc2CC(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL574212";"";"None";"1125.79";"None";"None";"18";"CCN1/C(=C\C=C\C=C\C2=[N+](CCCCCC(=O)NCCNC(=O)CCC#Cc3nc(NCc4cccc(Cl)c4)c4ncn([C@H]5[C@H](O)[C@H](O)[C@@]6(C(=O)NC)C[C@H]56)c4n3)c3ccccc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)[O-])ccc21";"IC50";"'='";"1.09";"nM";"8.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1053707";"Agonist activity at human recombinant adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production treated 45 mins before forskolin challenge measured after 15 mins by radioimmunoassay relative to NECA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154768";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL221886";"SISOMICIN";"3.0";"447.53";"2";"-3.85";"SISOMICIN";"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL469";"KETOROLAC";"4.0";"255.27";"0";"2.29";"KETOROLAC";"O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL154";"NAPROXEN";"4.0";"230.26";"0";"3.04";"NAPROXEN";"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1400945";"PREGNENOLONE CARBONITRILE ";"None";"341.50";"0";"4.26";"PREGNENOLONE-16ALPHA-CARBONITRILE";"CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL81977";"3-AMINOBENZAMIDE";"None";"136.15";"0";"0.37";"3-AMINOBENZAMIDE";"NC(=O)c1cccc(N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL838";"BENAZEPRIL";"4.0";"424.50";"0";"2.57";"BENAZEPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL844";"BRIMONIDINE";"4.0";"292.14";"0";"1.76";"BRIMONIDINE";"Brc1c(NC2=NCCN2)ccc2nccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL24";"ATENOLOL";"4.0";"266.34";"0";"0.45";"ATENOLOL";"CC(C)NCC(O)COc1ccc(CC(N)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL420";"GUANABENZ";"4.0";"231.09";"0";"1.81";"GUANABENZ";"N=C(N)N/N=C/c1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1527608";"DOXOFYLLINE";"3.0";"266.26";"0";"-1.19";"DOXOFYLLINE";"Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1670";"MITOTANE";"4.0";"320.05";"1";"5.93";"MITOTANE";"Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1";"IC50";"'='";"7445.0";"nM";"5.13";"";"";"UO_0000065";"16.02";"0.39";"-0.80";"None";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119385";"NEFLAMAPIMOD";"2.0";"436.27";"1";"5.49";"VX-745";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"IC50";"'='";"8547.0";"nM";"5.07";"";"";"UO_0000065";"11.62";"0.25";"-0.42";"10.72";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL648";"CYCLIZINE";"4.0";"266.39";"0";"3.02";"CYCLIZINE";"CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201220";"DIATRIZOIC ACID";"4.0";"613.91";"1";"3.12";"DIATRIZOIC ACID";"CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1042";"CHOLECALCIFEROL";"4.0";"384.65";"1";"7.62";"CHOLECALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1515";"METHIMAZOLE";"4.0";"114.17";"0";"0.71";"METHIMAZOLE";"Cn1ccnc1S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2042300";"";"None";"506.36";"1";"0.58";"8c";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(Br)cc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"259.0";"nM";"6.59";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2042307";"";"None";"686.61";"1";"4.24";"9c";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(Br)cc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"149.0";"nM";"6.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2042308";"";"None";"839.05";"4";"7.33";"16a";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)cc(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"1390.0";"nM";"5.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL498847";"SECNIDAZOLE";"4.0";"185.18";"0";"0.48";"SECNIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CC(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800789";"";"None";"417.47";"0";"2.97";"36";"C=CCN1C(=O)N2CC(C)N=C2c2[nH]c(-c3cc(OCc4ccccc4)nn3C)nc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL193482";"ESTRIOL";"4.0";"288.39";"0";"2.58";"ESTRIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL493";"BROMOCRIPTINE";"4.0";"654.61";"1";"3.19";"BROMOCRIPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909075";"";"None";"None";"None";"None";"QUINOLONE, CHEMI-LINZ ; CYANAMID";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1210154";"";"None";"336.42";"1";"5.39";"10i";"C/C(=N\OC(=O)Nc1ccccc1)c1cccc(-c2cccs2)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"26.75";"0.51";"3.61";"17.75";"0";"CHEMBL1212463";"Displacement of [3H]AB-MECA from human recombinant A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208724";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3307715";"";"";""
"CHEMBL1258730";"";"None";"449.51";"1";"5.80";"24";"CCc1nn(-c2ccccc2C)c(Nc2ccccc2C(=O)O)c1-c1ccc2nccnc2c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1909076";"";"None";"270.38";"0";"1.21";"S-(N-BENZYLTHIOCARBAMOYL)-L-CYSTEINE";"N[C@H](CSC(=S)NCc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1539";"SULFADOXINE";"4.0";"310.34";"0";"0.88";"SULFADOXINE";"COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL227934";"STRYCHNINE";"-1.0";"334.42";"0";"2.09";"STRYCHNINE";"O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL340978";"BENOXAPROFEN";"4.0";"301.73";"0";"4.34";"BENOXAPROFEN";"CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1306";"TERCONAZOLE";"4.0";"532.47";"1";"4.46";"TERCONAZOLE";"CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1065";"METHYSERGIDE";"None";"353.47";"0";"1.94";"METHYSERGIDE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1568";"FLUDARABINE";"None";"285.24";"0";"-1.84";"FLUDARABINE";"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL211501";"ANTIMYCIN A";"None";"548.63";"1";"3.48";"ANTIMYCIN A";"CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19215";"METERGOLINE";"4.0";"403.53";"0";"4.06";"METERGOLINE";"CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL54126";"NEOSTIGMINE BROMIDE";"4.0";"303.20";"0";"1.94";"NEOSTIGMINE BROMIDE";"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267894";"AMOBARBITAL";"4.0";"226.28";"0";"1.18";"AMOBARBITAL";"CCC1(CCC(C)C)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1282";"IMIQUIMOD";"4.0";"240.31";"0";"2.82";"IMIQUIMOD";"CC(C)Cn1cnc2c(N)nc3ccccc3c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL496";"HEXACHLOROPHENE";"4.0";"406.91";"1";"6.61";"HEXACHLOROPHENE";"Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl";"IC50";"'='";"638.9";"nM";"6.20";"";"";"UO_0000065";"15.22";"0.40";"-0.42";"15.31";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1536";"ERGOCALCIFEROL";"4.0";"396.66";"1";"7.64";"ERGOCALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201146";"NORETHINDRONE ACETATE";"4.0";"340.46";"0";"4.06";"NORETHINDRONE ACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL435";"HYDROCHLOROTHIAZIDE";"4.0";"297.75";"0";"-0.35";"HYDROCHLOROTHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL25";"ASPIRIN";"4.0";"180.16";"0";"1.31";"ASPIRIN";"CC(=O)Oc1ccccc1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1487";"ATORVASTATIN";"4.0";"558.65";"2";"6.31";"ATORVASTATIN";"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL36994";"ANIRACETAM";"2.0";"219.24";"0";"1.46";"ANIRACETAM";"COc1ccc(C(=O)N2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL900";"ORPHENADRINE";"4.0";"269.39";"0";"3.66";"ORPHENADRINE";"Cc1ccccc1C(OCCN(C)C)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4";"OFLOXACIN";"4.0";"361.37";"0";"1.54";"3";"CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL621";"TRAZODONE";"4.0";"371.87";"0";"2.36";"TRAZODONE";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL242273";"SAFROLE";"-1.0";"162.19";"0";"2.14";"SAFROLE";"C=CCc1ccc2c(c1)OCO2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL553025";"VINORELBINE";"4.0";"778.95";"2";"4.75";"VINORELBINE";"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"TERFENADINE";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL438";"SULFAMERAZINE";"4.0";"264.31";"0";"1.17";"SULFAMERAZINE";"Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL852";"MELPHALAN";"4.0";"305.21";"0";"1.93";"MELPHALAN";"N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL277474";"ANTIPYRINE";"4.0";"188.23";"0";"1.48";"ANTIPYRINE";"Cc1cc(=O)n(-c2ccccc2)n1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL508102";"CARBIMAZOLE";"4.0";"186.24";"0";"1.56";"CARBIMAZOLE";"CCOC(=O)n1ccn(C)c1=S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL95";"TACRINE";"4.0";"198.27";"0";"2.70";"TACRINE";"Nc1c2c(nc3ccccc13)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1070";"NABUMETONE";"4.0";"228.29";"0";"3.37";"NABUMETONE";"COc1ccc2cc(CCC(C)=O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL84158";"TIAPRIDE";"3.0";"328.43";"0";"1.17";"TIAPRIDE";"CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1679";"LEUCOVORIN";"4.0";"473.45";"1";"-0.73";"LEUCOVORIN";"Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL269732";"TACROLIMUS ANHYDROUS";"4.0";"804.03";"2";"4.64";"TACROLIMUS";"C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL720";"BENZYL ALCOHOL";"4.0";"108.14";"0";"1.18";"BENZYL ALCOHOL";"OCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL15770";"SULINDAC";"4.0";"356.42";"0";"4.37";"SULINDAC";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19224";"PAPAVERINE";"4.0";"339.39";"0";"3.86";"PAPAVERINE";"COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL20883";"TEGAFUR";"4.0";"200.17";"0";"-0.02";"TEGAFUR";"O=c1[nH]c(=O)n(C2CCCO2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL56367";"NIMESULIDE";"4.0";"308.31";"0";"2.76";"NIMESULIDE";"CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL118";"CELECOXIB";"4.0";"381.38";"0";"3.51";"CELECOXIB";"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1";"IC50";"'='";"24622.0";"nM";"4.61";"";"";"UO_0000065";"12.08";"0.24";"1.10";"5.91";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1517";"OXYTETRACYCLINE";"4.0";"460.44";"1";"-1.24";"OXYTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL127";"MEROPENEM";"4.0";"383.47";"0";"-0.31";"meropenem";"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL476";"DACARBAZINE";"4.0";"182.19";"0";"0.07";"DACARBAZINE";"CN(C)/N=N/c1[nH]cnc1C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909056";"COBALT(II) ACETYLACETONATE";"None";"257.15";"None";"None";"COBALT(II) ACETYLACETONATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1055";"CHLORTHALIDONE";"4.0";"338.77";"0";"0.92";"CHLORTHALIDONE";"NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1771";"CLOPIDOGREL";"4.0";"321.83";"0";"3.67";"CLOPIDOGREL";"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL659";"GALANTAMINE";"4.0";"287.36";"0";"1.85";"GALANTAMINE";"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL727";"THIOGUANINE";"4.0";"167.20";"0";"0.60";"THIOGUANINE";"Nc1nc2[nH]cnc2c(=S)[nH]1";"IC50";"'='";"21687.0";"nM";"4.66";"";"";"UO_0000065";"27.89";"0.58";"4.06";"5.59";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL515";"CHLORAMBUCIL";"4.0";"304.22";"0";"3.38";"CHLORAMBUCIL";"O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL788";"IDOXURIDINE";"4.0";"354.10";"0";"-1.22";"IDOXURIDINE";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL30";"CIMETIDINE";"4.0";"252.35";"0";"0.60";"CIMETIDINE";"CN/C(=N\CCSCc1nc[nH]c1C)NC#N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200604";"TROPICAMIDE";"4.0";"284.36";"0";"2.21";"SID90341160";"CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL254219";"DIGITOXIN";"4.0";"764.95";"2";"3.25";"DIGITOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL545";"ALCOHOL";"4.0";"46.07";"0";"0.00";"ETHANOL";"CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL650";"METHYLPREDNISOLONE";"4.0";"374.48";"0";"1.80";"METHYLPREDNISOLONE";"C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1333512";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"None";"260.34";"1";"5.17";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL211071";"";"None";"565.65";"1";"2.34";"27";"CCCn1c(=O)n(C)c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccc6c(c5)OCO6)CC4)cc3)cc21";"IC50";"'='";"14860.0";"nM";"4.83";"";"";"UO_0000065";"8.54";"0.16";"2.49";"4.06";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL101168";"";"None";"134.14";"0";"0.15";"1-AMINOBENZOTRIAZOLE";"Nn1nnc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL139835";"CYPROTERONE ACETATE";"4.0";"416.95";"0";"4.61";"CYPROTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12";"DIAZEPAM";"4.0";"284.75";"0";"3.15";"diazepam";"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL316561";"PROGLUMIDE";"4.0";"334.42";"0";"2.30";"PROGLUMIDE";"CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"CLOZAPINE";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1463";"FLUCYTOSINE";"4.0";"129.09";"0";"-0.51";"FLUCYTOSINE";"Nc1nc(=O)[nH]cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL945";"AMILORIDE";"4.0";"229.63";"0";"-1.08";"AMILORIDE";"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1454946";"FLUBENDAZOLE";"2.0";"313.29";"0";"3.11";"FLUBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL49080";"CLENBUTEROL";"4.0";"277.19";"0";"3.00";"CLENBUTEROL";"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"FLUNARIZINE";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"IC50";"'='";"5198.0";"nM";"5.28";"";"";"UO_0000065";"13.06";"0.24";"-0.11";"81.55";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL181";"DIAZOXIDE";"4.0";"230.68";"0";"1.68";"DIAZOXIDE";"CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19299";"LOXOPROFEN";"4.0";"246.31";"0";"2.79";"LOXOPROFEN";"CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1455";"ALTRETAMINE";"4.0";"210.28";"0";"0.07";"ALTRETAMINE";"CN(C)c1nc(N(C)C)nc(N(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL188921";"BUFLOMEDIL";"4.0";"307.39";"0";"2.77";"BUFLOMEDIL";"COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL531";"PERGOLIDE";"4.0";"314.50";"0";"4.27";"PERGOLIDE";"CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL428";"TROVAFLOXACIN";"4.0";"416.36";"0";"1.89";"TROVAFLOXACIN";"N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3559671";"POLYVINYL ALCOHOL";"4.0";"None";"None";"None";"POLYVINYL ALCOHOL";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL572";"NITROFURANTOIN";"4.0";"238.16";"0";"0.07";"NITROFURANTOIN";"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL64";"ISONIAZID";"4.0";"137.14";"0";"-0.31";"Isoniazid";"NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL403";"SULBACTAM";"4.0";"233.24";"0";"-0.79";"SULBACTAM";"CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL38737";"THIOACETAMIDE";"None";"75.14";"0";"0.91";"THIOACETAMIDE";"CC(=N)S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL479";"THIORIDAZINE";"4.0";"370.59";"1";"5.89";"THIORIDAZINE";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1908355";"TENIDAP";"2.0";"320.76";"0";"3.25";"TENIDAP";"NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL434534";"";"None";"337.38";"0";"1.91";"64";"CCCn1c(=O)c2c(nc3[nH]c(C)cn32)n(Cc2ccccc2)c1=O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2181966";"";"None";"347.38";"0";"-0.44";"70";"CCCCC#Cc1nc2c(N)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL325372";"METHYLPARABEN";"-1.0";"152.15";"0";"1.18";"METHYLPARABEN";"COC(=O)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL43064";"CINNARIZINE";"4.0";"368.52";"1";"5.11";"CINNARIZINE";"C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1512";"FLUNISOLIDE";"4.0";"434.50";"0";"2.27";"FLUNISOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1451";"TRIAMCINOLONE";"4.0";"394.44";"0";"0.62";"TRIAMCINOLONE";"C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL193";"NIFEDIPINE";"4.0";"346.34";"0";"2.18";"NIFEDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"IC50";"'='";"7214.0";"nM";"5.14";"";"";"UO_0000065";"14.85";"0.28";"2.96";"4.77";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL475534";"NITRENDIPINE";"4.0";"360.37";"0";"2.57";"NITRENDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL569";"PROCAINE";"4.0";"236.31";"0";"1.77";"PROCAINE";"CCN(CC)CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12131";"CLOSANTEL";"2.0";"663.08";"2";"7.12";"CLOSANTEL";"Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O";"IC50";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"10.58";"0.32";"-0.10";"9.60";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL72";"DESIPRAMINE";"4.0";"266.39";"0";"3.53";"DESIPRAMINE";"CNCCCN1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1754";"DOXAPRAM";"4.0";"378.52";"0";"3.17";"DOXAPRAM";"CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL540445";"PARTHENOLIDE";"2.0";"248.32";"0";"2.76";"PARTHENOLIDE";"C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1460";"DIDANOSINE";"4.0";"236.23";"0";"-0.21";"SID49718183";"O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1073";"GLIPIZIDE";"4.0";"445.55";"0";"2.08";"GLIPIZIDE";"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL453";"SULFISOXAZOLE";"4.0";"267.31";"0";"1.67";"SULFISOXAZOLE";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1493";"FLAVOXATE";"4.0";"391.47";"0";"4.41";"FLAVOXATE";"Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL265587";"";"None";"506.50";"3";"-1.13";"A";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccc(S(N)(=O)=O)cc4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL826591";"Inhibition of (10 uM) forskolin-mediated cAMP production in CHO cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138800";"1";"Scientific Literature";"J Med Chem";"2004";"CHEMBL3308072";"";"";""
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"FLUOXETINE";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200624";"ETHYNODIOL DIACETATE";"4.0";"384.52";"0";"4.43";"ETHYNODIOL DIACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL125340";"";"None";"356.77";"0";"2.73";"1h";"O=C(O)CCCc1nc2[nH]cnc2c2nc(-c3ccc(Cl)cc3)nn12";"IC50";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"23.17";"0.45";"5.54";"7.58";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL372795";"STREPTOMYCIN";"4.0";"581.58";"3";"-8.16";"STREPTOMYCIN";"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1198";"PRAMOXINE";"4.0";"293.41";"0";"2.97";"PRAMOXINE";"CCCCOc1ccc(OCCCN2CCOCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL932";"DIPYRIDAMOLE";"4.0";"504.64";"2";"-0.02";"DIPYRIDAMOLE";"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL122512";"";"None";"292.35";"0";"3.01";"7";"CCCCc1nc2[nH]cnc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"0.25";"nM";"9.60";"";"";"UO_0000065";"32.84";"0.60";"6.59";"13.38";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL1201139";"MEGESTROL ACETATE";"4.0";"384.52";"0";"4.58";"MEGESTROL ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2322909";"";"None";"433.47";"0";"4.61";"28";"Cc1nc(N(C(=O)c2ccccc2)C(=O)c2ccccc2)c2nn(-c3ccccc3)cc2n1";"IC50";"'='";"115.0";"nM";"6.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2330938";"Inhibition of human A3 adenosine receptor transfected in CHO cells assessed as inhibition of forskolin-induced cyclic AMP production after 10 mins by competitive protein binding assay in presence of CI-IB-MECA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321860";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2322930";"";"None";"391.43";"0";"4.73";"15";"O=C(Nc1nc(-c2ccccc2)nc2cn(-c3ccccc3)nc12)c1ccccc1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2330938";"Inhibition of human A3 adenosine receptor transfected in CHO cells assessed as inhibition of forskolin-induced cyclic AMP production after 10 mins by competitive protein binding assay in presence of CI-IB-MECA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321860";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL44";"GENISTEIN";"2.0";"270.24";"0";"2.58";"GENISTEIN";"O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL567597";"ARTEMISININ";"4.0";"282.34";"0";"2.39";"ARTEMISININ";"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12089";"BERBERINE CHLORIDE";"1.0";"371.82";"0";"3.10";"BERBERINE CHLORIDE";"COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3215298";"ABAMECTIN";"3.0";"1732.15";"None";"None";"ABAMECTIN";"CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"'='";"870.0";"nM";"6.06";"";"";"UO_0000065";"3.50";"None";"None";"None";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL415";"CLOMIPRAMINE";"4.0";"314.86";"0";"4.53";"ChlorImipramine";"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL70927";"DEFERIPRONE";"4.0";"139.15";"0";"0.40";"DEFERIPRONE";"Cc1c(O)c(=O)ccn1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL13341";"NIMETAZEPAM";"2.0";"295.30";"0";"2.41";"NIMETAZEPAM";"CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2106399";"KITASAMYCIN";"2.0";"785.97";"2";"2.44";"KITASAMYCIN";"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL123310";"";"None";"230.28";"0";"1.65";"11";"CCCCc1nc2[nH]cnc2c2nc(C)nn12";"IC50";"'='";"610.0";"nM";"6.21";"";"";"UO_0000065";"26.99";"0.50";"4.56";"8.66";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL2181977";"";"None";"471.47";"1";"5.17";"37";"Cc1ccc(-c2nc(NC(=O)Nc3ccc(F)cc3)c3nnn(Cc4ccccc4F)c3n2)cc1";"IC50";"'='";"148.0";"nM";"6.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL117405";"";"None";"248.33";"0";"1.91";"(S)-(-)-PINDOLOL";"CC(C)NC[C@H](O)COc1cccc2[nH]ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL894";"BUPROPION";"4.0";"239.75";"0";"3.30";"BUPROPION";"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1598608";"AZASETRON";"2.0";"349.82";"0";"1.52";"AZASETRON";"CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800788";"";"None";"405.46";"0";"2.80";"35";"CCC1CN2C(=O)N(Cc3ccccc3)c3nc(-c4cc(OC)nn4C)[nH]c3C2=N1";"IC50";"'='";"20.4";"nM";"7.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1480987";"CYCLANDELATE";"4.0";"276.38";"0";"3.48";"CYCLANDELATE";"CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL44618";"CHLOROFORM";"4.0";"119.38";"0";"1.99";"CHLOROFORM";"ClC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2071039";"";"None";"452.48";"0";"1.59";"21";"CCNC(=O)N1CCC(NC(=O)Nc2nc3nn(C)cc3c3nc(-c4ccco4)nn23)CC1";"IC50";"'='";"116.0";"nM";"6.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL179166";"SODIUM ORTHOVANAD";"None";"183.91";"None";"None";"SODIUM ORTHOVANADATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL34259";"METHOTREXATE";"4.0";"454.45";"0";"0.27";"METHOTREXATE";"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3952824";"";"None";"380.50";"0";"4.55";"BDBM177999";"CCc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1";"IC50";"'='";"360.8";"nM";"6.44";"";"323831";"UO_0000065";"";"";"";"";"0";"CHEMBL3887222";"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886219";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL408";"TROGLITAZONE";"4.0";"441.55";"0";"4.37";"TROGLITAZONE";"Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2";"IC50";"'='";"5208.0";"nM";"5.28";"";"";"UO_0000065";"11.97";"0.23";"0.91";"6.23";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2070880";"";"None";"381.40";"0";"1.14";"5";"Cn1cc2c(nc(NC(=O)NC3CCNCC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"262.0";"nM";"6.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1258731";"";"None";"421.46";"1";"5.23";"25";"Cc1ccccc1-n1ncc(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL462547";"URETHANE";"4.0";"89.09";"0";"0.10";"URETHANE";"CCOC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3770679";"";"None";"482.54";"0";"1.13";"20";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"269.15";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3772952";"Agonist activity at human Adenosine A3 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769381";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307512";"";"";""
"CHEMBL1096754";"";"None";"329.36";"0";"3.28";"2a";"Cn1cc2c(NC(=O)c3ccccc3)nc(-c3ccccc3)nc2n1";"IC50";"'='";"0.74";"nM";"9.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120806";"Antagonist activity at adenosine A3 receptor in human U87MG cells assessed as inhibition of Cl-IB-MECA-mediated ERK1/2 phosphorylation after 30 mins by ELISA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87MG ATCC";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157749";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307575";"";"";""
"CHEMBL211862";"";"None";"546.54";"1";"4.72";"47";"COc1ccc(-n2nc3c(NC(=O)C(c4ccccc4)c4ccccc4)nc4c([N+](=O)[O-])cccc4n3c2=O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2181975";"";"None";"249.29";"0";"2.17";"29";"COc1ccc(-c2nsc(NC(C)=O)n2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1800737";"";"None";"375.44";"0";"2.71";"30";"Cc1cc(-c2nc3c([nH]2)C2=NC(C)CN2C(=O)N3Cc2ccccc2)n(C)n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800739";"";"None";"389.46";"0";"3.10";"R-31";"CC[C@@H]1CN2C(=O)N(Cc3ccccc3)c3nc(-c4cc(C)nn4C)[nH]c3C2=N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL3751978";"";"None";"387.42";"0";"4.39";"27";"O=C(Nc1nc(-c2cccs2)nc2cn(-c3ccccc3)nc12)c1ccco1";"IC50";"'='";"5.47";"nM";"8.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3753544";"";"None";"451.49";"0";"4.75";"32";"COc1ccc(C(=O)Nc2nc(-c3ccc(OC)cc3)nc3cn(-c4ccccc4)nc23)cc1";"IC50";"'='";"4.27";"nM";"8.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL141550";"";"None";"439.26";"1";"5.49";"40";"O=C(Nc1cccc(Cl)c1)Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644491";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL499815";"ATRACTYLOSIDE";"None";"803.00";"2";"1.67";"ATRACTYLOSIDE";"C=C1[C@@H]2CCC3[C@@](CC[C@@H]4[C@H](C(=O)O)C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@]34C)(C2)[C@@H]1O.[K+].[K+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL122928";"";"None";"306.37";"0";"2.93";"12";"CCCCc1nc2[nH]cnc2c2nc(Cc3ccccc3)nn12";"IC50";"'='";"680.0";"nM";"6.17";"";"";"UO_0000065";"20.13";"0.37";"3.24";"8.59";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL265096";"";"None";"522.56";"2";"6.00";"25, MRS1334";"CCO/C(O)=C1\C(C)=NC(c2ccccc2)=C(C(=O)OCc2ccc([N+](=O)[O-])cc2)C1C#Cc1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3939800";"";"None";"349.37";"0";"3.63";"BDBM214689";"Cc1cc(Nc2nc([C@@H](O)c3ccc(F)cc3)nc3ccccc23)n[nH]1";"IC50";"'='";"1.55";"nM";"8.81";"";"312380";"UO_0000065";"25.22";"0.46";"5.18";"10.16";"0";"CHEMBL3887155";"Adenosine A3 Receptor Radioligand Binding Assay: .(R)- and (S)-(4-Fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol was tested in a radioligand binding assay, according to the procedure described in Olah et al., Mol. Pharmacol. 1994, 45, 978-982 and Salvatore et al., Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10365-10369, in human recombinant CHO-K1 cells expressing the human adenosine A3 receptor. Incubations of a range of concentration of each compound were carried out in duplicates for 1 h at 25° C. in 25 mM HEPES, pH 7.4, 5 mM MgCl2, 1 mM CaCl2, 0.1% BSA, in the presence of 0.5 nM [125I] AB-MECA. Non-specific binding was determined in the presence of 1 uM IB-MECA.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886191";"37";"BindingDB Database";"";"2016";"CHEMBL3307512";"";"";""
"CHEMBL1902981";"EPERISONE";"3.0";"259.39";"0";"3.55";"EPERISONE";"CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL122037";"";"None";"326.79";"0";"3.66";"2f";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(Cl)cc3)nn12";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"25.43";"0.49";"4.65";"11.58";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL1098108";"";"None";"359.39";"0";"3.29";"2b";"COc1ccc(C(=O)Nc2nc(-c3ccccc3)nc3nn(C)cc23)cc1";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120804";"Antagonist activity human recombinant adenosine A3 receptor expressed in CHO cells assessed as blockade of NECA-mediated inhibition of forskolin-stimulated [3H]cAMP production treated 15 mins before NECA challenge measured after 30 mins by liquid scintillation spectrometry";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157749";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1501";"FLUOCINONIDE";"4.0";"494.53";"0";"2.94";"FLUOCINONIDE";"CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL63560";"(R)-BICALUTAMIDE";"None";"430.38";"0";"2.88";"(R)-BICALUTAMIDE";"C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL420499";"";"None";"497.64";"1";"5.27";"48";"COc1ccc(CN2CCN(C(=O)CCn3cc(C)c4ccccc43)CC2)cc1OCc1ccccc1";"IC50";"'='";"3730.0";"nM";"5.43";"";"";"UO_0000065";"10.91";"0.20";"0.16";"11.56";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL4522981";"";"None";"433.45";"0";"2.10";"8; BAY-545";"CCn1c(=O)c2c(C)c(C(=O)N3CCC(O)CC3)sc2n(CCC(F)(F)F)c1=O";"IC50";"'>'";"6700.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4423025";"Antagonist activity at recombinant human A3 adenosine receptor expressed in CHO cells after 3 to 4 hrs by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422615";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308072";"";"";""
"CHEMBL1200656";"NATAMYCIN";"4.0";"665.73";"3";"0.12";"PIMARICIN";"C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL113";"CAFFEINE";"4.0";"194.19";"0";"-1.03";"CAFFEINE";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2070888";"";"None";"505.97";"1";"3.71";"13";"Cn1cc2c(nc(NC(=O)NC3CCN(Cc4ccc(Cl)cc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"91.0";"nM";"7.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1054";"TRICHLORMETHIAZIDE";"4.0";"380.66";"0";"0.82";"TRICHLORMETHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267744";"TICRYNAFEN";"4.0";"331.18";"0";"3.75";"TICRYNAFEN";"O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL124137";"";"None";"278.32";"0";"2.62";"2b";"CCCc1nc2[nH]ncc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"30.14";"0.55";"5.77";"11.69";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"IB-MECA";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"16.86";"0.41";"8.19";"6.40";"0";"CHEMBL982005";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155111";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL388590";"BENZBROMARONE";"4.0";"424.09";"1";"5.46";"BENZBROMARONE";"CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1";"IC50";"'='";"5222.0";"nM";"5.28";"";"";"UO_0000065";"12.46";"0.33";"-0.18";"10.47";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1518";"PROPYLTHIOURACIL";"4.0";"170.24";"0";"1.38";"PROPYLTHIOURACIL";"CCCc1cc(=O)[nH]c(=S)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL293492";"CINNAMALDEHYDE";"-1.0";"132.16";"0";"1.90";"CINNAMALDEHYDE";"O=C/C=C/c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL110691";"CHLORMADINONE ACETATE";"4.0";"404.93";"0";"4.75";"CHLORMADINONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200585";"OXYMETHOLONE";"4.0";"332.48";"0";"4.40";"OXYMETHOLONE";"C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL188035";"";"None";"275.31";"0";"3.59";"45";"Cc1ccc(-n2cc3c(O)nc4ccccc4c3n2)cc1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1447";"LINCOMYCIN";"4.0";"406.55";"0";"-0.86";"LINCOMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1902627";"CLORPRENALINE";"-1.0";"213.71";"0";"2.37";"CLORPRENALINE";"CC(C)NCC(O)c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL330873";"";"None";"264.29";"0";"2.23";"5";"CCc1nc2[nH]cnc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"0.45";"nM";"9.35";"";"";"UO_0000065";"35.37";"0.64";"7.12";"13.03";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL371404";"";"None";"350.42";"0";"2.63";"65";"CCCn1c(=O)c2c(nc3n2CC(CC)=C3)n(Cc2ccccc2)c1=O";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL116463";"";"None";"517.62";"2";"6.18";"46";"N#Cc1ccc(CCOC(=O)NC2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1";"IC50";"'='";"5980.0";"nM";"5.22";"";"";"UO_0000065";"10.09";"0.19";"-0.96";"7.99";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL2070889";"";"None";"485.55";"0";"3.37";"14";"Cc1ccc(CN2CCC(NC(=O)Nc3nc4nn(C)cc4c4nc(-c5ccco5)nn34)CC2)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2070891";"";"None";"496.54";"0";"2.93";"16";"Cn1cc2c(nc(NC(=O)NC3CCN(Cc4ccc(C#N)cc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1386";"TRANSPLATIN";"3.0";"300.05";"None";"None";"TRANS-PLATINUM(II)DIAMMINE DICHLORIDE";"";"IC50";"'='";"989.1";"nM";"6.00";"";"";"UO_0000065";"20.01";"None";"None";"None";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1351";"CARBOPLATIN";"4.0";"371.25";"None";"None";"SID568180";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1762";"TOCAINIDE";"4.0";"192.26";"0";"1.59";"TOCAINIDE";"Cc1cccc(C)c1NC(=O)C(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL126150";"";"None";"371.24";"0";"3.77";"2h";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(Br)cc3)nn12";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"20.80";"0.46";"3.95";"10.76";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL121339";"";"None";"326.79";"0";"3.66";"1b";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(Cl)cc3)nn12";"IC50";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"28.73";"0.56";"5.73";"13.08";"1";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL1236282";"THIAMPHENICOL";"2.0";"356.23";"0";"0.40";"THIAMPHENICOL";"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL504";"DIMETHYL SULFOXIDE";"4.0";"78.14";"0";"-0.01";"DIMETHYL SULFOXIDE";"C[S+](C)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2322907";"";"None";"421.46";"0";"4.74";"26";"COc1ccc(-n2cc3nc(-c4ccccc4)nc(NC(=O)c4ccccc4)c3n2)cc1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2330938";"Inhibition of human A3 adenosine receptor transfected in CHO cells assessed as inhibition of forskolin-induced cyclic AMP production after 10 mins by competitive protein binding assay in presence of CI-IB-MECA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321860";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL4128926";"";"None";"583.78";"2";"5.76";"1j";"CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12";"IC50";"'='";"0.17";"nM";"9.77";"";"";"UO_0000065";"16.73";"0.33";"4.01";"7.79";"0";"CHEMBL4121467";"Displacement of [125I]AB-MECA from human recombinant adenosine A3 receptor after 120 mins by scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118122";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL16";"PHENYTOIN";"4.0";"252.27";"0";"1.77";"PHENYTOIN";"O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL566534";"ARTEMETHER";"4.0";"298.38";"0";"2.84";"ARTEMETHER";"CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4088238";"";"None";"447.93";"0";"1.97";"10";"Cc1cc(C)n(C[C@H]2O[C@@H](n3cnc4c(NC5CCCC5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1";"IC50";"'='";"1910.0";"nM";"5.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4027925";"Antagonist activity at recombinant human adenosine A3 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase in presence of [alpha-31P]ATP";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024784";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL404811";"DIGITONIN";"None";"1229.32";"None";"None";"DIGITONIN";"C[C@@H]1CC[C@@]2(OC1)O[C@H]1[C@@H](O)[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O[C@@H]7O[C@H](CO)C(O)[C@H](O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL437";"SULFATHIAZOLE";"4.0";"255.32";"0";"1.53";"SULFATHIAZOLE";"Nc1ccc(S(=O)(=O)Nc2nccs2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL122";"ROFECOXIB";"4.0";"314.36";"0";"2.56";"rofecoxib";"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1935747";"";"None";"403.40";"0";"3.53";"9a";"COc1ccc(NC(=O)Nc2nc3cn(C)cc3c3nc(-c4ccco4)nn23)cc1";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1936208";"Antagonist activity at human adenosine A3 receptor expressed in forskolin-stimulated CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1932966";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL583";"GREPAFLOXACIN";"4.0";"359.40";"0";"2.28";"GREPAFLOXACIN";"Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL611";"TERAZOSIN";"4.0";"387.44";"0";"1.06";"TERAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL56564";"TROPISETRON";"4.0";"284.36";"0";"2.95";"TROPISETRON";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1c[nH]c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL21731";"MAPROTILINE";"4.0";"277.41";"0";"4.21";"MAPROTILINE";"CNCCCC12CCC(c3ccccc31)c1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1456";"MYCOPHENOLATE MOFETIL";"4.0";"433.50";"0";"2.52";"MYCOPHENOLATE MOFETIL";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2071048";"";"None";"528.58";"1";"3.08";"31";"Cc1ccc(CNC(=O)N2CCC(NC(=O)Nc3nc4nn(C)cc4c4nc(-c5ccco5)nn34)CC2)cc1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL115076";"";"None";"443.89";"0";"3.13";"19";"O=C(OCc1cc2c(cc1Cl)OCO2)N1CCC2(CC1)C(=O)NCN2c1ccccc1";"IC50";"'='";"5470.0";"nM";"5.26";"";"";"UO_0000065";"11.85";"0.23";"2.13";"6.55";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL2042311";"";"None";"492.51";"0";"1.57";"18";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(F)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"7.04";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3753507";"";"None";"398.45";"0";"4.19";"30";"O=C(Nc1nc(-c2cccs2)nc2cn(-c3ccccc3)nc12)c1ccncc1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3753976";"";"None";"481.49";"1";"5.22";"34";"O=C(c1ccco1)N(C(=O)c1ccco1)c1nc(-c2cccs2)nc2cn(-c3ccccc3)nc12";"IC50";"'='";"4.37";"nM";"8.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL332091";"";"None";"375.35";"0";"2.31";"52, MRE-3005-F20";"Cn1cc2c(nc(NC(=O)Nc3ccncc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL422820";"";"None";"494.52";"0";"4.63";"9";"COc1ccc(NC(=O)Nc2nc3nn(CCc4ccccc4)cc3c3nc(-c4ccco4)nn23)cc1";"IC50";"'='";"12.4";"nM";"7.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644508";"Inhibitory concentration as antagonistic activity against cAMP generation inhibited by IB-MECA in CHO cell membranes transfected with human A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132457";"1";"Scientific Literature";"J Med Chem";"1999";"CHEMBL3308072";"";"";""
"CHEMBL554955";"";"None";"483.92";"0";"3.36";"55";"CCNc1c2c(nc(NC(=O)Nc3ccc(OC)cc3)n3nc(-c4ccco4)nc23)nn1C.Cl";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644554";"Antagonist activity as inhibition of cAMP generation after agonist-modulation of Adenosine A3 receptor with 100 nM CI-IB-MECA";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136743";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL600325";"PROSCILLARIDIN";"4.0";"530.66";"1";"3.01";"Proscillaridin A";"C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1554";"DACTINOMYCIN";"4.0";"1255.44";"None";"None";"DACTINOMYCIN";"Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800864";"";"None";"392.42";"0";"3.05";"47";"CCC1CN2C(=O)N(Cc3ccccc3)c3nc(-c4cc(OC)no4)[nH]c3C2=N1";"IC50";"'='";"25.3";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.4898";"nM";"9.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3772952";"Agonist activity at human Adenosine A3 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769381";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307512";"";"";""
"CHEMBL196";"ASCORBIC ACID";"4.0";"176.12";"0";"-1.41";"ASCORBIC ACID";"O=C1O[C@H]([C@@H](O)CO)C(O)=C1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL660";"AMANTADINE";"4.0";"151.25";"0";"1.91";"AMANTADINE";"NC12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL195437";"4-OCTYLPHENOL";"None";"206.33";"0";"4.30";"4-OCTYLPHENOL";"CCCCCCCCc1ccc(O)cc1";"IC50";"'='";"6014.0";"nM";"5.22";"";"";"UO_0000065";"25.30";"0.48";"0.92";"25.81";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.04898";"nM";"10.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322691";"Agonist activity at wild type human A3 receptor I253'6.58A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"I253A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL787";"MONTELUKAST";"4.0";"586.20";"2";"8.95";"MONTELUKAST";"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1";"IC50";"'='";"434.0";"nM";"6.36";"";"";"UO_0000065";"10.85";"0.21";"-2.59";"9.04";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL128929";"";"None";"355.40";"0";"4.56";"33, VUF8504";"COc1ccc(C(=O)Nc2nc(-c3ccccn3)cc3ccccc23)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1385840";"ERGOCORNINE";"None";"561.68";"1";"2.04";"ERGOCORNINE";"CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL276832";"HYDRALAZINE";"4.0";"160.18";"0";"0.92";"HYDRALAZINE";"NNc1nncc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL404520";"CHLORTETRACYCLINE";"4.0";"478.89";"1";"0.44";"CHLORTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL783";"NATEGLINIDE";"4.0";"317.43";"0";"3.26";"NATEGLINIDE";"CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL8";"CIPROFLOXACIN";"4.0";"331.35";"0";"1.58";"30 Ciprofloxacin";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1726";"NISOLDIPINE";"4.0";"388.42";"0";"3.20";"NISOLDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]";"IC50";"'='";"7120.0";"nM";"5.15";"";"";"UO_0000065";"13.25";"0.25";"1.95";"4.78";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL457299";"MACROGOL";"4.0";"62.07";"0";"-1.03";"ETHYLENE GLYCOL";"OCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL716";"QUETIAPINE";"4.0";"383.52";"0";"2.86";"QUETIAPINE";"OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2181967";"";"None";"519.70";"1";"2.29";"73";"OC[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1F";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL322250";"";"None";"334.38";"0";"2.27";"61";"CCCn1c(=O)c2c(nc3ccccn32)n(Cc2ccccc2)c1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL310555";"OXYQUINOLINE";"-1.0";"145.16";"0";"1.94";"OXYQUINOLINE";"Oc1cccc2cccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1480";"FELODIPINE";"4.0";"384.26";"0";"3.96";"SID170464849";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl";"IC50";"'='";"1057.0";"nM";"5.98";"";"";"UO_0000065";"15.55";"0.33";"2.02";"9.25";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1109";"SULFAPHENAZOLE";"4.0";"314.37";"0";"2.26";"SULFAPHENAZOLE";"Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL357995";"BOPINDOLOL";"2.0";"380.49";"0";"4.47";"BOPINDOLOL";"Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1006";"AMIFOSTINE";"4.0";"214.23";"0";"-0.25";"AMIFOSTINE";"NCCCNCCSP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL330286";"";"None";"446.47";"0";"4.19";"23";"CCCCn1cc2c(nc(NC(=O)Nc3ccc(OC)cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644497";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 2.9-6.0";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL144979";"";"None";"434.84";"0";"4.84";"39";"COc1ccc(NC(=O)Nc2nc3ccc(Cl)cc3c3nc(-c4ccco4)nn23)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644492";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 1.1-3.8";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL741";"LAMOTRIGINE";"4.0";"256.10";"0";"2.01";"LAMOTRIGINE";"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3754229";"";"None";"427.49";"0";"4.80";"25";"COc1ccc(C(=O)Nc2nc(-c3cccs3)nc3cn(-c4ccccc4)nc23)cc1";"IC50";"'='";"0.11";"nM";"9.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3754475";"";"None";"411.49";"0";"4.73";"26";"O=C(Cc1ccccc1)Nc1nc(-c2cccs2)nc2cn(-c3ccccc3)nc12";"IC50";"'='";"8.45";"nM";"8.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3753642";"";"None";"398.45";"0";"4.19";"29";"O=C(Nc1nc(-c2cccs2)nc2cn(-c3ccccc3)nc12)c1cccnc1";"IC50";"'='";"1.01";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3751909";"";"None";"421.46";"0";"4.74";"31";"COc1ccc(-c2nc(NC(=O)c3ccccc3)c3nn(-c4ccccc4)cc3n2)cc1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL516966";"";"None";"368.40";"0";"4.73";"4";"Cc1ccc(C(=O)Nc2nc3ccccc3c3cn(-c4ccccc4)nc23)o1";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1013711";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of CI-IB-MECA-mediated inhibition of cAMP accumulation by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152204";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1766358";"";"None";"416.44";"0";"4.05";"18";"COc1ccc(OC)c(NC(=O)Nc2nn(-c3ccccc3)c(=O)c3ccccc23)c1";"IC50";"'='";"8.25";"nM";"8.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1769841";"Antagonist activity at human cloned adenosine A3 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1764987";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL2181965";"";"None";"374.24";"0";"3.25";"67, KF26777";"CCCN1C(=O)N2CCN=C2c2[nH]c(-c3ccc(Br)cc3)nc21";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2187060";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells by [S35]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL186113";"GW-328267";"1.0";"482.51";"1";"-0.58";"76";"CCn1nnc([C@H]2O[C@@H](n3cnc4c(N)nc(N[C@H](CO)Cc5ccccc5)nc43)[C@H](O)[C@@H]2O)n1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1800736";"";"None";"339.40";"0";"2.09";"29";"C=CCN1C(=O)N2CC(CC)N=C2c2[nH]c(-c3cc(C)nn3C)nc21";"IC50";"'='";"30.3";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800783";"";"None";"355.40";"0";"1.79";"R-33";"C=CCN1C(=O)N2C[C@@H](CC)N=C2c2[nH]c(-c3cc(OC)nn3C)nc21";"IC50";"'='";"23.4";"nM";"7.63";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800785";"";"None";"391.44";"0";"2.41";"34";"COc1cc(-c2nc3c([nH]2)C2=NC(C)CN2C(=O)N3Cc2ccccc2)n(C)n1";"IC50";"'='";"27.6";"nM";"7.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1562432";"";"None";"398.68";"0";"4.45";"PAB10";"CC[C@@H]1CN2C(=O)N(C)c3nc(-c4cc(Cl)cc(Cl)c4Cl)[nH]c3C2=N1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803414";"Inverse agonist activity at human recombinant A3 adenosine receptor expressed CHO cells by [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL427526";"(R)-IBUPROPHEN";"1.0";"206.28";"0";"3.07";"R(-)-IBUPROFEN";"CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL198779";"";"None";"260.30";"0";"3.48";"36";"Cc1cccc2[nH]c(-c3cnc4ccccc4n3)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1110";"ALOSETRON";"4.0";"294.36";"0";"2.41";"ALOSETRON";"Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1113";"AMOXAPINE";"4.0";"313.79";"0";"3.43";"AMOXAPINE";"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1087";"MEPIVACAINE";"4.0";"246.35";"0";"2.73";"MEPIVACAINE";"Cc1cccc(C)c1NC(=O)C1CCCCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL351211";"";"None";"404.39";"0";"2.92";"18";"COc1ccccc1NC(=O)Nc1nc2nn(C)cc2c2nc(-c3ccco3)nn12";"IC50";"'='";"5.6";"nM";"8.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644486";"Inhibition of IB-MECA agonist-mediated cAMP production in CHO cell membranes expressing human Adenosine A3 receptor; range 3.0-10.8";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL490605";"";"None";"497.72";"0";"2.61";"33b, MRS-5127";"O[C@@H]1[C@H](O)[C@@H]2C[C@@H]2[C@H]1n1cnc2c(NCc3cccc(I)c3)nc(Cl)nc21";"IC50";"'='";"29.8";"nM";"7.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL982634";"Antagonist activity at NECA-stimulated human adenosine A3 receptor expressed in CHO cells by [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144175";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL477";"ADENOSINE";"4.0";"267.25";"0";"-1.98";"Adenosine";"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O";"IC50";"'='";"1.148";"nM";"8.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3772952";"Agonist activity at human Adenosine A3 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769381";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307512";"";"";""
"CHEMBL3769641";"";"None";"458.52";"0";"0.08";"17";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(O)(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3772952";"Agonist activity at human Adenosine A3 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769381";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307512";"";"";""
"CHEMBL21572";"";"None";"463.48";"1";"2.90";"49";"CSc1c2c(nc(NC(=O)Cc3ccc4c(c3)OCO4)n3nc(-c4ccco4)nc23)nn1C";"IC50";"'='";"466.0";"nM";"6.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644554";"Antagonist activity as inhibition of cAMP generation after agonist-modulation of Adenosine A3 receptor with 100 nM CI-IB-MECA";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136743";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL139182";"";"None";"508.54";"2";"5.02";"11";"COc1ccc(NC(=O)Nc2nc3nn(CCCc4ccccc4)cc3c3nc(-c4ccco4)nn23)cc1";"IC50";"'='";"19.81";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644508";"Inhibitory concentration as antagonistic activity against cAMP generation inhibited by IB-MECA in CHO cell membranes transfected with human A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132457";"1";"Scientific Literature";"J Med Chem";"1999";"CHEMBL3308072";"";"";""
"CHEMBL122667";"";"None";"326.79";"0";"3.66";"16";"CCCCc1nc2[nH]cnc2c2nc(-c3cccc(Cl)c3)nn12";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"27.41";"0.53";"5.30";"12.48";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL44814";"CARBON TETRACHLORIDE";"-1.0";"153.82";"0";"2.55";"CARBON TETRACHLORIDE";"ClC(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL16687";"CGS-15943";"None";"285.69";"0";"2.77";"CGS-15943";"Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12";"IC50";"'='";"406.0";"nM";"6.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644491";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL326389";"";"None";"467.36";"0";"4.94";"ID-9";"CCOC(=O)CNC(c1ccccc1)c1cc(Br)ccc1NC(=O)c1ccccc1";"IC50";"'='";"407.0";"nM";"6.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644553";"Inhibition of [35S]GTP-gamma-S, binding stimulated by 5 uM 5''-N-ethyluronamidoadenosine (NECA) in membranes of HEK293 cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133025";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307715";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.2089";"nM";"9.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322685";"Agonist activity at wild type human A3 receptor V169'5.30E mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"V169E";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL521";"IBUPROFEN";"4.0";"206.28";"0";"3.07";"SID90341584";"CC(C)Cc1ccc(C(C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1566249";"AMPIROXICAM";"2.0";"447.47";"0";"2.56";"AMPIROXICAM";"CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1297";"FENOPROFEN";"4.0";"242.27";"0";"3.67";"15";"CC(C(=O)O)c1cccc(Oc2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL341259";"";"None";"336.83";"0";"4.94";"3s";"CCCCc1nc2cccc(Cl)c2c2nc(-c3ccccc3)nn12";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"17.81";"0.34";"1.06";"13.93";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL340657";"";"None";"292.35";"0";"3.01";"2c";"CCCCc1nc2[nH]ncc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"29.68";"0.54";"5.67";"12.09";"1";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL235742";"";"None";"308.30";"0";"-1.57";"19";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](OC)[C@@H]1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL1909050";"";"None";"293.41";"0";"4.09";"1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL44884";"ETHAMBUTOL";"4.0";"204.31";"0";"-0.29";"ETHAMBUTOL";"CC[C@@H](CO)NCCN[C@@H](CC)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL22113";"";"None";"450.48";"0";"3.65";"46";"COc1ccc(NC(=O)Nc2nc3nn(C)c(SC)c3c3nc(-c4ccco4)nn23)cc1";"IC50";"'='";"813.0";"nM";"6.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644554";"Antagonist activity as inhibition of cAMP generation after agonist-modulation of Adenosine A3 receptor with 100 nM CI-IB-MECA";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136743";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL123705";"";"None";"360.34";"0";"4.03";"1c";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(C(F)(F)F)cc3)nn12";"IC50";"'='";"0.61";"nM";"9.21";"";"";"UO_0000065";"25.57";"0.48";"5.18";"12.84";"1";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL458019";"PARAQUAT DICHLORIDE";"None";"257.16";"0";"1.00";"PARAQUAT DICHLORIDE";"C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1080241";"";"None";"367.46";"0";"3.57";"BDBM50310922";"Nc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1";"IC50";"'='";"233.1";"nM";"6.63";"";"323829";"UO_0000065";"";"";"";"";"0";"CHEMBL3887222";"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886219";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL56337";"EPALRESTAT";"4.0";"319.41";"0";"2.92";"EPALRESTAT";"CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL723";"CARVEDILOL";"4.0";"406.48";"0";"3.74";"CARVEDILOL";"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL189171";"ACEMETACIN";"4.0";"415.83";"0";"3.47";"ACEMETACIN";"COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1935748";"";"None";"431.46";"0";"4.40";"9b";"CCCn1cc2nc(NC(=O)Nc3ccc(OC)cc3)n3nc(-c4ccco4)nc3c2c1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1936208";"Antagonist activity at human adenosine A3 receptor expressed in forskolin-stimulated CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1932966";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL253376";"BROMHEXINE";"4.0";"376.14";"0";"4.56";"BROMHEXINE";"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6273";"FLEROXACIN";"2.0";"369.34";"0";"1.70";"FLEROXACIN";"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1159650";"CLOBETASOL PROPIONATE";"4.0";"466.98";"0";"4.10";"CLOBETASOL PROPIONATE";"CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL175";"DEXIBUPROFEN";"4.0";"206.28";"0";"3.07";"DEXIBUPROFEN";"CC(C)Cc1ccc([C@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL123694";"";"None";"316.41";"0";"4.60";"3t";"CCCCc1nc2cc(C)ccc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"21.99";"0.40";"2.36";"16.15";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL562";"GRISEOFULVIN";"4.0";"352.77";"0";"2.81";"G";"COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL338790";"";"None";"212.21";"0";"1.31";"4-AMINO-1,8-NAPHTHALIMIDE";"Nc1ccc2c3c(cccc13)C(=O)NC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"IMATINIB";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1169";"AMINOSALICYLIC ACID";"4.0";"153.14";"0";"0.67";"AMINOSALICYLIC ACID";"Nc1ccc(C(=O)O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL77675";"";"None";"211.27";"0";"3.15";"1,3-DIPHENYLGUANIDINE";"N=C(Nc1ccccc1)Nc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL40583";"3-METHYLCHOLANTHRENE";"None";"268.36";"1";"5.55";"3-METHYLCHOLANTHRENE";"Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3";"IC50";"'='";"5544.0";"nM";"5.26";"";"";"UO_0000065";"19.59";"0.34";"-0.29";"None";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL415690";"BETADEX";"3.0";"1134.99";"None";"None";"BETA CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL89093";"";"None";"363.24";"1";"5.86";"32, MRS1067";"Cc1ccc(-c2oc3ccc(Cl)cc3c(=O)c2Cl)c(OC(C)C)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL826";"ENOXACIN";"4.0";"320.32";"0";"0.66";"ENOXACINE";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1425";"MERCAPTOPURINE ANHYDROUS";"4.0";"152.18";"0";"0.64";"MERCAPTOPURINE";"Sc1ncnc2nc[nH]c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1614641";"FLUNOXAPROFEN";"2.0";"285.27";"0";"3.82";"FLUNOXAPROFEN";"C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL50588";"EMETINE";"2.0";"480.65";"0";"4.94";"EMETINE";"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL52440";"DEXTROMETHORPHAN";"4.0";"271.40";"0";"3.38";"DEXTROMETHORPHAN";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL123705";"";"None";"360.34";"0";"4.03";"23";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(C(F)(F)F)cc3)nn12";"IC50";"'='";"0.61";"nM";"9.21";"";"";"UO_0000065";"25.57";"0.48";"5.18";"12.84";"0";"CHEMBL883238";"Displacement of [3H]CGS-21680 from human Adenosine A3 receptor expressed in HEK293 cells at 10000 nM";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL1201353";"DEXCHLORPHENIRAMINE";"4.0";"274.80";"0";"3.82";"DEXCHLORPHENIRAMINE";"CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL184";"ACYCLOVIR";"4.0";"225.21";"0";"-1.33";"ACYCLOVIR";"Nc1nc2c(ncn2COCCO)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL340221";"";"None";"264.29";"0";"2.23";"2a";"CCc1nc2[nH]ncc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"31.06";"0.56";"5.98";"11.44";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL4078360";"";"None";"508.34";"1";"3.15";"16";"Cc1cc(C)n(C[C@H]2O[C@@H](n3cnc4c(Nc5ccc(Cl)cc5F)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1";"IC50";"'='";"701.0";"nM";"6.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4027925";"Antagonist activity at recombinant human adenosine A3 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase in presence of [alpha-31P]ATP";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024784";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL942";"BISACODYL";"4.0";"361.40";"0";"4.11";"BISACODYL";"CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL661";"ALPRAZOLAM";"4.0";"308.77";"0";"3.58";"ALPRAZOLAM";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL153062";"4-NONYLPHENOL";"None";"220.36";"0";"4.69";"4-NONYLPHENOL";"CCCCCCCCCc1ccc(O)cc1";"IC50";"'='";"1915.0";"nM";"5.72";"";"";"UO_0000065";"25.95";"0.49";"1.03";"28.26";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL294199";"CAPSAICIN";"4.0";"305.42";"0";"3.79";"CAPSAICIN";"COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200558";"BACITRACIN";"4.0";"1422.72";"None";"None";"BACITRACIN";"CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL696";"ETHOSUXIMIDE";"4.0";"141.17";"0";"0.45";"ETHOSUXIMIDE";"CCC1(C)CC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL338057";"";"None";"318.38";"0";"3.99";"3i";"CCCCc1nc2ccccc2c2nc(-c3ccc(O)cc3)nn12";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"25.13";"0.46";"4.01";"12.64";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL1261";"CITRIC ACID";"4.0";"192.12";"0";"-1.25";"CITRIC ACID";"O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL529";"AZITHROMYCIN";"4.0";"749.00";"2";"1.90";"AZITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL30327";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"None";"321.97";"1";"6.20";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1626";"CLEMASTINE";"4.0";"343.90";"1";"5.10";"CLEMASTINE";"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5314360";"ACONITINE";"-1.0";"645.75";"2";"0.65";"ACONITINE";"CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)[C@@]34[C@@H]5C[C@@]6(O)[C@H](OC(=O)c7ccccc7)[C@@H]5[C@@](OC(C)=O)([C@@H]([C@H](OC)[C@H]23)[C@@H]14)[C@@H](O)[C@@H]6OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1481";"GLIMEPIRIDE";"4.0";"490.63";"0";"3.07";"GLIMEPIRIDE";"CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1535";"HYDROXYCHLOROQUINE";"4.0";"335.88";"0";"3.78";"HYDROXYCHLOROQUINE";"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201151";"MESTRANOL";"4.0";"310.44";"0";"3.92";"MESTRANOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL122685";"";"None";"306.37";"0";"3.32";"20";"CCCCc1nc2[nH]cnc2c2nc(-c3cccc(C)c3)nn12";"IC50";"'='";"0.27";"nM";"9.57";"";"";"UO_0000065";"31.23";"0.57";"6.25";"13.33";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL217899";"TOFIMILAST";"2.0";"339.47";"0";"4.10";"19, Tofimilast";"CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"15.67";"0.30";"1.22";"10.96";"0";"CHEMBL909522";"Inhibition of adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139839";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL340093";"";"None";"336.83";"0";"4.94";"3l";"CCCCc1nc2cc(Cl)ccc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"21.73";"0.42";"2.38";"16.99";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"1.202";"nM";"8.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322691";"Agonist activity at wild type human A3 receptor I253'6.58A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"I253A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.257";"nM";"9.59";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322697";"Agonist activity at wild type human A3 receptor V169'5.30A/W185'5.46A double mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"V169A,W185A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL989";"FLUOCINOLONE ACETONIDE";"4.0";"452.49";"0";"2.37";"FLUOCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL434063";"";"None";"495.58";"0";"4.94";"GW-1929";"CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1";"IC50";"'='";"14318.0";"nM";"4.84";"";"";"UO_0000065";"9.77";"0.18";"-0.10";"5.28";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL629";"AMITRIPTYLINE";"4.0";"277.41";"0";"4.17";"AMITRIPTYLINE";"CN(C)CCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200623";"ETHYLESTRENOL";"4.0";"288.48";"1";"5.09";"ETHYLESTRENOL";"CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL521589";"BAMBUTEROL";"3.0";"367.45";"0";"2.23";"BAMBUTEROL";"CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1144";"PRAVASTATIN";"4.0";"424.53";"0";"2.44";"PRAVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL504760";"CAMPHOR";"4.0";"152.24";"0";"2.40";"CAMPHRE";"CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1566";"ACARBOSE";"4.0";"645.61";"3";"-8.56";"ACARBOSE";"C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL290916";"EDARAVONE";"4.0";"174.20";"0";"1.80";"EDARAVONE";"CC1=NN(c2ccccc2)C(=O)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1766352";"";"None";"386.41";"0";"4.04";"12";"COc1ccc(NC(=O)Nc2nn(-c3ccccc3)c(=O)c3ccccc23)cc1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1769841";"Antagonist activity at human cloned adenosine A3 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1764987";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL55";"PENTAMIDINE";"4.0";"340.43";"0";"2.88";"PENTAMIDINE";"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1366";"AURANOFIN";"4.0";"678.49";"None";"None";"AURANOFIN";"";"IC50";"'='";"1688.0";"nM";"5.77";"";"";"UO_0000065";"8.51";"None";"None";"None";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1308";"FOMEPIZOLE";"4.0";"82.11";"0";"0.72";"4-METHYLPYRAZOLE";"Cc1cn[nH]c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL280888";"";"None";"329.39";"0";"2.36";"42";"CCCSc1c2c(nc(N)n3nc(-c4ccco4)nc23)nn1C";"IC50";"'='";"852.0";"nM";"6.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644554";"Antagonist activity as inhibition of cAMP generation after agonist-modulation of Adenosine A3 receptor with 100 nM CI-IB-MECA";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136743";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL398440";"CHLOROXYLENOL";"4.0";"156.61";"0";"2.66";"CHLOROXYLENOL";"Cc1cc(O)cc(C)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL324735";"";"None";"374.36";"0";"2.92";"59";"Cn1cc2c(nc(NC(=O)Nc3ccccc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644557";"Inhibition of IB-MECA agonist-mediated cAMP production in membranes of CHO cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL332577";"";"None";"360.34";"0";"4.03";"9b-3";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(C(F)(F)F)cc3)nn12";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"19.11";"0.36";"2.86";"9.60";"0";"CHEMBL644555";"Binding affinity for human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL29292";"UBENIMEX";"2.0";"308.38";"0";"0.53";"UBENIMEX";"CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL508338";"THIMEROSAL";"4.0";"404.82";"None";"None";"THIMEROSAL";"";"IC50";"'='";"3386.0";"nM";"5.47";"";"";"UO_0000065";"13.51";"None";"None";"None";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL118923";"";"None";"411.81";"0";"2.31";"4";"Cl.Cn1cc2c(nc(NC(=O)Nc3ccncc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"24.39";"0.45";"6.84";"7.15";"0";"CHEMBL644504";"Inhibitory activity against Human Adenosine A3 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135541";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL400812";"";"None";"425.45";"0";"3.58";"21";"COc1ccc(C(=O)Nc2nc3ccccc3n3c(=O)c(-c4ccc(C)cc4)nn23)cc1";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL901023";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137613";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3308072";"";"";""
"CHEMBL577294";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"3.0";"1541.55";"None";"None";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"CC(O)COC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8COCC(C)O)O[C@@H]7COCC(C)O)O[C@@H]6COCC(C)O)O[C@@H]5COCC(C)O)O[C@@H]4COCC(C)O)O[C@@H]3COCC(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5315124";"LEVOFLOXACIN";"4.0";"740.76";"0";"1.54";"LEVOFLOXACIN";"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL434";"ISOPROTERENOL";"4.0";"211.26";"0";"1.13";"ISOPRENALINE";"CC(C)NCC(O)c1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL338837";"";"None";"371.27";"1";"5.59";"3m";"CCCCc1nc2cc(Cl)ccc2c2nc(-c3ccc(Cl)cc3)nn12";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"17.49";"0.35";"0.90";"15.08";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL200732";"";"None";"560.81";"1";"1.78";"3 Thio-Cl-IB-MECA";"CNC(=O)[C@H]1S[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644507";"Inhibitory concentration against human Adenosine A3 receptor mediated inhibition of cyclic AMP in transfected CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145992";"1";"Scientific Literature";"J Med Chem";"2003";"CHEMBL3308072";"";"";""
"CHEMBL25719";"GERANIOL";"None";"154.25";"0";"2.67";"SID74795";"CC(C)=CCC/C(C)=C/CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL407030";"";"None";"1281.13";"None";"None";"GAMMA-CYCLODEXTRIN";"OC[C@H]1OC2C3[C@@H](CO)OC(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)C(OC1[C@H](O)[C@H]2O)O[C@@H]9CO)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)[C@H](O)[C@H]3O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1289";"HALOPROGIN";"4.0";"361.39";"0";"4.42";"HALOPROGIN";"Clc1cc(Cl)c(OCC#CI)cc1Cl";"IC50";"'='";"223.0";"nM";"6.65";"";"";"UO_0000065";"18.41";"0.65";"2.23";"72.07";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL185";"FLUOROURACIL";"4.0";"130.08";"0";"-0.80";"5-FU";"O=c1[nH]cc(F)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL806";"FLUTAMIDE";"4.0";"276.21";"0";"3.21";"FLUTAMIDE";"CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL975";"MESNA";"4.0";"164.18";"0";"-0.20";"MESNA";"O=S(=O)([O-])CCS.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL101818";"";"None";"267.31";"0";"3.32";"7";"Oc1nc2ccccc2c2cc(-c3cccs3)nn12";"IC50";"'='";"263.0";"nM";"6.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320331";"Activity at human adenosine A3 receptor transfected in CHO cells assessed as Cl-IB-MECA-inhibited cAMP accumulation by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311495";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1399";"ANASTROZOLE";"4.0";"293.37";"0";"2.93";"ANASTROZOLE";"CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1196";"PROPARACAINE";"4.0";"294.39";"0";"2.56";"PROPARACAINE";"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1255901";"HUPERZINE A";"2.0";"242.32";"0";"2.00";"HUPERZINE A";"C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL488";"AMINOGLUTETHIMIDE";"4.0";"232.28";"0";"1.35";"AMINOGLUTETHIMIDE";"CCC1(c2ccc(N)cc2)CCC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL311350";"PIROMIDIC ACID";"2.0";"288.31";"0";"1.11";"PIROMIDIC ACID";"CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL15245";"YOHIMBINE";"4.0";"354.45";"0";"2.65";"YOHIMBINE";"COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL113420";"";"None";"410.48";"0";"3.94";"62";"CCCn1c(=O)c2c(nc3cc(-c4ccccc4)ccn32)n(Cc2ccccc2)c1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL99178";"";"None";"292.30";"0";"2.66";"48";"COc1ccc(-c2nc3c(O)nc4ccccc4n3n2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL88147";"";"None";"403.83";"0";"4.37";"42, MRS1220";"O=C(Cc1ccccc1)Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2187060";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells by [S35]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2322898";"";"None";"405.46";"0";"4.66";"17";"O=C(Cc1ccccc1)Nc1nc(-c2ccccc2)nc2cn(-c3ccccc3)nc12";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2330938";"Inhibition of human A3 adenosine receptor transfected in CHO cells assessed as inhibition of forskolin-induced cyclic AMP production after 10 mins by competitive protein binding assay in presence of CI-IB-MECA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321860";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3908849";"";"None";"475.43";"0";"4.10";"7";"NC(=O)n1cc(NC(=O)N2CCC[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2)c2ccccc21";"IC50";"'='";"8800.0";"nM";"5.06";"";"";"UO_0000065";"10.63";"0.20";"0.96";"4.26";"0";"CHEMBL4013297";"Antagonist activity at adenosine 3 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4011635";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL54";"HALOPERIDOL";"4.0";"375.87";"0";"4.43";"HALOPERIDOL";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL549";"CITALOPRAM";"4.0";"324.40";"0";"3.81";"CITALOPRAM";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4847106";"CC-90001";"2.0";"321.43";"0";"1.75";"CC-90001";"C[C@@H]1CC[C@@H](Nc2nc(NC(C)(C)C)ncc2C(N)=O)C[C@H]1O";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"16.73";"0.32";"3.63";"4.75";"0";"CHEMBL4842279";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840378";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL1567463";"CHOLINE ALFOSCERATE";"None";"257.22";"0";"-1.45";"CHOLINE ALFOSCERATE";"C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL691";"ETHINYL ESTRADIOL";"4.0";"296.41";"0";"3.61";"ETHINYLESTRADIOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C";"IC50";"'='";"32925.0";"nM";"4.48";"";"";"UO_0000065";"15.12";"0.28";"0.87";"11.08";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1108";"DROPERIDOL";"4.0";"379.44";"0";"3.68";"DROPERIDOL";"O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL707";"DOXAZOSIN";"4.0";"451.48";"0";"1.72";"DOXAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"DANAZOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"'='";"11160.0";"nM";"4.95";"";"";"UO_0000065";"14.68";"0.27";"0.73";"10.71";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL339655";"";"None";"250.27";"0";"1.98";"4";"Cc1nc2[nH]cnc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"35.96";"0.65";"7.02";"12.54";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"IB-MECA";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.48";"0.42";"8.51";"6.64";"1";"CHEMBL953121";"Displacement of radiolabeled IB-MECA from human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140203";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL331837";"";"None";"348.45";"0";"4.31";"2l";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(C(C)(C)C)cc3)nn12";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"19.58";"0.36";"2.51";"9.51";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL544678";"";"None";"334.77";"0";"1.28";"53";"CCNc1c2c(nc(N)n3nc(-c4ccco4)nc23)nn1C.Cl";"IC50";"'='";"103.0";"nM";"6.99";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644554";"Antagonist activity as inhibition of cAMP generation after agonist-modulation of Adenosine A3 receptor with 100 nM CI-IB-MECA";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136743";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"IB-MECA";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"18.07";"0.43";"8.81";"6.86";"0";"CHEMBL3779525";"Displacement of [125I]ABMECA from human recombinant adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774372";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"CHEMBL3307715";"";"";""
"CHEMBL330664";"";"None";"295.73";"0";"3.91";"4";"Oc1nc2ccccc2c2cc(-c3ccc(Cl)cc3)nn12";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320331";"Activity at human adenosine A3 receptor transfected in CHO cells assessed as Cl-IB-MECA-inhibited cAMP accumulation by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311495";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2312719";"";"None";"291.31";"0";"2.85";"2";"COc1ccc(-c2cc3c4ccccc4[nH]c(=O)n3n2)cc1";"IC50";"'='";"324.0";"nM";"6.49";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320331";"Activity at human adenosine A3 receptor transfected in CHO cells assessed as Cl-IB-MECA-inhibited cAMP accumulation by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311495";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL123172";"";"None";"322.37";"0";"3.02";"26";"CCCCc1nc2[nH]cnc2c2nc(-c3cccc(OC)c3)nn12";"IC50";"'='";"0.22";"nM";"9.66";"";"";"UO_0000065";"29.96";"0.55";"6.64";"11.92";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL121";"ROSIGLITAZONE";"4.0";"357.44";"0";"2.49";"rosiglitazone";"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL14060";"PHENOL";"4.0";"94.11";"0";"1.39";"PHENOL";"Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2108139";"POVIDONE";"4.0";"None";"None";"None";"POLYVINYLPYRROLIDONE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL107";"COLCHICINE";"4.0";"399.44";"0";"2.87";"1a";"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1540";"PENCICLOVIR";"4.0";"253.26";"0";"-0.90";"PENCICLOVIR";"Nc1nc(O)c2ncn(CCC(CO)CO)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL80";"NALOXONE";"4.0";"327.38";"0";"1.30";"NALOXONE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL98350";"LY-294002";"-1.0";"307.35";"0";"3.30";"LY-294002";"O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL880";"FAMCICLOVIR";"4.0";"321.34";"0";"0.54";"FAMCICLOVIR";"CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200600";"FLUOROMETHOLONE";"4.0";"376.47";"0";"2.92";"FLUOROMETHOLONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800784";"";"None";"355.40";"0";"1.79";"S-33";"C=CCN1C(=O)N2C[C@H](CC)N=C2c2[nH]c(-c3cc(OC)nn3C)nc21";"IC50";"'='";"10.5";"nM";"7.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL2252949";"(-)-CAMPHOR";"None";"152.24";"0";"2.40";"L-CAMPHOR";"CC1(C)[C@H]2CC[C@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL167911";"DICHLORVOS";"2.0";"220.98";"0";"2.68";"DICHLORVOS";"COP(=O)(OC)OC=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL506";"PRIMAQUINE";"4.0";"259.35";"0";"2.78";"PRIMAQUINE";"COc1cc(NC(C)CCCN)c2ncccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL295416";"PIRINIXIC ACID";"2.0";"323.81";"0";"3.67";"PIRINIXIC ACID";"Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1464";"WARFARIN";"4.0";"308.33";"0";"3.61";"warfarin";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL499";"TIMOLOL";"4.0";"316.43";"0";"0.50";"TIMOLOL";"CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL134";"CLONIDINE";"4.0";"230.10";"0";"2.36";"CLONIDINE";"Clc1cccc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL773";"GLYCINE";"4.0";"75.07";"0";"-0.97";"GLYCINE";"NCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1544";"LIOTHYRONINE";"4.0";"650.98";"1";"3.95";"3,3',5-TRIIODO-L-THYRONINE";"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3311508";"";"None";"421.84";"0";"0.71";"11c";"COc1ccc(Cl)cc1CNc1ncnc2c1ncn2[C@@H]1OC[C@@](O)(CO)[C@H]1O";"IC50";"'='";"1560.0";"nM";"5.81";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3365949";"Agonist activity at human recombinant A3AR expressed in CHO cells assessed as inhibition of forskolin-induced stimulation of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351911";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1373";"MODAFINIL";"4.0";"273.36";"0";"2.01";"MODAFINIL";"NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL53463";"DOXORUBICIN";"4.0";"543.53";"3";"0.00";"Doxorubicin";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL964";"DISULFIRAM";"4.0";"296.55";"0";"3.62";"DISULFIRAM";"CCN(CC)C(=S)SSC(=S)N(CC)CC";"IC50";"'='";"356.0";"nM";"6.45";"";"";"UO_0000065";"21.75";"0.55";"2.83";"99.51";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL290106";"BITHIONOL";"4.0";"356.06";"1";"5.86";"BITHIONOL";"Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O";"IC50";"'='";"829.0";"nM";"6.08";"";"";"UO_0000065";"17.08";"0.44";"0.22";"15.03";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL45245";"";"None";"195.22";"0";"2.68";"6(5H)-PHENANTHRIDINONE";"O=c1[nH]c2ccccc2c2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL231225";"";"None";"443.47";"1";"5.42";"58";"O=C(NCc1ccc(N2[C@@H]3CCC[C@H]2CC3)c(C(F)(F)F)c1)Nc1cccc2[nH]ncc12";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL890252";"Binding affinity to adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145452";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL24441";"BETAHISTINE";"4.0";"136.20";"0";"0.84";"BETAHISTINE";"CNCCc1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL565";"CLOFIBRATE";"4.0";"242.70";"0";"3.06";"CLOFIBRATE";"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1395";"METHYLTESTOSTERONE";"4.0";"302.46";"0";"4.27";"17-METHYLTESTOSTERONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL902";"FAMOTIDINE";"4.0";"337.46";"0";"-0.77";"FAMOTIDINE";"NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200391";"TROMETHAMINE";"4.0";"121.14";"0";"-2.34";"TROMETHAMINE";"NC(CO)(CO)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL333860";"";"None";"350.43";"0";"3.80";"29";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(OCCC)cc3)nn12";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"27.17";"0.50";"5.72";"11.76";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL123450";"";"None";"308.35";"0";"2.72";"25";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(O)cc3)nn12";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"28.36";"0.52";"6.02";"9.51";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL282575";"ESTRADIOL BENZOATE";"4.0";"376.50";"1";"5.12";"BETA-ESTRADIOL 3-BENZOATE";"C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"'='";"21780.0";"nM";"4.66";"";"";"UO_0000065";"12.38";"0.23";"-0.46";"10.02";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1515611";"BROMISOVALUM";"2.0";"223.07";"0";"0.60";"BROMISOVALUM";"CC(C)C(Br)C(=O)NC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL376180";"AMINOPTERIN";"2.0";"440.42";"1";"0.24";"AMINOPTERIN";"Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL116";"AMPRENAVIR";"4.0";"505.64";"1";"2.40";"AMPRENAVIR";"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909049";"";"None";"309.41";"0";"3.79";"1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1476898";"CADMIUM ACETATE";"None";"230.50";"None";"None";"CADMIUM ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL34431";"CILOSTAMIDE";"2.0";"342.44";"0";"3.48";"CILOSTAMIDE";"CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800740";"";"None";"389.46";"0";"3.10";"S-31";"CC[C@H]1CN2C(=O)N(Cc3ccccc3)c3nc(-c4cc(C)nn4C)[nH]c3C2=N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800797";"";"None";"375.44";"0";"2.71";"42";"Cc1cc(-c2nc3c([nH]2)C2=NC(C)CN2C(=O)N3Cc2ccccc2)nn1C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800862";"";"None";"342.36";"0";"2.04";"45";"C=CCN1C(=O)N2CC(CC)N=C2c2[nH]c(-c3cc(OC)no3)nc21";"IC50";"'='";"14.6";"nM";"7.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1200406";"DIMENHYDRINATE";"4.0";"469.97";"None";"None";"DIMENHYDRINATE";"CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL799";"CILOSTAZOL";"4.0";"369.47";"0";"3.46";"cilostazol";"O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL88";"CYCLOPHOSPHAMIDE ANHYDROUS";"4.0";"261.09";"0";"1.88";"CYCLOPHOSPHAMIDE";"O=P1(N(CCCl)CCCl)NCCCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909055";"COBALTOUS CHLORIDE";"4.0";"129.84";"None";"None";"COBALT (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL461727";"AMYGDALIN";"None";"457.43";"2";"-3.11";"AMYGDALIN(D)";"N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL557555";"CIPROFIBRATE";"4.0";"289.16";"0";"3.59";"CIPROFIBRATE";"CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL163";"RITONAVIR";"4.0";"720.96";"2";"5.91";"RITONAVIR";"CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL446";"SULFAMETHAZINE";"4.0";"278.34";"0";"1.48";"SULFAMETHAZINE";"Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL129";"ZIDOVUDINE";"4.0";"267.24";"0";"-0.20";"ZIDOVUDINE";"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL584";"NELFINAVIR";"4.0";"567.80";"1";"4.75";"NELFINAVIR";"Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C";"IC50";"'='";"14796.0";"nM";"4.83";"";"";"UO_0000065";"8.51";"0.16";"0.08";"4.74";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201631";"INSULIN HUMAN";"4.0";"None";"None";"None";"INSULIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"VERAPAMIL";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL547";"ISOTRETINOIN";"4.0";"300.44";"1";"5.60";"ISOTRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1";"IC50";"'='";"4169.0";"nM";"5.38";"";"";"UO_0000065";"17.91";"0.33";"-0.22";"14.42";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1490";"TRIHEXYPHENIDYL";"4.0";"301.47";"0";"4.33";"TRIHEXYPHENIDYL";"OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157101";"KETOCONAZOLE";"4.0";"531.44";"1";"4.21";"KETOCONAZOLE";"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL429";"LABETALOL";"4.0";"328.41";"0";"2.14";"LABETALOL";"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909083";"ZIRCONIUM(IV) CHLORIDE";"None";"233.04";"None";"None";"ZIRCONIUM(IV) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL695";"TRIMETHADIONE";"4.0";"143.14";"0";"0.37";"TRIMETHADIONE";"CN1C(=O)OC(C)(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1208572";"SALINOMYCIN";"2.0";"751.01";"2";"6.19";"SALINOMYCIN";"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL90555";"VINCRISTINE";"4.0";"824.97";"2";"3.52";"VINCRISTINE";"CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL689";"MANNITOL";"4.0";"182.17";"1";"-3.59";"MANNITOL";"OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909062";"LEAD (II) ACETATE";"None";"325.29";"None";"None";"LEAD (II) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL302795";"TENOXICAM";"4.0";"337.38";"0";"1.64";"TENOXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL631";"PROPAFENONE";"4.0";"341.45";"0";"3.24";"PROPAFENONE";"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL34139";"GENACONAZOLE";"None";"331.34";"0";"0.88";"GENACONAZOLE (RR(+) ISOMER)";"C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL135";"ESTRADIOL";"4.0";"272.39";"0";"3.61";"BETA-ESTRADIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL402794";"BIS(2-ETHYLHEXYL)PHTHALATE";"None";"390.56";"1";"6.43";"BIS(2-ETHYLHEXYL)PHTHALATE";"CCCC[C@@H](CC)COC(=O)c1ccccc1C(=O)OC[C@@H](CC)CCCC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL128";"SUMATRIPTAN";"4.0";"295.41";"0";"1.32";"SUMATRIPTAN";"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL101";"PHENYLBUTAZONE";"4.0";"308.38";"0";"3.79";"PHENYLBUTAZONE";"CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL959";"RIMANTADINE";"4.0";"179.31";"0";"2.55";"RIMANTADINE";"CC(N)C12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1935753";"";"None";"283.30";"0";"1.73";"41a";"CCCn1ncc2nc(N)n3nc(-c4ccco4)nc3c21";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1936208";"Antagonist activity at human adenosine A3 receptor expressed in forskolin-stimulated CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1932966";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL809";"SERTRALINE";"4.0";"306.24";"1";"5.18";"SERTRALINE";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL637";"VENLAFAXINE";"4.0";"277.41";"0";"3.04";"VENLAFAXINE";"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL841";"LOPERAMIDE";"4.0";"477.05";"1";"5.09";"LOPERAMIDE";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267044";"LEVOSULPIRIDE";"2.0";"341.43";"0";"0.56";"LEVOSULPIRIDE";"CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL79";"LIDOCAINE";"4.0";"234.34";"0";"2.58";"LIDOCAINE";"CCN(CC)CC(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL58";"MITOXANTRONE";"4.0";"444.49";"1";"-0.14";"Mitoxantrone";"O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL191";"LOSARTAN";"4.0";"422.92";"0";"4.27";"LOSARTAN";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL490";"PAROXETINE";"4.0";"329.37";"0";"3.33";"PAROXETINE";"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL503";"LOVASTATIN";"4.0";"404.55";"0";"4.20";"LOVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800735";"";"None";"325.38";"0";"1.70";"S-28";"C=CCN1C(=O)N2C[C@H](C)N=C2c2[nH]c(-c3cc(C)nn3C)nc21";"IC50";"'='";"40.9";"nM";"7.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800792";"";"None";"481.56";"0";"4.37";"39";"CCC1CN2C(=O)N(Cc3ccccc3)c3nc(-c4cc(OCc5ccccc5)nn4C)[nH]c3C2=N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800795";"";"None";"325.38";"0";"1.70";"R-41";"C=CCN1C(=O)N2C[C@@H](C)N=C2c2[nH]c(-c3cc(C)n(C)n3)nc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL73237";"";"None";"281.27";"0";"-1.33";"18";"CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)ncnc21";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL235543";"";"None";"494.29";"0";"0.64";"16";"OC[C@@]12CN[C@@H]([C@H](n3cnc4c(NCc5cccc(I)c5)ncnc43)O1)[C@@H]2O";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL14192";"BENZYLIMIDAZOLE";"None";"158.20";"0";"1.93";"1-BENZYLIMIDAZOLE";"c1ccc(Cn2ccnc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200528";"CHROMIC CHLORIDE";"4.0";"158.36";"None";"None";"CHROMIUM(III) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL457";"GEMFIBROZIL";"4.0";"250.34";"0";"3.57";"GEMFIBROZIL";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL283196";"ALPHA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"ALPHA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL115769";"";"None";"334.35";"0";"3.97";"RWJ-68354";"COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL138332";"";"None";"436.86";"0";"4.44";"21";"CCCn1cc2c(nc(NC(=O)Nc3cccc(Cl)c3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL644500";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 4.0-7.5";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL1231";"OXYBUTYNIN";"4.0";"357.49";"0";"3.34";"OXYBUTYNIN";"CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL411";"DIETHYLSTILBESTROL";"4.0";"268.36";"0";"4.83";"DIETHYLSTILBESTROL";"CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"'='";"2208.0";"nM";"5.66";"";"";"UO_0000065";"21.08";"0.39";"0.83";"13.98";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1123";"DICYCLOMINE";"4.0";"309.49";"0";"4.40";"DICYCLOMINE";"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800782";"";"None";"355.40";"0";"1.79";"33";"C=CCN1C(=O)N2CC(CC)N=C2c2[nH]c(-c3cc(OC)nn3C)nc21";"IC50";"'='";"12.2";"nM";"7.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1727";"CEPHALEXIN ANHYDROUS";"4.0";"347.40";"0";"0.44";"CEPHALEXIN";"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1729";"CISAPRIDE";"4.0";"465.95";"0";"3.36";"CISAPRIDE";"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1873703";"DIELDRIN";"2.0";"380.91";"0";"4.48";"DIELDRIN";"ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@@H]([C@H]5O[C@@H]45)[C@@H]3[C@@]1(Cl)C2(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL174";"AMPICILLIN";"4.0";"349.41";"0";"0.32";"AMPICILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2071045";"";"None";"542.60";"1";"3.20";"28";"Cn1cc2c(nc(NC(=O)NC3CCN(C(=O)NCCCc4ccccc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.4898";"nM";"9.31";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4322684";"Agonist activity at wild type human A3 receptor V169'5.30A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"V169A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL2322903";"";"None";"359.39";"0";"3.38";"22";"COc1ccc(-n2cc3nc(C)nc(NC(=O)c4ccccc4)c3n2)cc1";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2330938";"Inhibition of human A3 adenosine receptor transfected in CHO cells assessed as inhibition of forskolin-induced cyclic AMP production after 10 mins by competitive protein binding assay in presence of CI-IB-MECA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321860";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL679";"EPINEPHRINE";"4.0";"183.21";"0";"0.35";"EPINEPHRINE";"CNC[C@H](O)c1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200629";"VECURONIUM BROMIDE";"4.0";"637.74";"2";"5.97";"VECURONIUM BROMIDE";"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2107687";"VALETHAMATE BROMIDE";"-1.0";"386.37";"0";"3.85";"VALETHAMATE BROMIDE";"CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL340182";"";"None";"368.44";"0";"4.68";"2n";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(-c4ccccc4)cc3)nn12";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"17.23";"0.31";"1.67";"8.84";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL1381098";"1-NAPHTHYLISOTHIOCYANATE";"None";"185.25";"0";"3.57";"1-NAPHTHYL ISOTHIOCYANATE";"S=C=Nc1cccc2ccccc12";"IC50";"'='";"6100.0";"nM";"5.21";"";"";"UO_0000065";"28.15";"0.55";"1.64";"42.19";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL888";"GEMCITABINE";"4.0";"263.20";"0";"-1.29";"GEMCITABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL250699";"";"None";"357.79";"0";"4.87";"A-803467";"COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"13.75";"0.27";"0.05";"8.11";"0";"CHEMBL928132";"Displacement of [125I]AB-MECA from adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142222";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"None";"";"";""
"CHEMBL42442";"OXFENDAZOLE";"2.0";"315.35";"0";"2.91";"OXFENDAZOLE";"COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL762";"OXYMETAZOLINE";"4.0";"260.38";"0";"2.85";"OXYMETAZOLINE";"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2322908";"";"None";"435.49";"0";"4.67";"27";"COc1ccc(-n2cc3nc(-c4ccccc4)nc(NC(=O)Cc4ccccc4)c3n2)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2330938";"Inhibition of human A3 adenosine receptor transfected in CHO cells assessed as inhibition of forskolin-induced cyclic AMP production after 10 mins by competitive protein binding assay in presence of CI-IB-MECA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321860";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3415022";"";"None";"243.29";"0";"2.36";"1";"Cc1nc2sc(-c3ccccc3)nc2c(=O)[nH]1";"IC50";"'='";"221.0";"nM";"6.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3419499";"Antagonist activity against human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-induced inhibition of forskolin-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414467";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";"";"";""
"CHEMBL322983";"";"None";"364.41";"0";"4.83";"1";"O=C(Nc1nc2ccccc2c2cn(-c3ccccc3)nc12)c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1013711";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of CI-IB-MECA-mediated inhibition of cAMP accumulation by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152204";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL517867";"";"None";"354.37";"0";"4.42";"2";"O=C(Nc1nc2ccccc2c2cn(-c3ccccc3)nc12)c1ccco1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1013711";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of CI-IB-MECA-mediated inhibition of cAMP accumulation by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152204";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1790041";"RANITIDINE";"4.0";"314.41";"0";"1.46";"RANITIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL115444";"";"None";"429.86";"0";"4.10";"3";"O=C(OCc1cc2c(cc1Cl)OCO2)N1CCC(n2c(O)nc3ccccc32)CC1";"IC50";"'='";"1780.0";"nM";"5.75";"";"";"UO_0000065";"13.38";"0.26";"1.65";"6.68";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL1077";"BROMFENAC";"4.0";"334.17";"0";"2.89";"BROMFENAC";"Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL391279";"";"None";"305.30";"0";"-2.25";"15";"CNC(=O)[C@@]12CN[C@@H]([C@H](n3cnc4c(N)ncnc43)O1)[C@@H]2O";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL3752840";"";"None";"397.46";"0";"4.80";"24";"O=C(Nc1nc(-c2cccs2)nc2cn(-c3ccccc3)nc12)c1ccccc1";"IC50";"'='";"5.32";"nM";"8.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4102409";"";"None";"368.44";"0";"3.99";"15";"CCCn1c(Oc2cccc(OC)c2)nc2nc(C3CCCC3)[nH]c2c1=O";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"17.28";"0.32";"2.38";"7.76";"0";"CHEMBL3994395";"Displacement of [3H]HEMADO from human adenosine A3 receptor expressed in HEK293 cell membranes after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992564";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3307715";"";"";""
"CHEMBL495778";"PENICILLIC ACID";"None";"170.16";"0";"0.34";"SID24841461";"C=C(C)C1(O)OC(=O)C=C1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL31";"GATIFLOXACIN";"4.0";"375.40";"0";"1.98";"GATIFLOXACIN";"COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL441687";"GLYCYRRHIZIN";"2.0";"822.94";"3";"2.25";"GLYCYRRHIZIN";"CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1219";"RABEPRAZOLE";"4.0";"359.45";"0";"2.99";"RABEPRAZOLE";"COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C";"IC50";"'='";"3219.0";"nM";"5.49";"";"";"UO_0000065";"15.28";"0.30";"2.50";"6.61";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1214185";"ROXITHROMYCIN";"4.0";"837.06";"2";"2.21";"ROXITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL666";"FOSCARNET";"4.0";"126.00";"0";"-0.16";"FOSCARNET";"O=C(O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1103";"FURAZOLIDONE";"4.0";"225.16";"0";"0.97";"FURAZOLIDONE";"O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL558551";"";"None";"258.23";"0";"0.09";"(+)-THALIDOMIDE";"O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL212464";"";"None";"467.55";"0";"2.02";"24";"CCCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCc4ccccn4)cc3)cc2n(C)c1=O";"IC50";"'='";"844.0";"nM";"6.07";"";"";"UO_0000065";"12.99";"0.25";"4.05";"5.11";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL45";"MELATONIN";"4.0";"232.28";"0";"1.86";"MELATONIN";"COc1ccc2[nH]cc(CCNC(C)=O)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL40";"PHENOBARBITAL";"4.0";"232.24";"0";"0.70";"PHENOBARBITAL";"CCC1(c2ccccc2)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL518258";"";"None";"378.44";"1";"5.13";"21";"Cc1ccc(C(=O)Nc2nc3ccccc3c3cn(-c4ccccc4)nc23)cc1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1013711";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of CI-IB-MECA-mediated inhibition of cAMP accumulation by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152204";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL515914";"AZARIBINE";"4.0";"371.30";"1";"-1.74";"AZARIBINE";"CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2322923";"";"None";"329.36";"0";"3.38";"8";"Cc1nc(NC(=O)c2ccccc2)c2nn(-c3ccccc3)cc2n1";"IC50";"'='";"19.7";"nM";"7.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2330938";"Inhibition of human A3 adenosine receptor transfected in CHO cells assessed as inhibition of forskolin-induced cyclic AMP production after 10 mins by competitive protein binding assay in presence of CI-IB-MECA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321860";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"IB-MECA";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.78";"nM";"9.11";"";"";"UO_0000065";"17.85";"0.43";"8.70";"6.78";"0";"CHEMBL2395289";"Displacement of [3H]ABMECA from human recombinant adenosine receptor A3 expressed in CHOK1 cells after 60 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307512";"";"";""
"CHEMBL3754500";"";"None";"397.46";"0";"4.80";"23";"O=C(Nc1nc(-c2ccccc2)nc2cn(-c3ccccc3)nc12)c1cccs1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL1081160";"";"None";"395.51";"0";"4.06";"BDBM50310925";"CN(C)c1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1";"IC50";"'='";"130.3";"nM";"6.88";"";"323827";"UO_0000065";"";"";"";"";"0";"CHEMBL3887222";"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886219";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL114613";"";"None";"497.06";"1";"5.97";"47";"COc1ccc(SCCC(=O)N2CCN(Cc3cccc(Oc4ccc(Cl)cc4)c3)CC2)cc1";"IC50";"'='";"3750.0";"nM";"5.43";"";"";"UO_0000065";"10.92";"0.22";"-0.54";"12.92";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL2070881";"";"None";"395.43";"0";"1.49";"6";"CN1CCC(NC(=O)Nc2nc3nn(C)cc3c3nc(-c4ccco4)nn23)CC1";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2070882";"";"None";"423.48";"0";"2.27";"7";"CCCN1CCC(NC(=O)Nc2nc3nn(C)cc3c3nc(-c4ccco4)nn23)CC1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2070884";"";"None";"419.45";"0";"1.49";"9";"C#CCN1CCC(NC(=O)Nc2nc3nn(C)cc3c3nc(-c4ccco4)nn23)CC1";"IC50";"'='";"105.0";"nM";"6.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2070886";"";"None";"471.53";"0";"3.06";"11";"Cn1cc2c(nc(NC(=O)NC3CCN(Cc4ccccc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"121.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2071038";"";"None";"467.49";"1";"1.42";"20";"CCOC(=O)CN1CCC(NC(=O)Nc2nc3nn(C)cc3c3nc(-c4ccco4)nn23)CC1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1201195";"CEFMETAZOLE";"4.0";"471.55";"1";"-0.73";"CEFMETAZOLE";"CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL81";"RALOXIFENE";"4.0";"473.59";"1";"6.08";"RALOXIFENE";"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1618305";"NALOXONAZINE";"None";"650.78";"1";"3.28";"NALOXONAZINE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL330394";"";"None";"251.25";"0";"2.85";"6";"Oc1nc2ccccc2c2cc(-c3ccco3)nn12";"IC50";"'='";"138.0";"nM";"6.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320331";"Activity at human adenosine A3 receptor transfected in CHO cells assessed as Cl-IB-MECA-inhibited cAMP accumulation by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311495";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL99193";"";"None";"275.31";"0";"3.56";"3";"Cc1ccc(-c2cc3c4ccccc4nc(O)n3n2)cc1";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320331";"Activity at human adenosine A3 receptor transfected in CHO cells assessed as Cl-IB-MECA-inhibited cAMP accumulation by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311495";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL802";"MINOXIDIL";"4.0";"209.25";"0";"-0.13";"MINOXIDIL";"Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL354161";"";"None";"419.36";"0";"2.82";"13";"Cn1cc2c(nc(NC(=O)Nc3ccc([N+](=O)[O-])cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644557";"Inhibition of IB-MECA agonist-mediated cAMP production in membranes of CHO cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL2042298";"";"None";"427.47";"0";"-0.18";"8a";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccccc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"104.0";"nM";"6.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2181964";"";"None";"390.44";"0";"2.59";"63";"COc1ccn2c(c1)nc1c2c(=O)n(CC2CC2)c(=O)n1Cc1ccc(C)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2181976";"";"None";"386.48";"1";"5.14";"31";"Cc1cc(C)cc(-c2nc(NC(=O)c3cccnc3)sc2-c2ccncc2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2181968";"";"None";"439.39";"0";"1.11";"74";"OC[C@H]1O[C@@H](n2cnc3c(C(F)(F)F)nc(NCCc4ccccc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.16";"nM";"9.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2177153";"";"None";"560.81";"1";"1.56";"86, MRS3057";"CNC(=O)[C@]1(n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)SC[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL209944";"";"None";"563.72";"1";"3.92";"22";"CCCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NC4CCN(Cc5ccccc5)CC4)cc3)cc2n(CCC)c1=O";"IC50";"'='";"1467.0";"nM";"5.83";"";"";"UO_0000065";"10.35";"0.20";"1.91";"5.34";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL3133075";"";"None";"315.39";"0";"4.19";"13";"CCOc1cc2occ(-c3nc(C)cs3)c(=O)c2cc1CC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3135329";"Displacement of [125I]AB-MECA from adenosine A3 receptor (unknown origin) expressed in CHO-K1 cells after 60 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3132836";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307512";"";"";""
"CHEMBL14";"CARBACHOL";"4.0";"182.65";"0";"-0.21";"CARBACHOL";"C[N+](C)(C)CCOC(N)=O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1016";"CANDESARTAN";"3.0";"440.46";"0";"4.03";"CANDESARTAN";"CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"'='";"1219.9";"nM";"5.91";"";"";"UO_0000065";"13.43";"0.24";"1.88";"4.98";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2071050";"";"None";"615.53";"1";"2.48";"33";"Cn1cc2c(nc(NC(=O)NC3CCN(C(=O)Nc4ccncc4)CC3)n3nc(-c4ccco4)nc23)n1.O=C(O)C(F)(F)F";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1201356";"METHYLERGONOVINE";"4.0";"339.44";"0";"1.92";"METHYLERGONOVINE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909064";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"None";"None";"None";"None";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL75435";"DEXKETOPROFEN";"4.0";"254.29";"0";"3.11";"DEXKETOPROFEN";"C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1256017";"ARCAINE SULFATE";"None";"270.31";"1";"-1.27";"ARCAINE SULFATE";"N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL632";"BETAMETHASONE";"4.0";"392.47";"0";"1.90";"BETAMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL990";"BUTENAFINE";"4.0";"317.48";"1";"5.77";"BUTENAFINE";"CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4649901";"";"None";"1495.48";"None";"None";"BLEOMYCIN A2";"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1094143";"";"None";"405.46";"0";"4.79";"2g";"O=C(Nc1nc(-c2ccccc2)nc2nn(Cc3ccccc3)cc12)c1ccccc1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120804";"Antagonist activity human recombinant adenosine A3 receptor expressed in CHO cells assessed as blockade of NECA-mediated inhibition of forskolin-stimulated [3H]cAMP production treated 15 mins before NECA challenge measured after 30 mins by liquid scintillation spectrometry";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157749";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL2070885";"";"None";"514.03";"0";"3.44";"10";"Cl.Cn1cc2c(nc(NC(=O)NC3CCN(CC4CCCCC4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2071040";"";"None";"466.51";"0";"1.97";"22";"CC(C)NC(=O)N1CCC(NC(=O)Nc2nc3nn(C)cc3c3nc(-c4ccco4)nn23)CC1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2069325";"";"None";"528.58";"1";"2.81";"27";"Cn1cc2c(nc(NC(=O)NC3CCN(C(=O)NCCc4ccccc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2071046";"";"None";"532.54";"1";"2.91";"29";"Cn1cc2c(nc(NC(=O)NC3CCN(C(=O)NCc4ccc(F)cc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2071047";"";"None";"549.00";"1";"3.42";"30";"Cn1cc2c(nc(NC(=O)NC3CCN(C(=O)NCc4ccc(Cl)cc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2071049";"";"None";"544.58";"1";"2.78";"32";"COc1ccc(CNC(=O)N2CCC(NC(=O)Nc3nc4nn(C)cc4c4nc(-c5ccco5)nn34)CC2)cc1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL126061";"";"None";"322.37";"0";"3.02";"2o";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(OC)cc3)nn12";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL123203";"";"None";"320.40";"0";"3.79";"9";"CCCCCCc1nc2[nH]cnc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"0.61";"nM";"9.21";"";"";"UO_0000065";"28.76";"0.52";"5.42";"12.84";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL115249";"";"None";"396.53";"0";"4.01";"43";"CCOc1ccc(CCOC(=O)N2CCN(CCCc3ccccc3)CC2)cc1";"IC50";"'='";"4180.0";"nM";"5.38";"";"";"UO_0000065";"13.56";"0.25";"1.37";"12.80";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL3922797";"";"None";"458.57";"0";"5.00";"BDBM178000";"O=C(c1cccs1)c1nc(NCc2cccnc2)nc2cc(NCc3cccnc3)sc12";"IC50";"'='";"308.3";"nM";"6.51";"";"323832";"UO_0000065";"";"";"";"";"0";"CHEMBL3887222";"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886219";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL136478";"SODIUM NITROPRUSSIDE";"4.0";"261.92";"None";"None";"SODIUM NITROPRUSSIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1440";"TETRACYCLINE";"4.0";"444.44";"1";"-0.21";"TETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL83";"TAMOXIFEN";"4.0";"371.52";"1";"6.00";"TAMOXIFEN";"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1";"IC50";"'='";"3701.0";"nM";"5.43";"";"";"UO_0000065";"14.62";"0.26";"-0.57";"43.56";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL866";"MYCOPHENOLIC ACID";"4.0";"320.34";"0";"2.73";"MYCOPHENOLIC ACID";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL742";"KETAMINE";"4.0";"237.73";"0";"2.90";"KETAMINE";"CNC1(c2ccccc2Cl)CCCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL164290";"N-NITROSODIETHYLAMINE";"None";"102.14";"0";"1.01";"N-NITROSODIETHYLAMINE";"CCN(CC)N=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1255834";"BW-723C86";"None";"286.40";"0";"3.70";"BW-723C86";"CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL62193";"SULFADIMETHOXINE";"4.0";"310.34";"0";"0.88";"SULFADIMETHOXINE";"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1167";"SPECTINOMYCIN";"4.0";"332.35";"0";"-2.93";"SPECTINOMYCIN";"CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"IB-MECA";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"19.37";"0.47";"9.48";"7.35";"0";"CHEMBL2395711";"Binding affinity to human adenosine A3 receptor by radioligand displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390830";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL330982";"";"None";"312.34";"0";"3.33";"10";"c1ccc(-c2nc3c4[nH]cnc4nc(-c4ccccc4)n3n2)cc1";"IC50";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"30.05";"0.53";"6.06";"13.08";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL344501";"";"None";"408.81";"0";"3.57";"19";"Cn1cc2c(nc(NC(=O)Nc3cccc(Cl)c3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644496";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 2.8-8.1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL123462";"";"None";"335.42";"0";"3.08";"32";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(N(C)C)cc3)nn12";"IC50";"'='";"0.67";"nM";"9.17";"";"";"UO_0000065";"27.35";"0.50";"6.09";"12.23";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL124788";"";"None";"326.79";"0";"3.66";"15";"CCCCc1nc2[nH]cnc2c2nc(-c3ccccc3Cl)nn12";"IC50";"'='";"0.29";"nM";"9.54";"";"";"UO_0000065";"29.19";"0.57";"5.88";"13.29";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL3601563";"";"None";"339.82";"0";"4.98";"27, PF-04822163";"COc1ccc2c([C@H]3CCc4ccc(Cl)cc43)nccc2c1OC";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"18.93";"0.37";"1.45";"20.52";"0";"CHEMBL3603032";"Inhibition of adenosine A3 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600381";"1";"Scientific Literature";"Medchemcomm";"2014";"None";"";"";""
"CHEMBL1243";"SULFABENZAMIDE";"4.0";"276.32";"0";"1.39";"SULFABENZAMIDE";"Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL313493";"METHANESULFONIC ACID METHYL ESTER";"None";"110.13";"0";"-0.41";"METHYL METHANESULFONATE";"COS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200559";"LACTIC ACID";"4.0";"90.08";"0";"-0.55";"LACTIC ACID";"CC(O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL469912";"PUROMYCIN";"2.0";"471.52";"1";"-0.79";"PUROMYCIN";"COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2042299";"";"None";"442.48";"2";"-0.60";"8b";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(N)cc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"141.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL306043";"GOLD SODIUM THIOMALATE";"4.0";"346.11";"None";"None";"GOLD SODIUM THIOMALATE";"";"IC50";"'='";"1492.0";"nM";"5.83";"";"";"UO_0000065";"16.83";"None";"None";"None";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL104";"CLOTRIMAZOLE";"4.0";"344.85";"1";"5.38";"SID11532882";"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1";"IC50";"'='";"4752.0";"nM";"5.32";"";"";"UO_0000065";"15.44";"0.29";"-0.06";"29.87";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL160";"CYCLOSPORINE";"4.0";"1202.63";"None";"None";"CYCLOSPORIN A";"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL865";"VALDECOXIB";"4.0";"314.37";"0";"2.96";"VALDECOXIB";"Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1504";"TRIAMCINOLONE ACETONIDE";"4.0";"434.50";"0";"2.42";"TRIAMCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL165";"RESVERATROL";"3.0";"228.25";"0";"2.97";"RESVERATROL";"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL481";"IRINOTECAN";"4.0";"586.69";"1";"4.09";"IRINOTECAN";"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201193";"LEVOBUPIVACAINE";"4.0";"288.44";"0";"3.90";"LEVOBUPIVACAINE";"CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4079314";"";"None";"517.63";"1";"3.60";"17";"Cc1cc(C)cc(-c2nc(NC3CCCC3)c3ncn([C@@H]4O[C@H](Cn5nc(C)cc5C)[C@@H](O)[C@H]4O)c3n2)c1";"IC50";"'='";"1940.0";"nM";"5.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4027925";"Antagonist activity at recombinant human adenosine A3 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase in presence of [alpha-31P]ATP";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024784";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL123346";"";"None";"368.44";"0";"4.68";"24";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(-c4ccccc4)cc3)nn12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"22.53";"0.40";"3.62";"11.57";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL112";"ACETAMINOPHEN";"4.0";"151.16";"0";"1.35";"ACETAMINOPHEN";"CC(=O)Nc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL427216";"GLICLAZIDE";"4.0";"323.42";"0";"1.63";"GLICLAZIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL95764";"GLYPHOSATE";"None";"169.07";"0";"-1.20";"Glyphosate";"O=C(O)CNCP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1630578";"TIRILAZAD";"3.0";"624.87";"2";"5.46";"TIRILAZAD";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL832";"SULFINPYRAZONE";"4.0";"404.49";"0";"3.80";"SULFINPYRAZONE";"O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1660";"RIFAPENTINE";"4.0";"877.04";"4";"5.65";"RIFAPENTINE";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL138332";"";"None";"436.86";"0";"4.44";"8";"CCCn1cc2c(nc(NC(=O)Nc3cccc(Cl)c3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644508";"Inhibitory concentration as antagonistic activity against cAMP generation inhibited by IB-MECA in CHO cell membranes transfected with human A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132457";"1";"Scientific Literature";"J Med Chem";"1999";"CHEMBL3308072";"";"";""
"CHEMBL333535";"";"None";"382.42";"0";"3.04";"30";"CCCCc1nc2[nH]cnc2c2nc(-c3cc(OC)c(OC)c(OC)c3)nn12";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"23.43";"0.44";"5.92";"9.01";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL339019";"";"None";"371.27";"1";"5.59";"3p";"CCCCc1nc2ccc(Cl)cc2c2nc(-c3ccc(Cl)cc3)nn12";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"20.34";"0.41";"1.96";"17.53";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL304726";"";"None";"430.43";"0";"3.57";"22";"C=CCn1cc2c(nc(NC(=O)Nc3ccc(OC)cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644499";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 3.5-7.6";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL210457";"";"None";"455.50";"0";"1.11";"6";"COc1ccc(CNS(=O)(=O)c2ccc(-c3cc4c([nH]3)c(=O)n(C)c(=O)n4C)cc2)nc1";"IC50";"'='";"38050.0";"nM";"4.42";"";"";"UO_0000065";"9.70";"0.19";"3.31";"3.45";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL1349";"VALACYCLOVIR";"4.0";"324.34";"0";"-0.80";"VALACYCLOVIR";"CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1321154";"ROXARSONE";"None";"263.04";"None";"None";"ROXARSONE";"O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1098108";"";"None";"359.39";"0";"3.29";"2b";"COc1ccc(C(=O)Nc2nc(-c3ccccc3)nc3nn(C)cc23)cc1";"IC50";"'='";"0.061";"nM";"10.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120806";"Antagonist activity at adenosine A3 receptor in human U87MG cells assessed as inhibition of Cl-IB-MECA-mediated ERK1/2 phosphorylation after 30 mins by ELISA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87MG ATCC";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157749";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307575";"";"";""
"CHEMBL378527";"";"None";"467.55";"0";"2.11";"21";"CCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCc4ccccn4)cc3)cc2n(CC)c1=O";"IC50";"'='";"18950.0";"nM";"4.72";"";"";"UO_0000065";"10.10";"0.20";"2.61";"3.97";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL332800";"";"None";"398.43";"0";"3.74";"1g";"O=C(O)CCCc1nc2[nH]cnc2c2nc(-c3ccc(-c4ccccc4)cc3)nn12";"IC50";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"20.23";"0.37";"4.32";"7.39";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL333415";"";"None";"310.34";"0";"3.15";"18";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(F)cc3)nn12";"IC50";"'='";"0.25";"nM";"9.60";"";"";"UO_0000065";"30.94";"0.57";"6.45";"13.38";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL339066";"";"None";"381.28";"1";"5.05";"43";"CCCCc1nc2ccccc2c2nc(-c3ccc(Br)cc3)nn12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL123465";"";"None";"278.32";"0";"2.62";"6";"CCCc1nc2[nH]cnc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"0.23";"nM";"9.64";"";"";"UO_0000065";"34.63";"0.63";"7.02";"13.43";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL122512";"";"None";"292.35";"0";"3.01";"1a";"CCCCc1nc2[nH]cnc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"0.25";"nM";"9.60";"";"";"UO_0000065";"32.84";"0.60";"6.59";"13.38";"1";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL125062";"";"None";"334.43";"0";"3.96";"2k";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(CCC)cc3)nn12";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"22.06";"0.40";"3.42";"10.28";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL431733";"NAMODENOSON";"3.0";"544.74";"1";"1.06";"Cl-IB-MECA";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL826591";"Inhibition of (10 uM) forskolin-mediated cAMP production in CHO cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138800";"1";"Scientific Literature";"J Med Chem";"2004";"CHEMBL3308072";"";"";""
"CHEMBL108705";"";"None";"434.00";"1";"6.38";"26, MRS1505";"CCCOC(=O)c1c(-c2cccc(Cl)c2)nc(CC)c(C(=O)SCCC)c1CC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2042303";"";"None";"630.80";"3";"2.47";"15c";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)CCCC[C@H]5CCSS5)cc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"121.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2042301";"";"None";"658.80";"3";"3.67";"15a";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)cc(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"60097.0";"nM";"4.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2042304";"";"None";"506.54";"1";"1.96";"5";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(F)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL65271";"";"None";"418.42";"0";"3.41";"1";"CCn1cc2c(nc(NC(=O)Nc3ccc(OC)cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644495";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 2.5-9.3";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL1431";"METFORMIN";"4.0";"129.17";"0";"-1.03";"METFORMIN";"CN(C)C(=N)NC(=N)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL115";"INDINAVIR";"4.0";"613.80";"1";"2.87";"INDINAVIR";"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1221";"SULCONAZOLE";"4.0";"397.76";"1";"6.52";"SULCONAZOLE";"Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"'='";"2628.0";"nM";"5.58";"";"";"UO_0000065";"14.03";"0.32";"-0.94";"31.32";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL21";"SULFANILAMIDE";"4.0";"172.21";"0";"-0.08";"SULFANILAMIDE";"Nc1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL245416";"L-MIMOSINE";"None";"198.18";"0";"-1.03";"L-MIMOSINE";"N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL252556";"IDEBENONE";"4.0";"338.44";"0";"3.46";"IDEBENONE";"COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1747";"TOBRAMYCIN";"4.0";"467.52";"2";"-6.30";"TOBRAMYCIN";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1191";"SULFAMETHIZOLE";"4.0";"270.34";"0";"1.23";"SULFAMETHIZOLE";"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1592";"QUINAPRIL";"4.0";"438.52";"0";"2.57";"QUINAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL36715";"PIRACETAM";"4.0";"142.16";"0";"-0.91";"PIRACETAM";"NC(=O)CN1CCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL159";"VINBLASTINE";"4.0";"810.99";"2";"3.99";"VINBLASTINE";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL164992";"";"None";"404.39";"0";"2.92";"19";"COc1cccc(NC(=O)Nc2nc3nn(C)cc3c3nc(-c4ccco4)nn23)c1";"IC50";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644489";"Inhibition of IB-MECA agonist-mediated cAMP production in CHO cell membranes expressing human Adenosine A3 receptor; range 5.5-10.9";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL2071044";"";"None";"514.55";"1";"2.77";"26";"Cn1cc2c(nc(NC(=O)NC3CCN(C(=O)NCc4ccccc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL348925";"";"None";"453.26";"0";"3.68";"15";"Cn1cc2c(nc(NC(=O)Nc3ccc(Br)cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644484";"Inhibition of IB-MECA agonist-mediated cAMP production in CHO cell membranes expressing human Adenosine A3 receptor; range 2.7-6.6";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL125288";"";"None";"370.38";"1";"5.31";"3g";"CCCCc1nc2ccccc2c2nc(-c3ccc(C(F)(F)F)cc3)nn12";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"17.04";"0.32";"1.00";"14.65";"1";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL275742";"DEXPROPRANOLOL";"-1.0";"259.35";"0";"2.58";"R-(+)-PROPRANOLOL";"CC(C)NC[C@@H](O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1766353";"";"None";"386.41";"0";"4.04";"13";"COc1cccc(NC(=O)Nc2nn(-c3ccccc3)c(=O)c3ccccc23)c1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1769841";"Antagonist activity at human cloned adenosine A3 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1764987";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL3183075";"NIZATIDINE";"4.0";"331.47";"0";"1.32";"NIZATIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1766354";"";"None";"386.41";"0";"4.04";"14";"COc1ccccc1NC(=O)Nc1nn(-c2ccccc2)c(=O)c2ccccc12";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1769841";"Antagonist activity at human cloned adenosine A3 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1764987";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL765";"GUANETHIDINE";"4.0";"198.31";"0";"0.74";"GUANETHIDINE";"N=C(N)NCCN1CCCCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL47244";"PICROTOXININ";"None";"292.29";"0";"-0.06";"COCCULIN";"C=C(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1231530";"BETAMIPRON";"2.0";"193.20";"0";"0.89";"BETAMIPRON";"O=C(O)CCNC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL998";"LORATADINE";"4.0";"382.89";"0";"4.89";"LORATADINE";"CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL683";"CLOFIBRIC ACID";"2.0";"214.65";"0";"2.58";"CLOFIBRIC ACID";"CC(C)(Oc1ccc(Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL585";"TRIAMTERENE";"4.0";"253.27";"0";"0.83";"TRIAMTERENE";"Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL113956";"";"None";"521.65";"2";"5.85";"44";"CCOc1ccc(CCNC(=O)N2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1";"IC50";"'='";"2460.0";"nM";"5.61";"";"";"UO_0000065";"10.75";"0.20";"-0.24";"12.52";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL235513";"";"None";"445.87";"0";"3.92";"23";"COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3n3c(=O)c(-c4ccccc4)nn23)cc1";"IC50";"'='";"3.14";"nM";"8.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL901023";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137613";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3308072";"";"";""
"CHEMBL4098408";"";"None";"414.22";"0";"2.22";"7";"O[C@@H]1[C@H](O)[C@@H](CCl)O[C@H]1n1cnc2c(Nc3ccc(Cl)cc3F)ncnc21";"IC50";"'='";"4140.0";"nM";"5.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4027925";"Antagonist activity at recombinant human adenosine A3 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase in presence of [alpha-31P]ATP";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024784";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL123669";"";"None";"366.85";"0";"4.95";"3n";"CCCCc1nc2cc(Cl)ccc2c2nc(-c3ccc(OC)cc3)nn12";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"20.36";"0.39";"2.52";"14.28";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL1258621";"";"None";"479.54";"1";"5.80";"22";"CCc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccc(OC)cc1C(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL333843";"";"None";"403.82";"0";"3.44";"4";"O=C(NCCCn1c(O)nc2ccccc21)OCc1cc2c(cc1Cl)OCO2";"IC50";"'='";"3330.0";"nM";"5.48";"";"";"UO_0000065";"13.56";"0.27";"2.04";"5.78";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL124659";"";"None";"415.72";"1";"5.70";"3q";"CCCCc1nc2ccc(Cl)cc2c2nc(-c3ccc(Br)cc3)nn12";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"18.42";"0.42";"1.96";"17.78";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL222863";"OUABAIN";"4.0";"584.66";"3";"-1.51";"OUABAIN";"C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL498";"CHLORPROPAMIDE";"4.0";"276.75";"0";"1.74";"CHLORPROPAMIDE";"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL715";"OLANZAPINE";"4.0";"312.44";"0";"3.44";"OLANZAPINE";"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL635";"PREDNISONE";"4.0";"358.43";"0";"1.77";"PREDNISONE";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1096754";"";"None";"329.36";"0";"3.28";"2a";"Cn1cc2c(NC(=O)c3ccccc3)nc(-c3ccccc3)nc2n1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120804";"Antagonist activity human recombinant adenosine A3 receptor expressed in CHO cells assessed as blockade of NECA-mediated inhibition of forskolin-stimulated [3H]cAMP production treated 15 mins before NECA challenge measured after 30 mins by liquid scintillation spectrometry";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157749";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1237044";"TRAMADOL";"4.0";"263.38";"0";"2.63";"TRAMADOL";"COc1cccc(C2(O)CCCCC2CN(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1489254";"TRIACETIN";"2.0";"218.21";"0";"0.04";"TRIACETIN";"CC(=O)OCC(COC(C)=O)OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL64391";"ITRACONAZOLE";"4.0";"705.65";"3";"5.58";"ITRACONAZOLE";"CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL164281";"";"None";"408.81";"0";"3.57";"20";"Cn1cc2c(nc(NC(=O)Nc3ccccc3Cl)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644488";"Inhibition of IB-MECA agonist-mediated cAMP production in CHO cell membranes expressing human Adenosine A3 receptor; range 4.4-15.2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL895";"NALBUPHINE";"4.0";"357.45";"0";"1.71";"NALBUPHINE";"Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3358920";"ETRASIMOD";"4.0";"457.49";"1";"6.93";"(R)-4, APD334";"O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"11.98";"0.23";"-1.45";"8.80";"0";"CHEMBL3373701";"Binding affinity to human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352115";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1475";"TRIOXSALEN";"4.0";"228.25";"0";"3.46";"TRIOXSALEN";"Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL137";"METRONIDAZOLE";"4.0";"171.16";"0";"0.09";"METRONIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL960";"LEFLUNOMIDE";"4.0";"270.21";"0";"3.25";"LEFLUNOMIDE";"Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL445206";"ISOEUGENOL";"None";"164.20";"0";"2.43";"ISOEUGENOL";"C/C=C\c1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL870";"ALENDRONIC ACID";"4.0";"249.10";"1";"-1.27";"ALENDRONIC ACID";"NCCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL64894";"GENTIAN VIOLET";"4.0";"407.99";"0";"4.46";"GENTIAN VIOLET";"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]";"IC50";"'='";"4166.0";"nM";"5.38";"";"";"UO_0000065";"14.44";"0.26";"0.92";"56.69";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL105";"MITOMYCIN";"4.0";"334.33";"0";"-1.65";"MITOMYCIN C";"CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201010";"FLUDROCORTISONE ACETATE";"4.0";"422.49";"0";"2.44";"FLUDROCORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL18701";"RO-201724";"None";"278.35";"0";"2.10";"Ro-201724";"CCCCOc1cc(CC2CNC(=O)N2)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL980";"GUAIFENESIN";"4.0";"198.22";"0";"0.43";"GUAIFENESIN";"COc1ccccc1OCC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL433257";"HARRINGTONINE";"None";"531.60";"1";"2.19";"HARRINGTONINE";"COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201216";"DAPIPRAZOLE";"4.0";"325.46";"0";"2.29";"DAPIPRAZOLE";"Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL60889";"MOSAPRIDE";"3.0";"421.90";"0";"3.09";"MOSAPRIDE";"CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL748";"PRALIDOXIME CHLORIDE";"4.0";"172.62";"0";"0.32";"PRALIDOXIME CHLORIDE";"C[n+]1ccccc1/C=N/O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL307145";"PYROGALLOL";"4.0";"126.11";"0";"0.80";"PYROGALLOL";"Oc1cccc(O)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL141343";"";"None";"520.72";"1";"4.21";"U-78517F";"Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2";"IC50";"'='";"10750.0";"nM";"4.97";"";"";"UO_0000065";"9.54";"0.18";"0.76";"7.29";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL567";"PERPHENAZINE";"4.0";"403.98";"0";"3.94";"PERPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL273348";"TOSUFLOXACIN";"2.0";"404.35";"0";"2.04";"TOSUFLOXACIN";"NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL443";"SULFAMETHOXAZOLE";"4.0";"253.28";"0";"1.37";"SULFAMETHOXAZOLE";"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL510139";"CITRININ";"None";"250.25";"0";"1.72";"CITRININ";"CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL393362";"";"None";"524.32";"1";"1.06";"21";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](OC)[C@@H]1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL393578";"";"None";"279.26";"0";"-1.57";"10";"Nc1ncnc2c1ncn2[C@@H]1O[C@@]2(CO)CO[C@@H]1[C@@H]2O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL391483";"";"None";"521.32";"1";"0.39";"17";"CNC(=O)[C@@]12CN[C@@H]([C@H](n3cnc4c(NCc5cccc(I)c5)ncnc43)O1)[C@@H]2O";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL516851";"";"None";"399.84";"0";"4.87";"15";"O=C(Nc1nc2ccccc2c2cn(-c3ccc(Cl)cc3)nc12)c1ccncc1";"IC50";"'='";"145.0";"nM";"6.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1013711";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of CI-IB-MECA-mediated inhibition of cAMP accumulation by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152204";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL235542";"";"None";"278.27";"0";"-2.00";"14";"Nc1ncnc2c1ncn2[C@@H]1O[C@@]2(CO)CN[C@@H]1[C@@H]2O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL391278";"";"None";"522.30";"1";"0.82";"13";"CNC(=O)[C@@]12CO[C@@H]([C@H](n3cnc4c(NCc5cccc(I)c5)ncnc43)O1)[C@@H]2O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL212416";"";"None";"546.65";"1";"2.48";"23";"CCCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccc(C#N)cc5)CC4)cc3)cc2n(C)c1=O";"IC50";"'='";"950.0";"nM";"6.02";"";"";"UO_0000065";"11.02";"0.21";"3.54";"4.85";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL236373";"";"None";"295.30";"0";"2.18";"6";"COc1ccc(NC(=O)c2nc(=O)[nH]c3ccccc23)cc1";"IC50";"'='";"125.0";"nM";"6.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL902658";"Activity at human adenosine A3 receptor expressed in CHO cells assessed as antagonism of Cl-IB-MECA-inhibited cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138345";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3308072";"";"";""
"CHEMBL2042310";"";"None";"811.05";"4";"6.13";"16c";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)CCCC[C@H]5CCSS5)cc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"113.0";"nM";"6.95";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3752862";"";"None";"403.49";"0";"4.86";"28";"O=C(Nc1nc(-c2cccs2)nc2cn(-c3ccccc3)nc12)c1cccs1";"IC50";"'='";"5.59";"nM";"8.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL891";"CLOXACILLIN";"4.0";"435.89";"0";"2.55";"CLOXACILLIN";"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5314404";"AJMALINE";"3.0";"326.44";"0";"1.55";"AJMALINE";"CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)c5ccccc5[C@]45C[C@@H]([C@@H]2[C@H]5O)N3[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.003311";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322685";"Agonist activity at wild type human A3 receptor V169'5.30E mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"V169E";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"109.65";"nM";"6.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322687";"Agonist activity at wild type human A3 receptor M177'5.38A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"M177A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.02291";"nM";"10.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322688";"Agonist activity at wild type human A3 receptor W185'5.46A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"W185A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.7762";"nM";"9.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322693";"Agonist activity at wild type human A3 receptor L264'7.35A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"L264A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL1024";"IFOSFAMIDE";"4.0";"261.09";"0";"1.88";"IFOSFAMIDE";"O=P1(NCCCl)OCCCN1CCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL936";"DIPHENIDOL";"4.0";"309.45";"0";"4.19";"DIPHENIDOL";"OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL622";"ETODOLAC";"4.0";"287.36";"0";"3.38";"ETODOLAC";"CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL534";"KETOTIFEN";"4.0";"309.43";"0";"4.01";"KETOTIFEN";"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1255837";"DIHYDROERGOCRISTINE MESYLATE";"None";"707.85";"1";"2.72";"DIHYDROERGOCRISTINE MESYLATE";"CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800733";"";"None";"325.38";"0";"1.70";"28";"C=CCN1C(=O)N2CC(C)N=C2c2[nH]c(-c3cc(C)nn3C)nc21";"IC50";"'='";"34.2";"nM";"7.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800793";"";"None";"325.38";"0";"1.70";"40";"C=CCN1C(=O)N2CC(C)N=C2c2[nH]c(-c3cc(C)n(C)n3)nc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800794";"";"None";"339.40";"0";"2.09";"41";"C=CCN1C(=O)N2CC(CC)N=C2c2[nH]c(-c3cc(C)n(C)n3)nc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800796";"";"None";"325.38";"0";"1.70";"S-41";"C=CCN1C(=O)N2C[C@H](C)N=C2c2[nH]c(-c3cc(C)n(C)n3)nc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL580";"LORAZEPAM";"4.0";"321.16";"0";"3.10";"LORAZEPAM";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL502896";"CETRAXATE HYDROCHLORIDE";"-1.0";"341.83";"0";"2.37";"CETRAXATE";"Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1384";"KANAMYCIN";"4.0";"484.50";"2";"-7.29";"KANAMYCIN";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL628";"PENTOXIFYLLINE";"4.0";"278.31";"0";"0.19";"PENTOXIFYLLINE";"CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1499";"CORTISONE";"3.0";"360.45";"0";"1.99";"CORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL516";"CYPROHEPTADINE";"4.0";"287.41";"0";"4.70";"CYPROHEPTADINE";"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL897";"PROBENECID";"4.0";"285.37";"0";"2.20";"PROBENECID";"CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL686";"MEFENAMIC ACID";"4.0";"241.29";"0";"3.75";"MEFENAMIC ACID";"Cc1cccc(Nc2ccccc2C(=O)O)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL248702";"DEXFENFLURAMINE";"4.0";"231.26";"0";"3.25";"DEXFENFLURAMINE";"CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL193141";"";"None";"312.72";"0";"1.96";"3";"O=c1[nH]c2ccccc2n2c(=O)c(-c3ccc(Cl)cc3)nn12";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL901023";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137613";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3308072";"";"";""
"CHEMBL235717";"";"None";"459.89";"0";"4.23";"25";"COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3n3c(=O)c(-c4ccc(C)cc4)nn23)cc1";"IC50";"'='";"11.61";"nM";"7.93";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL901023";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137613";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3308072";"";"";""
"CHEMBL1094131";"";"None";"439.91";"1";"5.45";"2i";"O=C(Nc1nc(-c2ccccc2)nc2nn(Cc3ccccc3)cc12)c1cccc(Cl)c1";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120804";"Antagonist activity human recombinant adenosine A3 receptor expressed in CHO cells assessed as blockade of NECA-mediated inhibition of forskolin-stimulated [3H]cAMP production treated 15 mins before NECA challenge measured after 30 mins by liquid scintillation spectrometry";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157749";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL91";"MICONAZOLE";"4.0";"416.13";"1";"6.45";"table 3";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"'='";"2811.0";"nM";"5.55";"";"";"UO_0000065";"13.34";"0.30";"-0.90";"20.52";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL29";"BENZYLPENICILLIN";"4.0";"334.40";"0";"0.86";"PENICILLIN G";"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1643";"RIBAVIRIN";"4.0";"244.21";"0";"-3.01";"Ribavirin";"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2070894";"";"None";"472.51";"0";"2.45";"19";"Cn1cc2c(nc(NC(=O)NC3CCN(Cc4ccncc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"166.0";"nM";"6.78";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL324512";"";"None";"454.43";"0";"2.16";"63";"Cn1cc2c(nc(NC(=O)Nc3ccc(S(=O)(=O)O)cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL646733";"Inhibition of IB-MECA agonist-mediated cAMP production in CHO cell membranes expressing human Adenosine A3 receptor; range 130-279";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL2070883";"";"None";"421.47";"0";"2.04";"8";"C=CCN1CCC(NC(=O)Nc2nc3nn(C)cc3c3nc(-c4ccco4)nn23)CC1";"IC50";"'='";"212.0";"nM";"6.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2071042";"";"None";"506.57";"1";"2.90";"24";"Cn1cc2c(nc(NC(=O)NC3CCN(C(=O)NC4CCCCC4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2042306";"";"None";"622.73";"3";"3.06";"9b";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(N)cc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL325516";"";"None";"496.57";"1";"6.01";"39";"O=C(OCCc1ccc(F)cc1)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1";"IC50";"'='";"4210.0";"nM";"5.38";"";"";"UO_0000065";"10.83";"0.20";"-0.63";"16.40";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL2071043";"";"None";"520.60";"1";"3.29";"25";"Cn1cc2c(nc(NC(=O)NC3CCN(C(=O)NC4CCCCCC4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2071051";"";"None";"621.58";"1";"1.22";"34";"CN1CCN(C(=O)N2CCC(NC(=O)Nc3nc4nn(C)cc4c4nc(-c5ccco5)nn34)CC2)CC1.O=C(O)C(F)(F)F";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2042297";"";"None";"326.29";"0";"-1.70";"4";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(F)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2042302";"";"None";"674.80";"3";"3.37";"15b";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)c(O)c(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"756.0";"nM";"6.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2042309";"";"None";"855.05";"4";"7.03";"16b";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)c(O)c(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"1407.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2220442";"FLUVASTATIN";"4.0";"411.47";"0";"4.63";"FLUVASTATIN";"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1766";"DESOXIMETASONE";"4.0";"376.47";"0";"2.78";"DESOXIMETASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL685";"MEBENDAZOLE";"4.0";"295.30";"0";"2.97";"MEBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL210969";"";"None";"553.66";"1";"3.28";"20";"CCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NC4CCN(Cc5ccc(F)cc5)CC4)cc3)cc2n(CC)c1=O";"IC50";"'='";"4314.0";"nM";"5.37";"";"";"UO_0000065";"9.69";"0.19";"2.09";"4.91";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL1177";"PEMOLINE";"4.0";"176.18";"0";"0.60";"PEMOLINE";"NC1=NC(=O)C(c2ccccc2)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1630579";"MYRTECAINE";"2.0";"265.44";"0";"3.73";"MYRTECAINE";"CCN(CC)CCOCCC1=CCC2CC1C2(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL459";"METHYLDOPA";"4.0";"211.22";"0";"0.44";"METHYLDOPA";"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL488025";"EXISULIND";"3.0";"372.42";"0";"4.03";"SULINDAC SULFONE";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL991";"STAVUDINE";"4.0";"224.22";"0";"-0.71";"STAVUDINE";"Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL386630";"TESTOSTERONE";"4.0";"288.43";"0";"3.88";"TESTOSTERONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200679";"ZINC CHLORIDE";"4.0";"136.30";"None";"None";"ZINC CHLORIDE";"[Cl-].[Cl-].[Zn+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL442";"ERGOTAMINE";"4.0";"581.67";"1";"1.99";"ERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL340657";"";"None";"292.35";"0";"3.01";"9b-1";"CCCCc1nc2[nH]ncc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"29.68";"0.54";"5.67";"12.09";"0";"CHEMBL644555";"Binding affinity for human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL201706";"";"None";"358.81";"0";"-0.40";"4";"CNC(=O)[C@H]1S[C@@H](n2cnc3c(NC)nc(Cl)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644507";"Inhibitory concentration against human Adenosine A3 receptor mediated inhibition of cyclic AMP in transfected CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145992";"1";"Scientific Literature";"J Med Chem";"2003";"CHEMBL3308072";"";"";""
"CHEMBL212458";"";"None";"515.53";"1";"4.53";"20";"COc1ccc(-n2nc3c(N(C(=O)c4ccccc4)C(=O)c4ccccc4)nc4ccccc4n3c2=O)cc1";"IC50";"'='";"31.8";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL867251";"Antagonist activity against Cl-IB-MECA inhibited cAMP level in CHO cells transfected with human A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138044";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1909069";"";"None";"None";"None";"None";"MC 288769";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1321";"PROCARBAZINE";"4.0";"221.30";"0";"1.05";"PROCARBAZINE";"CNNCc1ccc(C(=O)NC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL241694";"ETHISTERONE";"3.0";"312.45";"0";"3.88";"ETHISTERONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2042305";"";"None";"607.72";"1";"3.48";"9a";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccccc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1466";"DICUMAROL";"4.0";"336.30";"0";"2.90";"DICUMAROL";"O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL726";"FLUPHENAZINE";"4.0";"437.53";"0";"4.31";"FLUPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"'='";"11935.0";"nM";"4.92";"";"";"UO_0000065";"11.25";"0.22";"0.61";"16.44";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL614";"PYRAZINAMIDE";"4.0";"123.11";"0";"-0.42";"PYRAZINAMIDE";"NC(=O)c1cnccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1371125";"BENZO[E]PYRENE";"None";"252.32";"1";"5.74";"BENZO[E]PYRENE";"c1ccc2c(c1)c1cccc3ccc4cccc2c4c31";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL445";"NORTRIPTYLINE";"4.0";"263.38";"0";"3.83";"NORTRIPTYLINE";"CNCCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909067";"";"None";"None";"None";"None";"MC 258714";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1766359";"";"None";"370.41";"0";"3.71";"19";"O=C(NCc1ccccc1)Nc1nn(-c2ccccc2)c(=O)c2ccccc12";"IC50";"'='";"1.15";"nM";"8.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1769841";"Antagonist activity at human cloned adenosine A3 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1764987";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL193692";"";"None";"447.50";"0";"1.68";"72, MRS3310";"OC[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL333799";"";"None";"353.29";"0";"1.24";"46";"COc1ccc(-n2nc3c(=O)[nH]c4c([N+](=O)[O-])cccc4n3c2=O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL363419";"";"None";"309.37";"0";"3.84";"38";"c1ccc(Oc2nc3ncnc-3c(NC3CCCCC3)[nH]2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL305975";"";"None";"371.40";"0";"4.34";"34, VUF5574";"COc1ccccc1NC(=O)Nc1nc(-c2ccccn2)nc2ccccc12";"IC50";"'='";"7.9";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL123705";"";"None";"360.34";"0";"4.03";"60, OT-7999";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(C(F)(F)F)cc3)nn12";"IC50";"'='";"0.61";"nM";"9.21";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL184618";"FRAMYCETIN";"3.0";"614.65";"3";"-8.90";"NEOMYCIN";"NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL918";"PHENACEMIDE";"4.0";"178.19";"0";"0.42";"PHENACEMIDE";"NC(=O)NC(=O)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800738";"";"None";"389.46";"0";"3.10";"31";"CCC1CN2C(=O)N(Cc3ccccc3)c3nc(-c4cc(C)nn4C)[nH]c3C2=N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800791";"";"None";"467.53";"0";"3.98";"38";"CC1CN2C(=O)N(Cc3ccccc3)c3nc(-c4cc(OCc5ccccc5)nn4C)[nH]c3C2=N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL672";"FENOFIBRATE";"4.0";"360.84";"0";"4.68";"FENOFIBRATE";"CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1";"IC50";"'='";"5701.0";"nM";"5.24";"";"";"UO_0000065";"14.53";"0.29";"0.56";"9.97";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1444";"LETROZOLE";"4.0";"285.31";"0";"2.66";"LETROZOLE";"N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1237174";"HYDRAZINE";"0.5";"32.05";"0";"-1.18";"HYDRAZINE";"NN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1433";"DOXYCYCLINE ANHYDROUS";"4.0";"444.44";"1";"-0.35";"DOXYCYCLINE";"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL588119";"SULOCTIDIL";"None";"337.57";"1";"5.56";"SULOCTIDIL";"CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1";"IC50";"'='";"3705.8";"nM";"5.43";"";"";"UO_0000065";"16.09";"0.32";"-0.13";"16.84";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL877";"TRANEXAMIC ACID";"4.0";"157.21";"0";"0.84";"TRANEXAMIC ACID";"NC[C@H]1CC[C@H](C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL571";"KETOPROFEN";"4.0";"254.29";"0";"3.11";"KETOPROFEN";"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL460291";"LACIDIPINE";"4.0";"455.55";"0";"4.40";"LACIDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C";"IC50";"'='";"4036.0";"nM";"5.39";"";"";"UO_0000065";"11.84";"0.22";"0.99";"5.93";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL331111";"";"None";"322.37";"0";"3.02";"27";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(OC)cc3)nn12";"IC50";"'<'";"0.1";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL1258283";"";"None";"469.93";"1";"6.19";"16";"Cc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccc(Cl)cc1C(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL389621";"HYDROCORTISONE";"4.0";"362.47";"0";"1.78";"HYDROCORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL340580";"";"None";"302.38";"0";"4.29";"3a";"CCCCc1nc2ccccc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"21.78";"0.39";"2.30";"15.29";"1";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL156455";"1,1-DICHLOROETHENE";"None";"96.94";"0";"1.94";"1,1-DICHLOROETHENE";"C=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL421611";"";"None";"326.79";"0";"3.66";"2d";"CCCCc1nc2[nH]ncc2c2nc(-c3ccccc3Cl)nn12";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL611104";"";"None";"586.63";"2";"0.59";"99";"C=CCN(CC=C)S(=O)(=O)c1ccc(NC(=O)Nc2ncnc3c2ncn3C2O[C@H](C(=O)NCC)[C@@H](O)[C@H]2O)cc1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL826591";"Inhibition of (10 uM) forskolin-mediated cAMP production in CHO cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138800";"1";"Scientific Literature";"J Med Chem";"2004";"CHEMBL3308072";"";"";""
"CHEMBL407";"FLUMAZENIL";"4.0";"303.29";"0";"1.77";"FLUMAZENIL";"CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"astemizole";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"IC50";"'='";"29120.0";"nM";"4.54";"";"";"UO_0000065";"9.89";"0.18";"-0.81";"10.72";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1372";"OXIGLUTATIONE";"4.0";"612.64";"3";"-3.88";"GLUTATHIONE, OXIDIZED FORM";"N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL9514";"NOCODAZOLE";"2.0";"301.33";"0";"3.03";"NOCODAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL418971";"BISPHENOL A";"None";"228.29";"0";"3.42";"BISPHENOL A";"CC(C)(c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1489";"AZACITIDINE";"4.0";"244.21";"0";"-3.17";"AZACITIDINE";"Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3084803";"ASTROMICIN";"-1.0";"405.50";"1";"-3.59";"ASTROMICIN";"CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1140";"NIACINAMIDE";"4.0";"122.13";"0";"0.18";"NIACINAMIDE";"NC(=O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2322929";"";"None";"329.36";"0";"3.44";"14";"CC(=O)Nc1nc(-c2ccccc2)nc2cn(-c3ccccc3)nc12";"IC50";"'='";"103.0";"nM";"6.99";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2330938";"Inhibition of human A3 adenosine receptor transfected in CHO cells assessed as inhibition of forskolin-induced cyclic AMP production after 10 mins by competitive protein binding assay in presence of CI-IB-MECA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321860";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1760";"TERBUTALINE";"4.0";"225.29";"0";"1.52";"TERBUTALINE";"CC(C)(C)NCC(O)c1cc(O)cc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL833";"TICLOPIDINE";"4.0";"263.79";"0";"3.96";"TICLOPIDINE";"Clc1ccccc1CN1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1258397";"";"None";"451.49";"1";"5.24";"19";"COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2)c(C(=O)O)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1259525";"Antagonist activity at adenosine A3 receptor by cAMP assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1117";"IDARUBICIN";"4.0";"497.50";"0";"1.02";"IDARUBICIN";"CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1732";"DIHYDROERGOTAMINE";"4.0";"583.69";"1";"2.08";"DIHYDROERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL511";"PYRILAMINE";"4.0";"285.39";"0";"2.66";"PYRILAMINE";"COc1ccc(CN(CCN(C)C)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL122511";"";"None";"306.37";"0";"3.40";"8";"CCCCCc1nc2[nH]cnc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"31.08";"0.57";"6.12";"13.27";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL828";"PHENOTHIAZINE";"2.0";"199.28";"0";"3.89";"PHENOTHIAZINE";"c1ccc2c(c1)Nc1ccccc1S2";"IC50";"'='";"25640.0";"nM";"4.59";"";"";"UO_0000065";"23.04";"0.45";"0.70";"38.16";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL485549";"NIFURSOL";"2.0";"365.21";"0";"1.47";"NIFURSOL";"O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL572765";"";"None";"392.35";"0";"3.05";"16";"Cn1cc2c(nc(NC(=O)Nc3ccc(F)cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644483";"Inhibition of IB-MECA agonist-mediated cAMP production in CHO cell membranes expressing human Adenosine A3 receptor; range 2.0-4.3";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL349019";"";"None";"443.25";"0";"4.22";"11";"Cn1cc2c(nc(NC(=O)Nc3ccc(Cl)c(Cl)c3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644482";"Inhibition of IB-MECA agonist-mediated cAMP production in CHO cell membranes expressing human Adenosine A3 receptor; range 15-44";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136016";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308072";"";"";""
"CHEMBL1082723";"CIPARGAMIN";"2.0";"390.24";"0";"4.34";"NITD609";"C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12";"IC50";"'='";"8300.0";"nM";"5.08";"";"";"UO_0000065";"13.02";"0.27";"0.74";"8.93";"0";"CHEMBL1247724";"Binding affinity to human recombinant adenosine 3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240532";"1";"Scientific Literature";"Science";"2010";"None";"";"";""
"CHEMBL2181969";"";"None";"522.30";"1";"0.55";"77, MRS1292";"O=C1NCCC12O[C@@H](n1cnc3c(NCc4cccc(I)c4)ncnc31)[C@H](O)[C@@H]2O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL11359";"CISPLATIN";"4.0";"300.05";"None";"None";"Cisplatin";"";"IC50";"'='";"4243.0";"nM";"5.37";"";"";"UO_0000065";"17.90";"None";"None";"None";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL451";"CHLORDIAZEPOXIDE";"4.0";"299.76";"0";"2.95";"CHLORDIAZEPOXIDE";"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1371";"CHLORZOXAZONE";"4.0";"169.57";"0";"1.77";"CHLORZOXAZONE";"O=c1[nH]c2cc(Cl)ccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1388";"MONOBENZONE";"4.0";"200.24";"0";"2.97";"MONOBENZONE";"Oc1ccc(OCc2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1278088";"";"None";"432.57";"0";"2.53";"17m";"Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1286229";"Displacement of [125I]AB-MECA from human recombinant adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1275331";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL341041";"";"None";"332.41";"0";"4.30";"3j";"CCCCc1nc2ccccc2c2nc(-c3ccc(OC)cc3)nn12";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"20.44";"0.37";"2.50";"12.99";"1";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL70586";"SPIRADOLINE";"None";"425.40";"0";"4.56";"SPIRADOLINE";"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL208705";"";"None";"411.44";"0";"1.43";"4";"Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)Nc4ccccn4)cc3)cc2n(C)c1=O";"IC50";"'='";"1315.0";"nM";"5.88";"";"";"UO_0000065";"14.29";"0.28";"4.45";"4.95";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL210931";"";"None";"539.63";"1";"2.84";"19";"CCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5cccc(F)c5)CC4)cc3)cc2n(CC)c1=O";"IC50";"'='";"21880.0";"nM";"4.66";"";"";"UO_0000065";"8.64";"0.17";"1.82";"4.64";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL211813";"";"None";"534.06";"1";"2.45";"17";"Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccc(Cl)s5)CC4)cc3)cc2n(C)c1=O";"IC50";"'='";"5249.0";"nM";"5.28";"";"";"UO_0000065";"9.89";"0.21";"2.83";"5.26";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL209208";"";"None";"455.50";"0";"0.98";"8";"Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCOc4ccccn4)cc3)cc2n(C)c1=O";"IC50";"'='";"6438.0";"nM";"5.19";"";"";"UO_0000065";"11.40";"0.22";"4.21";"4.05";"0";"CHEMBL864809";"Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138926";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308376";"";"";""
"CHEMBL1651906";"STREPTOZOCIN";"4.0";"265.22";"0";"-2.89";"STREPTOZOTOCIN";"CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1237";"LISINOPRIL ANHYDROUS";"4.0";"405.50";"0";"1.24";"LISINOPRIL";"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL182";"GANCICLOVIR";"4.0";"255.23";"0";"-1.97";"GANCICLOVIR";"Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1908847";"SPARTEINE";"4.0";"234.39";"0";"2.35";"SPARTEINE";"C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@@H]34)[C@H]2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1503";"OMEPRAZOLE";"4.0";"345.42";"0";"2.90";"Omeprazole";"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL871";"ETIDRONIC ACID";"4.0";"206.03";"0";"-0.99";"ETIDRONATE";"CC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL711";"PHENINDIONE";"4.0";"222.24";"0";"2.85";"PHENINDIONE";"O=C1c2ccccc2C(=O)C1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL334255";"CETYLPYRIDINIUM BROMIDE";"None";"384.45";"1";"6.46";"CETYLPYRIDINIUM BROMIDE";"CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]";"IC50";"'='";"4758.0";"nM";"5.32";"";"";"UO_0000065";"17.48";"0.33";"-1.14";"137.18";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19019";"NALTREXONE";"4.0";"341.41";"0";"1.53";"NALTREXONE";"O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2105807";"MADURAMICIN";"2.0";"934.17";"2";"4.32";"MADURAMICIN";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C.N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1687";"TUBOCURARINE CHLORIDE";"None";"645.20";"2";"6.70";"D-TUBOCURARINE CHLORIDE";"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL558";"MEXILETINE";"4.0";"179.26";"0";"2.03";"MEXILETINE";"Cc1cccc(C)c1OCC(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL517712";"ATROPINE";"4.0";"289.38";"0";"1.93";"ATROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1020";"TOLMETIN";"4.0";"257.29";"0";"2.19";"TOLMETIN";"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL702";"PIPERACILLIN";"4.0";"517.56";"1";"-0.24";"Piperacillin";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL803";"CYTARABINE";"4.0";"243.22";"0";"-2.56";"CYTARABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL898";"DIFLUNISAL";"4.0";"250.20";"0";"3.04";"DIFLUNISAL";"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL109";"VALPROIC ACID";"4.0";"144.21";"0";"2.29";"Na valproate";"CCCC(CCC)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909065";"MADURAMICIN";"2.0";"917.14";"2";"4.32";"LYSERGOL";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1513";"IRBESARTAN";"4.0";"428.54";"0";"4.78";"IRBESARTAN";"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL141";"LAMIVUDINE";"4.0";"229.26";"0";"-0.59";"LAMIVUDINE";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL608755";"";"None";"562.61";"2";"0.25";"97";"CCNC(=O)[C@H]1OC(n2cnc3c(NC(=O)Nc4ccc(S(=O)(=O)N(C)C(C)C)cc4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL826591";"Inhibition of (10 uM) forskolin-mediated cAMP production in CHO cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138800";"1";"Scientific Literature";"J Med Chem";"2004";"CHEMBL3308072";"";"";""
"CHEMBL63323";"NIFLUMIC ACID";"2.0";"282.22";"0";"3.54";"NIFLUMIC ACID";"O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909054";"CARBOXYMETHYLCELLULOSE";"None";"None";"None";"None";"CARBOXYMETHYLCELLULOSE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL460499";"CARMOFUR";"2.0";"257.26";"0";"0.81";"CARMOFUR";"CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL130";"CHLORAMPHENICOL";"4.0";"323.13";"0";"0.91";"CHLORAMPHENICOL";"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL710";"FINASTERIDE";"4.0";"372.55";"0";"3.81";"FINASTERIDE";"CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1082";"AMOXICILLIN";"4.0";"365.41";"0";"0.02";"AMX";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL46";"ONDANSETRON";"4.0";"293.37";"0";"3.13";"ONDANSETRON";"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1430";"PENICILLAMINE";"4.0";"149.21";"0";"0.11";"PENICILLAMINE";"CC(C)(S)[C@@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909063";"LEAD(IV) ACETATE";"None";"443.38";"None";"None";"LEAD(IV) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL93";"ZILEUTON";"4.0";"236.30";"0";"2.73";"3";"CC(c1cc2ccccc2s1)N(O)C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157138";"LISURIDE";"4.0";"338.46";"0";"2.84";"LISURIDE";"CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL578";"ENALAPRIL";"4.0";"376.45";"0";"1.60";"ENALAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1220";"TINIDAZOLE";"4.0";"247.28";"0";"0.53";"TINIDAZOLE";"CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL421";"SULFASALAZINE";"4.0";"398.40";"0";"3.70";"SULFASALAZINE";"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL422";"TRIFLUOPERAZINE";"4.0";"407.51";"0";"4.95";"TRIFLUOPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL698";"TETRACAINE";"4.0";"264.37";"0";"2.62";"TETRACAINE";"CCCCNc1ccc(C(=O)OCCN(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL42710";"EUGENOL";"0.5";"164.20";"0";"2.13";"EUGENOL";"C=CCc1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL192";"SILDENAFIL";"4.0";"474.59";"0";"1.61";"SILDENAFIL";"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL404";"TAZOBACTAM";"4.0";"300.30";"0";"-1.52";"TAZOBACTAM";"C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1628227";"DOXEPIN";"4.0";"279.38";"0";"3.96";"DOXEPIN";"CN(C)CCC=C1c2ccccc2COc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL47";"ALPHA-TOCOPHEROL";"None";"430.72";"1";"8.84";"ALPHA-TOCOPHEROL";"Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL573";"NIACIN";"4.0";"123.11";"0";"0.78";"NIACIN";"O=C(O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL108545";"METHYL SALICYLATE";"4.0";"152.15";"0";"1.18";"METHYL SALICYLATE";"COC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200862";"METYROSINE";"4.0";"195.22";"0";"0.74";"METYROSINE";"C[C@](N)(Cc1ccc(O)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL603";"ZAFIRLUKAST";"4.0";"575.69";"2";"5.70";"ZAFIRLUKAST";"COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12";"IC50";"'='";"1363.0";"nM";"5.87";"";"";"UO_0000065";"10.19";"0.20";"0.17";"5.07";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL238071";"VINDESINE";"4.0";"753.94";"1";"2.73";"VINDESINE";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL65";"CAMPTOTHECIN";"-1.0";"348.36";"0";"2.08";"CAMPTOTHECIN";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL339218";"";"None";"310.34";"0";"3.15";"2g";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(F)cc3)nn12";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"28.10";"0.52";"5.57";"12.15";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL1909073";"PIPERILATE ETHOBROMIDE";"None";"448.40";"0";"3.49";"PIPERILATE ETHOBROMIDE";"CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL339066";"";"None";"381.28";"1";"5.05";"3e";"CCCCc1nc2ccccc2c2nc(-c3ccc(Br)cc3)nn12";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"21.21";"0.46";"3.04";"18.77";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"15.49";"nM";"7.81";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322681";"Agonist activity at wild type human A3 receptor L90'3.32A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"L90A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"2.138";"nM";"8.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322681";"Agonist activity at wild type human A3 receptor L90'3.32A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"L90A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.009772";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322686";"Agonist activity at wild type human A3 receptor M174'5.35A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"M174A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL114535";"";"None";"416.50";"0";"3.62";"ID-4";"CCOC(=O)c1c(NC(=O)Cc2ccccc2)sc2c1CCN(C(=O)OCC)C2";"IC50";"'='";"186.0";"nM";"6.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644552";"Inhibition of [35S]GTP-gamma-S, binding stimulated by 20 uM 5''-N-ethyluronamidoadenosine (NECA) in membranes of HEK293 cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133025";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307715";"";"";""
"CHEMBL116735";"";"None";"480.57";"1";"5.79";"40";"O=C(CCc1ccc(F)cc1)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1";"IC50";"'='";"5080.0";"nM";"5.29";"";"";"UO_0000065";"11.02";"0.21";"-0.50";"22.48";"0";"CHEMBL644506";"Inhibition of human adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134625";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"65600.0";"nM";"4.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644503";"Inhibition of forskolin-stimulated cAMP accumulation in chinese hamster ovary cell membranes expressing human adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"ovary";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148450";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL820";"BUSULFAN";"4.0";"246.31";"0";"-0.28";"BUSULFAN";"CS(=O)(=O)OCCCCOS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL291338";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"4.0";"351.02";"1";"5.26";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1071";"OXAPROZIN";"4.0";"293.32";"0";"4.03";"SID11110656";"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL701";"BACLOFEN";"4.0";"213.66";"0";"1.86";"BACLOFEN";"NCC(CC(=O)O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL339066";"";"None";"381.28";"1";"5.05";"43";"CCCCc1nc2ccccc2c2nc(-c3ccc(Br)cc3)nn12";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"21.21";"0.46";"3.04";"18.77";"1";"CHEMBL2187068";"Displacement of [125I]I-AB-MECA from human recombinant adenosine A3 receptor expressed in CHO cells after 60 mins by gamma counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1697694";"AFLATOXIN";"None";"312.28";"0";"2.28";"AFLATOXIN B1";"COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL13378";"(R,S)-AMPA";"None";"186.17";"0";"-0.36";"(RS)-AMPA";"Cc1onc(O)c1CC(N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL284969";"";"None";"369.81";"0";"0.45";"CCPA";"OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"11.22";"nM";"7.95";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3772952";"Agonist activity at human Adenosine A3 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769381";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307512";"";"";""
"CHEMBL2203622";"";"None";"298.39";"0";"3.97";"97";"Cn1c2cnc1OCC/C=C\CCCCOc1ccccc1-2";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2208516";"Antagonist activity at adenosine A3 receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203227";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1201237";"LEVOBUNOLOL";"4.0";"291.39";"0";"2.33";"LEVOBUNOLOL";"CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1230333";"";"None";"170.23";"0";"2.16";"4-(2-THIENYL)BUTYRIC ACID";"O=C(O)CCCc1cccs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2221249";"COLISTIN";"4.0";"2296.97";"None";"None";"COLISTIN";"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL280998";"CATECHOL";"None";"110.11";"0";"1.10";"CATECHOL";"Oc1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL252557";"GLYCOLIC ACID";"2.0";"76.05";"0";"-0.94";"GLYCOLIC ACID";"O=C(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267648";"PEFLOXACIN";"4.0";"333.36";"0";"1.61";"PEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1413";"CICLOPIROX";"4.0";"207.27";"0";"2.44";"CICLOPIROX";"Cc1cc(C2CCCCC2)n(O)c(=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL57";"NEVIRAPINE";"4.0";"266.30";"0";"2.65";"NEVIRAPINE";"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2";"PRAZOSIN";"4.0";"383.41";"0";"1.78";"PRAZOSIN";"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909079";"STANNOUS FLUORIDE";"4.0";"156.71";"None";"None";"STANNOUS FLUORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL714";"ALBUTEROL";"4.0";"239.31";"0";"1.31";"SALBUTAMOL";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2079587";"STANOZOLOL";"4.0";"328.50";"0";"4.12";"STANOZOLOL";"C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"'='";"8325.0";"nM";"5.08";"";"";"UO_0000065";"15.46";"0.29";"0.96";"10.39";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL75880";"PERHEXILINE";"4.0";"277.50";"1";"5.30";"PERHEXILINE";"C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909070";"NAFENOPIN";"2.0";"310.39";"0";"4.40";"NAFENOPIN";"CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2220427";"ERYTHROMYCIN PROPIONATE";"4.0";"790.00";"2";"2.75";"ERYTHROMYCIN PROPIONATE";"CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200709";"CROTAMITON";"4.0";"203.28";"0";"2.92";"CROTAMITON";"C/C=C/C(=O)N(CC)c1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL428647";"PACLITAXEL";"4.0";"853.92";"2";"3.74";"taxol";"CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL856";"PRIMIDONE";"4.0";"218.26";"0";"0.54";"PRIMIDONE";"CCC1(c2ccccc2)C(=O)NCNC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL450895";"NYSTATIN";"4.0";"926.11";"3";"0.94";"NYSTATIN";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL395110";"MEPAZINE";"4.0";"310.47";"0";"4.63";"MEPAZINE";"CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL520122";"";"None";"365.40";"0";"4.22";"8";"O=C(Nc1nc2ccccc2c2cn(-c3ccccc3)nc12)c1ccccn1";"IC50";"'='";"107.0";"nM";"6.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1013711";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of CI-IB-MECA-mediated inhibition of cAMP accumulation by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152204";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL454780";"";"None";"365.40";"0";"4.22";"10";"O=C(Nc1nc2ccccc2c2cn(-c3ccccc3)nc12)c1ccncc1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1013711";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of CI-IB-MECA-mediated inhibition of cAMP accumulation by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152204";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL469664";"";"None";"510.21";"2";"5.26";"C2-8";"O=C(Nc1ccc(Br)cc1)c1cccc(S(=O)(=O)Nc2ccc(Br)cc2)c1";"IC50";"'='";"5760.0";"nM";"5.24";"";"";"UO_0000065";"10.27";"0.27";"-0.02";"6.96";"0";"CHEMBL968379";"Inhibition of adenosine A3 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156525";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"None";"";"";""
"CHEMBL121890";"";"None";"316.41";"0";"4.60";"3f";"CCCCc1nc2ccccc2c2nc(-c3ccc(C)cc3)nn12";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"23.60";"0.42";"2.87";"17.34";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL340262";"";"None";"336.40";"0";"3.41";"2p";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(OCC)cc3)nn12";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL1712923";"IRSOGLADINE MALEATE";"1.0";"372.17";"0";"2.01";"IRSOGLADINE MALEATE";"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL177";"AMIKACIN";"4.0";"585.61";"3";"-8.42";"AMIKACIN";"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL71";"CHLORPROMAZINE";"4.0";"318.87";"0";"4.89";"CHLORPROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909068";"";"None";"None";"None";"None";"MC 258717";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1235242";"";"None";"183.18";"0";"0.78";"4-FLUORO-L-PHENYLALANINE";"N[C@@H](Cc1ccc(F)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL203357";"";"None";"344.78";"0";"-0.86";"5";"CNC(=O)[C@H]1S[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644507";"Inhibitory concentration against human Adenosine A3 receptor mediated inhibition of cyclic AMP in transfected CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145992";"1";"Scientific Literature";"J Med Chem";"2003";"CHEMBL3308072";"";"";""
"CHEMBL426123";"";"None";"258.23";"0";"0.09";"(-)-THALIDOMIDE";"O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1365675";"AMITRAZ";"2.0";"293.41";"0";"4.87";"AMITRAZ";"Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL85728";"4,4'-METHYLENEDIANILINE";"None";"198.27";"0";"2.44";"4,4'-METHYLENEDIANILINE";"Nc1ccc(Cc2ccc(N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL862";"GUANFACINE";"4.0";"246.10";"0";"1.55";"GUANFACINE";"N=C(N)NC(=O)Cc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL20";"ACETAZOLAMIDE";"4.0";"222.25";"0";"-0.86";"ACETAZOLAMIDE";"CC(=O)Nc1nnc(S(N)(=O)=O)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3545252";"DOCETAXEL";"4.0";"861.94";"2";"3.26";"DOCETAXEL";"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"DOMPERIDONE";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL513";"CARMUSTINE";"4.0";"214.05";"0";"1.16";"CARMUSTINE";"O=NN(CCCl)C(=O)NCCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL926";"DOBUTAMINE";"4.0";"301.39";"0";"2.96";"DOBUTAMINE";"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL640";"PROCAINAMIDE";"4.0";"235.33";"0";"1.34";"PROCAINAMIDE";"CCN(CC)CCNC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL41543";"";"None";"238.29";"0";"3.00";"10,11-DIHYDRO-CARBAMAZEPINE";"NC(=O)N1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL122987";"";"None";"338.44";"0";"3.73";"31";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(SC)cc3)nn12";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"25.06";"0.48";"4.75";"11.82";"0";"CHEMBL644556";"Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135548";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3307715";"";"";""
"CHEMBL521606";"NADOLOL";"4.0";"309.41";"0";"0.63";"NADOLOL";"CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19236";"MOXONIDINE";"4.0";"241.68";"0";"0.82";"MOXONIDINE";"COc1nc(C)nc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1502";"PANTOPRAZOLE";"4.0";"383.38";"0";"2.88";"PANTOPRAZOLE";"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL37161";"FENBENDAZOLE";"2.0";"299.36";"0";"3.89";"FENBENDAZOLE";"COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL532";"ERYTHROMYCIN";"4.0";"733.94";"2";"1.79";"ERYTHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL611091";"";"None";"562.61";"2";"0.26";"100";"CCNC(=O)[C@H]1OC(n2cnc3c(NC(=O)Nc4ccc(S(=O)(=O)N(CC)CC)cc4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL826591";"Inhibition of (10 uM) forskolin-mediated cAMP production in CHO cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138800";"1";"Scientific Literature";"J Med Chem";"2004";"CHEMBL3308072";"";"";""
"CHEMBL2070887";"";"None";"489.52";"0";"3.20";"12";"Cn1cc2c(nc(NC(=O)NC3CCN(Cc4ccc(F)cc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2070890";"";"None";"501.55";"1";"3.07";"15";"COc1ccc(CN2CCC(NC(=O)Nc3nc4nn(C)cc4c4nc(-c5ccco5)nn34)CC2)cc1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2070893";"";"None";"472.51";"0";"2.45";"18";"Cn1cc2c(nc(NC(=O)NC3CCN(Cc4cccnc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2071041";"";"None";"492.54";"0";"2.51";"23";"Cn1cc2c(nc(NC(=O)NC3CCN(C(=O)NC4CCCC4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL431733";"NAMODENOSON";"3.0";"544.74";"1";"1.06";"Cl-IB-MECA";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"1.21";"nM";"8.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3365949";"Agonist activity at human recombinant A3AR expressed in CHO cells assessed as inhibition of forskolin-induced stimulation of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351911";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"CHEMBL3308072";"";"";""
"CHEMBL277041";"METHYLTHIOADENOSINE";"None";"297.34";"0";"-0.61";"MTA";"CSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"71000.0";"nM";"4.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644503";"Inhibition of forskolin-stimulated cAMP accumulation in chinese hamster ovary cell membranes expressing human adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"ovary";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148450";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL485259";"EUCALYPTOL";"3.0";"154.25";"0";"2.74";"EUCALYPTOL";"CC12CCC(CC1)C(C)(C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1752";"DYPHYLLINE";"4.0";"254.25";"0";"-2.21";"DYPHYLLINE";"Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL282468";"CHOLINE CHLORIDE";"4.0";"139.63";"None";"None";"CHOLINE CHLORIDE";"C[N+](C)(C)CCO.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL278172";"BENZOCAINE";"4.0";"165.19";"0";"1.45";"BENZOCAINE";"CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1491";"AMLODIPINE";"4.0";"408.88";"0";"2.27";"Amlodipine";"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL158";"AZTREONAM";"4.0";"435.44";"0";"-1.17";"Aztreonam";"C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909051";"";"None";"347.38";"0";"4.80";"4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE";"O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL153479";"AMBROXOL";"3.0";"378.11";"0";"3.19";"AMBROXOL";"Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.6166";"nM";"9.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322688";"Agonist activity at wild type human A3 receptor W185'5.46A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"W185A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL508112";"BENZOTHIAZYL DISULFIDE";"None";"332.50";"1";"5.71";"BENZOTHIAZYL DISULFIDE";"c1ccc2sc(SSc3nc4ccccc4s3)nc2c1";"IC50";"'='";"347.0";"nM";"6.46";"";"";"UO_0000065";"19.43";"0.44";"0.75";"25.06";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL123292";"CYCLOHEXIMIDE";"2.0";"281.35";"0";"1.04";"CYCLOHEXIMIDE";"C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1405";"ESTRONE";"4.0";"270.37";"0";"3.82";"ESTRONE";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL9419";"METACETAMOL";"2.0";"151.16";"0";"1.35";"3-ACETAMIDOPHENOL";"CC(=O)Nc1cccc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL87285";"ANDROSTERONE";"None";"290.45";"0";"3.96";"ANDROSTERONE";"C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL467";"HYDROXYUREA";"4.0";"76.05";"0";"-0.96";"HYDROXYUREA";"NC(=O)NO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL32749";"FERULATE";"-1.0";"194.19";"0";"1.50";"FERULIC ACID";"COc1cc(/C=C/C(=O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL35";"FUROSEMIDE";"4.0";"330.75";"0";"1.89";"FUROSEMIDE";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201346";"BALSALAZIDE";"4.0";"357.32";"0";"2.71";"BALSALAZIDE";"O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"CARBAMAZEPINE";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3927012";"";"None";"376.84";"0";"4.50";"L2";"COc1cc(Nc2nc(Cl)cc3c(C(C)C)n[nH]c23)cc(OC)c1OC";"IC50";"'='";"2.818";"nM";"8.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5196781";"";"None";"405.46";"0";"3.85";"L7";"COc1cc(Nc2nc(CN)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC";"IC50";"'='";"4.898";"nM";"8.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL332577";"";"None";"360.34";"0";"4.03";"2m";"CCCCc1nc2[nH]ncc2c2nc(-c3ccc(C(F)(F)F)cc3)nn12";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"19.11";"0.36";"2.86";"9.60";"1";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL114643";"";"None";"398.44";"0";"4.12";"ID-3";"COc1ccc(-c2csc(NC3OC(=O)c4c3ccc(OC)c4OC)n2)cc1";"IC50";"'='";"255.0";"nM";"6.59";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644552";"Inhibition of [35S]GTP-gamma-S, binding stimulated by 20 uM 5''-N-ethyluronamidoadenosine (NECA) in membranes of HEK293 cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133025";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307715";"";"";""
"CHEMBL5181728";"";"None";"401.43";"0";"4.27";"A17";"COc1cc(Nc2nc(C#N)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC";"IC50";"'='";"75.86";"nM";"7.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL235317";"";"None";"495.28";"0";"1.06";"12";"OC[C@@]12CO[C@@H]([C@H](n3cnc4c(NCc5cccc(I)c5)ncnc43)O1)[C@@H]2O";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL898448";"Antagonist activity at human adenosine A3 receptor after 15 to 30 mins";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149615";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"None";"";"";""
"CHEMBL1393";"SPIRONOLACTONE";"4.0";"416.58";"0";"4.85";"SPIRONOLACTONE";"CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL239193";"";"None";"306.33";"0";"2.84";"10";"CC(=O)Nc1nc(C(=O)Nc2ccccc2)c2ccccc2n1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL902658";"Activity at human adenosine A3 receptor expressed in CHO cells assessed as antagonism of Cl-IB-MECA-inhibited cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138345";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3308072";"";"";""
"CHEMBL279403";"";"None";"265.27";"0";"2.18";"7";"O=C(Nc1ccccc1)c1nc(=O)[nH]c2ccccc12";"IC50";"'='";"238.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL902658";"Activity at human adenosine A3 receptor expressed in CHO cells assessed as antagonism of Cl-IB-MECA-inhibited cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138345";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3308072";"";"";""
"CHEMBL447";"SECOBARBITAL";"4.0";"238.29";"0";"1.35";"SECOBARBITAL";"C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL31184";"BENZO[DEF]CHRYSENE";"0.5";"252.32";"1";"5.74";"BENZO[A]PYRENE";"c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2107797";"NORGESTREL";"4.0";"312.45";"0";"3.88";"NORGESTREL";"C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL657";"DIPHENHYDRAMINE";"4.0";"255.36";"0";"3.35";"DIPHENHYDRAMINE";"CN(C)CCOC(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL7002";"CIGLITAZONE";"2.0";"333.45";"0";"3.93";"CIGLITAZONE";"CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1";"IC50";"'='";"3047.0";"nM";"5.52";"";"";"UO_0000065";"16.54";"0.33";"1.59";"9.96";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1521";"ZALEPLON";"4.0";"305.34";"0";"2.64";"ZALEPLON";"CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL124138";"";"None";"346.43";"0";"4.69";"3k";"CCCCc1nc2ccccc2c2nc(-c3ccc(OCC)cc3)nn12";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"21.52";"0.39";"2.77";"14.25";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL595";"PIOGLITAZONE";"4.0";"356.45";"0";"3.16";"PIOGLITAZONE";"CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1625681";"";"None";"295.35";"0";"2.49";"66, PSB11";"CC[C@@H]1CN2C(=O)N(C)c3nc(-c4ccccc4)[nH]c3C2=N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2187061";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177029";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1537";"AZLOCILLIN";"4.0";"461.50";"0";"0.09";"AZLOCILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2042312";"";"None";"841.03";"4";"6.64";"20";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)c(O)c(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O";"IC50";"'='";"1721.0";"nM";"5.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044692";"Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2040819";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1262";"OXICONAZOLE";"4.0";"429.13";"1";"6.12";"OXICONAZOLE";"Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"'='";"634.5";"nM";"6.20";"";"";"UO_0000065";"14.44";"0.33";"0.08";"15.73";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.5888";"nM";"9.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322692";"Agonist activity at wild type human A3 receptor I253'6.58E mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"I253E";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL341041";"";"None";"332.41";"0";"4.30";"9c-2";"CCCCc1nc2ccccc2c2nc(-c3ccc(OC)cc3)nn12";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"20.44";"0.37";"2.50";"12.99";"0";"CHEMBL644555";"Binding affinity for human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL1069";"VALSARTAN";"4.0";"435.53";"0";"4.16";"VALSARTAN";"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL7568";"QUINACRINE";"2.0";"399.97";"1";"5.97";"QUINACRINE";"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL561";"LOMEFLOXACIN";"4.0";"351.35";"0";"1.80";"LOMEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1194";"PRILOCAINE";"4.0";"220.32";"0";"2.32";"PRILOCAINE";"CCCNC(C)C(=O)Nc1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1566956";"TROXIPIDE";"2.0";"294.35";"0";"1.19";"TROXIPIDE";"COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL416";"METHOXSALEN";"4.0";"216.19";"0";"2.55";"METHOXSALEN";"COc1c2occc2cc2ccc(=O)oc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL84";"TOPOTECAN";"4.0";"421.45";"0";"1.85";"topotecan";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1009";"LEVODOPA";"4.0";"197.19";"0";"0.05";"LEVODOPA";"N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL413";"SIROLIMUS";"4.0";"914.19";"3";"6.18";"RAPAMYCIN";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL139";"DICLOFENAC";"4.0";"296.15";"0";"4.36";"DICLOFENAC";"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL27";"PROPRANOLOL";"4.0";"259.35";"0";"2.58";"PROPRANOLOL";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL106";"FLUCONAZOLE";"4.0";"306.28";"0";"0.74";"F";"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1130";"DOXIFLURIDINE";"3.0";"246.19";"0";"-1.69";"DOXIFLURIDINE";"C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL417";"EPIRUBICIN";"4.0";"543.53";"3";"0.00";"EPIRUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800734";"";"None";"325.38";"0";"1.70";"R-28";"C=CCN1C(=O)N2C[C@@H](C)N=C2c2[nH]c(-c3cc(C)nn3C)nc21";"IC50";"'='";"35.9";"nM";"7.45";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800787";"";"None";"391.44";"0";"2.41";"S-34";"COc1cc(-c2nc3c([nH]2)C2=N[C@@H](C)CN2C(=O)N3Cc2ccccc2)n(C)n1";"IC50";"'='";"17.5";"nM";"7.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL3752438";"";"None";"422.45";"0";"4.14";"33";"COc1ccc(-c2nc(NC(=O)c3ccncc3)c3nn(-c4ccccc4)cc3n2)cc1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3756031";"Antagonist activity at human A3 receptor expressed in CHO cells assessed as inhibition of Cl-IB-MECA-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751669";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL103";"PROGESTERONE";"4.0";"314.47";"0";"4.72";"PROGESTERONE";"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL822";"TERBINAFINE";"4.0";"291.44";"0";"4.88";"TERBINAFINE";"CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL127516";"BUTAMBEN";"4.0";"193.25";"0";"2.23";"BUTAMBEN";"CCCCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL48449";"CANTHARIDIN";"4.0";"196.20";"0";"0.64";"CANTHARIDIN";"C[C@@]12C(=O)OC(=O)[C@]1(C)[C@H]1CC[C@@H]2O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201207";"BETAMETHASONE PHOSPHORIC ACID";"4.0";"472.45";"0";"2.01";"BETAMETHASONE PHOSPHATE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201012";"FLURANDRENOLIDE";"4.0";"436.52";"0";"2.50";"FLURANDRENOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL15511";"ENROFLOXACIN";"2.0";"359.40";"0";"2.32";"ENROFLOXACIN";"CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201469";"GRAMICIDIN";"4.0";"None";"None";"None";"GRAMICIDIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL264374";"BEZAFIBRATE";"4.0";"361.83";"0";"3.55";"BEZAFIBRATE";"CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1095699";"AZASERINE";"2.0";"173.13";"0";"-1.76";"AZASERINE";"[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL527";"PIROXICAM";"4.0";"331.35";"0";"1.58";"PIROXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1062";"HYDROXYPROGESTERONE";"2.0";"330.47";"0";"3.84";"HYDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"'='";"4730.0";"nM";"5.33";"";"";"UO_0000065";"16.11";"0.30";"1.49";"9.79";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL456";"ETHACRYNIC ACID";"4.0";"303.14";"0";"3.61";"ETHACRYNIC ACID";"C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL178";"DAUNORUBICIN";"4.0";"527.53";"2";"1.03";"DAUNORUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909057";"COPPER(II) OXIDE";"None";"79.55";"None";"None";"COPPER(II) OXIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL124887";"";"None";"412.45";"0";"4.13";"1i";"O=C(O)CCCCc1nc2[nH]cnc2c2nc(-c3ccc(-c4ccccc4)cc3)nn12";"IC50";"'='";"9.1";"nM";"8.04";"";"";"UO_0000065";"19.50";"0.35";"3.91";"7.37";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL1370561";"AMINOPHYLLINE";"4.0";"420.43";"0";"-1.04";"AMINOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2070892";"";"None";"516.52";"2";"2.97";"17";"Cn1cc2c(nc(NC(=O)NC3CCN(Cc4ccc([N+](=O)[O-])cc4)CC3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073225";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as forskolin/C1-IB-MECA-induced inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069218";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3";"NICOTINE";"4.0";"162.24";"0";"1.85";"Nicotine";"CN1CCC[C@H]1c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL270299";"BAY-11-7085";"None";"249.34";"0";"2.80";"BAY-117085";"CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1371937";"PANTHENOL";"3.0";"205.25";"0";"-1.14";"PANTHENOL";"CC(C)(CO)C(O)C(=O)NCCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1467";"ALLOPURINOL";"4.0";"136.11";"0";"0.06";"ALLOPURINOL";"Oc1ncnc2[nH]ncc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.05129";"nM";"10.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322693";"Agonist activity at wild type human A3 receptor L264'7.35A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"L264A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL329791";"";"None";"404.39";"0";"2.92";"18";"COc1ccc(NC(=O)Nc2nc3nn(C)cc3c3nc(-c4ccco4)nn23)cc1";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644493";"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 1.7-4.2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133118";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3308072";"";"";""
"CHEMBL1909048";"";"None";"313.83";"0";"4.43";"1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL744";"RILUZOLE";"4.0";"234.20";"0";"2.78";"RILUZOLE";"Nc1nc2ccc(OC(F)(F)F)cc2s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL429023";"ROTENONE";"None";"394.42";"0";"3.70";"ROTENONE";"C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"AMIODARONE";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"IC50";"'='";"17547.0";"nM";"4.76";"";"";"UO_0000065";"7.37";"0.21";"-2.18";"11.14";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL437002";"";"None";"297.37";"0";"3.92";"1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL93645";"ACECLOFENAC";"4.0";"354.19";"0";"3.91";"ACECLOFENAC";"O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL221753";"BENZETHONIUM CHLORIDE";"2.0";"448.09";"1";"6.07";"BENZETHONIUM CHLORIDE";"CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1542";"AZATHIOPRINE";"4.0";"277.27";"0";"1.15";"AZATHIOPRINE";"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1751";"DIGOXIN";"4.0";"780.95";"3";"2.22";"DIGOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1172";"DESLORATADINE";"4.0";"310.83";"0";"4.02";"DESLORATADINE";"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL728";"PROCHLORPERAZINE";"4.0";"373.95";"0";"4.58";"PROCHLORPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3127163";"";"None";"389.36";"0";"4.87";"22";"O=C(O)c1csc(-n2nc(-c3ccccc3)c3ccc(C(F)(F)F)cc32)n1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3130951";"Inhibition of adenosine A3 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124785";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL772";"RESERPINE";"4.0";"608.69";"1";"4.17";"RESERPINE";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL415324";"TRANILAST";"3.0";"327.34";"0";"3.05";"TRANILAST";"COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL38";"TRETINOIN";"4.0";"300.44";"1";"5.60";"TRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1";"IC50";"'='";"5275.0";"nM";"5.28";"";"";"UO_0000065";"17.57";"0.33";"-0.32";"14.15";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"IB-MECA";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.48";"0.42";"8.51";"6.64";"0";"CHEMBL881969";"Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140374";"1";"Scientific Literature";"J Med Chem";"2005";"CHEMBL3307715";"";"";""
"CHEMBL611095";"";"None";"560.59";"2";"0.03";"96";"C=CCN(C)S(=O)(=O)c1ccc(NC(=O)Nc2ncnc3c2ncn3C2O[C@H](C(=O)NCC)[C@@H](O)[C@H]2O)cc1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL826591";"Inhibition of (10 uM) forskolin-mediated cAMP production in CHO cells expressing human Adenosine A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138800";"1";"Scientific Literature";"J Med Chem";"2004";"CHEMBL3308072";"";"";""
"CHEMBL122512";"";"None";"292.35";"0";"3.01";"9a-1";"CCCCc1nc2[nH]cnc2c2nc(-c3ccccc3)nn12";"IC50";"'='";"0.25";"nM";"9.60";"";"";"UO_0000065";"32.84";"0.60";"6.59";"13.38";"1";"CHEMBL644555";"Binding affinity for human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL123705";"";"None";"360.34";"0";"4.03";"9a-3";"CCCCc1nc2[nH]cnc2c2nc(-c3ccc(C(F)(F)F)cc3)nn12";"IC50";"'='";"0.61";"nM";"9.21";"";"";"UO_0000065";"25.57";"0.48";"5.18";"12.84";"1";"CHEMBL644555";"Binding affinity for human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL65271";"";"None";"418.42";"0";"3.41";"5";"CCn1cc2c(nc(NC(=O)Nc3ccc(OC)cc3)n3nc(-c4ccco4)nc23)n1";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL644508";"Inhibitory concentration as antagonistic activity against cAMP generation inhibited by IB-MECA in CHO cell membranes transfected with human A3 receptor";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132457";"1";"Scientific Literature";"J Med Chem";"1999";"CHEMBL3308072";"";"";""
"CHEMBL3736433";"";"None";"260.15";"None";"None";"2";"CB1C=Cc2cccc(OCC(O)CN(C)C)c2N1";"IC50";"'>'";"5011.87";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3738125";"Antagonist activity at human wild-type A3 receptor expressed in CHO-K1 cells assessed as IB MECA-induced cAMP by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734721";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307512";"";"";""
"CHEMBL5199558";"";"None";"282.34";"0";"2.83";"30g; M2912";"Cc1ccc2c(=O)[nH]c(-c3ccc(C(C)(C)O)cc3)cn12";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5228307";"Inhibition of A3 adenosine receptor (unknown origin)";"T";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5226325";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL189";"MILRINONE";"4.0";"211.22";"0";"1.62";"MILRINONE";"Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6437";"MIANSERIN";"4.0";"264.37";"0";"3.08";"MIANSERIN";"CN1CCN2c3ccccc3Cc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3039597";"GENTAMICIN";"4.0";"1390.73";"None";"None";"Gm, gentamicin";"CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H](N)C[C@@H]2N)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4526845";"";"None";"317.14";"0";"3.93";"4";"O=c1oc2c(O)cccc2cc1-c1ccc(Br)cc1";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4379763";"Antagonist activity at human adenosine receptor A3 expressed in CHO cells assessed as suppression of NECA-induced decrease of cAMP accumulation by Glo-sensor cAMP assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376839";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL3415025";"";"None";"277.74";"0";"3.01";"4";"Cc1nc2sc(-c3ccc(Cl)cc3)nc2c(=O)[nH]1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3419499";"Antagonist activity against human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-induced inhibition of forskolin-induced cAMP production by scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414467";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1483";"ALBENDAZOLE";"4.0";"265.34";"0";"3.24";"ALBENDAZOLE";"CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.2951";"nM";"9.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322690";"Agonist activity at wild type human A3 receptor I249'6.54A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"I249A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL1168";"RAMIPRIL";"4.0";"416.52";"0";"2.38";"RAMIPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL983";"SUCCINYLCHOLINE CHLORIDE";"4.0";"361.31";"0";"0.27";"SUXAMETHONIUM CHLORIDE";"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL270676";"";"None";"351.86";"0";"4.17";"5m";"CCCSc1nc(NC(C)=O)cc(OCc2ccc(Cl)cc2)n1";"IC50";"'='";"9.2";"nM";"8.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL951866";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as reversal of NECA-mediated inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143166";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL272795";"";"None";"337.83";"0";"3.78";"5r";"CCSc1nc(NC(C)=O)cc(OCc2ccc(Cl)cc2)n1";"IC50";"'='";"1.84";"nM";"8.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL951866";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as reversal of NECA-mediated inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143166";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL402848";"";"None";"347.44";"0";"3.52";"5o";"CCCSc1nc(NC(C)=O)cc(OCc2ccc(OC)cc2)n1";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL951866";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as reversal of NECA-mediated inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143166";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL424";"SALICYLIC ACID";"4.0";"138.12";"0";"1.09";"SALICYLIC ACID";"O=C(O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6";"INDOMETHACIN";"4.0";"357.79";"0";"3.93";"INDOMETHACIN";"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1149";"LEVOCARNITINE";"4.0";"161.20";"0";"-1.81";"LEVOCARNITINE";"C[N+](C)(C)C[C@H](O)CC(=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL134342";"THIOCTIC ACID";"None";"206.33";"0";"2.79";"THIOCTIC ACID";"O=C(O)CCCC[C@@H]1CCSS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL154111";"SALSALATE";"4.0";"258.23";"0";"2.31";"SALSALATE";"O=C(Oc1ccccc1C(=O)O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4439336";"";"None";"517.54";"1";"1.71";"17b; LUF7602";"CCCn1c(=O)c2c(nc3cc(OC)ccn32)n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O";"IC50";"'='";"1072.0";"nM";"5.97";"";"";"UO_0000065";"11.53";"0.23";"4.26";"4.46";"0";"CHEMBL4392072";"Displacement of [3H]PSB11 from human A3 adenosine receptor Y265F (7.36) mutant transiently expressed in CHOK1 cell membranes measured after 2 hrs by scintillation spectrometric method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"Y265F";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4390672";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL1909078";"SODIUM ARSENITE";"None";"129.91";"None";"None";"SODIUM ARSENITE";"O=[As][O-].[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3769755";"";"None";"414.92";"0";"4.36";"CMPD-604";"COC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"14.11";"0.29";"1.49";"8.44";"0";"CHEMBL4199265";"Inhibition of adenosine A3 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196097";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL125147";"";"None";"370.42";"0";"3.52";"1e";"COCCc1nc2[nH]cnc2c2nc(-c3ccc(-c4ccccc4)cc3)nn12";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"24.42";"0.44";"5.53";"11.17";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL339529";"";"None";"336.83";"0";"4.94";"3c";"CCCCc1nc2ccccc2c2nc(-c3ccc(Cl)cc3)nn12";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"22.52";"0.43";"2.65";"17.61";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL456807";"PHENYLHYDRAZINE";"None";"108.14";"0";"0.97";"PHENYLHYDRAZINE";"NNc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200748";"CARBIDOPA";"4.0";"244.25";"0";"-0.05";"S(-)-CARBIDOPA";"C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.003548";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322697";"Agonist activity at wild type human A3 receptor V169'5.30A/W185'5.46A double mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"V169A,W185A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL262777";"VANCOMYCIN";"4.0";"1449.27";"None";"None";"Vancomycin";"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL364713";"NOSCAPINE";"4.0";"413.43";"0";"2.88";"NOSCAPINE";"COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200693";"MANGANESE CHLORIDE ANHYDROUS";"4.0";"125.84";"None";"None";"MANGANESE (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL514";"LOMUSTINE";"4.0";"233.70";"0";"2.25";"LOMUSTINE";"O=NN(CCCl)C(=O)NC1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL18797";"SULINDAC SULFIDE";"-1.0";"340.42";"1";"5.35";"SULINDAC SULFIDE";"CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1";"IC50";"'='";"7231.0";"nM";"5.14";"";"";"UO_0000065";"15.10";"0.29";"-0.21";"13.78";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL277100";"TEMAFLOXACIN";"4.0";"417.39";"0";"2.90";"TEMAFLOXACIN";"CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1454";"LEVAMISOLE";"4.0";"204.30";"0";"2.15";"LEVAMISOLE";"c1ccc([C@H]2CN3CCSC3=N2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1064";"SIMVASTATIN";"4.0";"418.57";"0";"4.59";"SIMVASTATIN";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL114";"SAQUINAVIR";"4.0";"670.86";"1";"3.09";"SAQUINAVIR";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL452";"CLONAZEPAM";"4.0";"315.72";"0";"3.04";"CLONAZEPAM";"O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL712";"ANISINDIONE";"4.0";"252.27";"0";"2.86";"ANISINDIONE";"COc1ccc(C2C(=O)c3ccccc3C2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL26";"SULPIRIDE";"4.0";"341.43";"0";"0.56";"SULPIRIDE";"CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1076211";"TOLPERISONE";"3.0";"245.37";"0";"3.30";"TOLPERISONE";"Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL519614";"";"None";"365.40";"0";"4.22";"9";"O=C(Nc1nc2ccccc2c2cn(-c3ccccc3)nc12)c1cccnc1";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1013711";"Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of CI-IB-MECA-mediated inhibition of cAMP accumulation by competition protein binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152204";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1909080";"STRONTIUM CHLORIDE HEXAHYDRATE";"None";"266.62";"None";"None";"STRONTIUM CHLORIDE HEXAHYDRATE";"O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5075422";"";"None";"308.30";"0";"1.33";"1a";"Cn1cc(-c2cnc(N)n3nc(-c4ccco4)nc23)ccc1=O";"IC50";"'='";"2023.0";"nM";"5.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046042";"Antagonist activity at human recombinant adenosine A3 receptor transfected in HEK293 cells co-transfected with Galpha15/16 assessed as intracellular calcium change incubated for 10 mins by microplate reader method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042554";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL125339";"";"None";"384.40";"0";"3.35";"1f";"O=C(O)CCc1nc2[nH]cnc2c2nc(-c3ccc(-c4ccccc4)cc3)nn12";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"20.35";"0.37";"4.47";"7.17";"0";"CHEMBL875928";"Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146808";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307715";"";"";""
"CHEMBL1231107";"CYROMAZINE";"2.0";"166.19";"0";"-0.39";"CYROMAZINE";"Nc1nc(N)nc(NC2CC2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL289469";"GRANISETRON";"4.0";"312.42";"0";"2.32";"GRANISETRON";"CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL311469";"2-ACETYLAMINOFLUORENE";"None";"223.27";"0";"3.22";"2-ACETYLAMINOFLUORENE";"CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL268291";"DIMETHYLFORMAMIDE";"None";"73.10";"0";"-0.30";"N,N-DIMETHYLFORMAMIDE";"CN(C)C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL413965";"FELBINAC";"4.0";"212.25";"0";"2.98";"FELBINAC";"O=C(O)Cc1ccc(-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL234926";"ALLYL ALCOHOL";"None";"58.08";"0";"0.16";"ALLYL ALCOHOL";"C=CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1477";"CERIVASTATIN";"4.0";"459.56";"0";"4.88";"CERIVASTATIN";"COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1612004";"";"None";"123.15";"0";"1.28";"O-ANISIDINE";"COc1ccccc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL976";"PRAZIQUANTEL";"4.0";"312.41";"0";"2.53";"PRAZIQUANTEL";"O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL564";"PROMAZINE";"4.0";"284.43";"0";"4.24";"PROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL13";"METOPROLOL";"4.0";"267.37";"0";"1.61";"22";"COCCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200633";"IVERMECTIN";"4.0";"1736.18";"None";"None";"IVERMECTIN";"CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"'='";"512.1";"nM";"6.29";"";"";"UO_0000065";"3.62";"None";"None";"None";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201024";"METHSCOPOLAMINE BROMIDE";"None";"398.30";"0";"1.06";"METHSCOPOLAMINE BROMIDE";"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@H]12.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL14053";"TRICHLOROACETIC ACID";"4.0";"163.39";"0";"1.44";"TRICHLOROACETIC ACID";"O=C(O)C(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL757";"NANDROLONE";"3.0";"274.40";"0";"3.49";"NANDROLONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201117";"METHOCARBAMOL";"4.0";"241.24";"0";"0.53";"METHOCARBAMOL";"COc1ccccc1OCC(O)COC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL608";"PROBUCOL";"4.0";"516.86";"2";"9.91";"PROBUCOL";"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL86";"METOCLOPRAMIDE";"4.0";"299.80";"0";"2.00";"METOCLOPRAMIDE";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6466";"COUMARIN";"4.0";"146.14";"0";"1.79";"COUMARIN";"O=c1ccc2ccccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12856";"INAMRINONE";"4.0";"187.20";"0";"1.02";"AMRINONE";"Nc1cc(-c2ccncc2)c[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1046";"AMINOCAPROIC ACID";"4.0";"131.18";"0";"0.59";"AMINOCAPROIC ACID";"NCCCCCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL286398";"PROPYLENE GLYCOL";"3.0";"76.10";"0";"-0.64";"PROPYLENE GLYCOL";"CC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL86754";"IODOQUINOL";"2.0";"396.95";"0";"3.15";"IODOQUINOL";"Oc1c(I)cc(I)c2cccnc12";"IC50";"'='";"933.0";"nM";"6.03";"";"";"UO_0000065";"15.19";"0.63";"2.88";"18.21";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1221512";"";"None";"559.80";"1";"1.75";"L-744832";"CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1089";"PHENELZINE";"4.0";"136.20";"0";"0.69";"PHENELZINE";"NNCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1800781";"";"None";"341.38";"0";"1.40";"32";"C=CCN1C(=O)N2CC(C)N=C2c2[nH]c(-c3cc(OC)nn3C)nc21";"IC50";"'='";"14.5";"nM";"7.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800786";"";"None";"391.44";"0";"2.41";"R-34";"COc1cc(-c2nc3c([nH]2)C2=N[C@H](C)CN2C(=O)N3Cc2ccccc2)n(C)n1";"IC50";"'='";"15.9";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800790";"";"None";"431.50";"0";"3.36";"37";"C=CCN1C(=O)N2CC(CC)N=C2c2[nH]c(-c3cc(OCc4ccccc4)nn3C)nc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1800798";"";"None";"389.46";"0";"3.10";"43";"CCC1CN2C(=O)N(Cc3ccccc3)c3nc(-c4cc(C)n(C)n4)[nH]c3C2=N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1803406";"Antagonist activity human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation after 150 mins by scintillation counter";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799944";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL4285494";"";"None";"331.44";"0";"3.90";"(S)-(-)-3";"CC[C@H](C)Oc1cc(NC(C)=O)nc(SCc2ccccc2)n1";"IC50";"'='";"152.9";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4263216";"Antagonist activity at recombinant human adenosine A3 receptor expressed in CHO cells assessed as reduction in Cl-IB-MECA-induced inhibition of forskolin-stimulated [3H]cAMP accumulation preincubated for 10 mins followed by Cl-IB-MECA addition measured after 30 mins by liquid scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261564";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL4282074";"";"None";"331.44";"0";"4.08";"(S)-(-)-1";"CCCSc1nc(NC(C)=O)cc(O[C@@H](C)c2ccccc2)n1";"IC50";"'='";"7.9";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4263216";"Antagonist activity at recombinant human adenosine A3 receptor expressed in CHO cells assessed as reduction in Cl-IB-MECA-induced inhibition of forskolin-stimulated [3H]cAMP accumulation preincubated for 10 mins followed by Cl-IB-MECA addition measured after 30 mins by liquid scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261564";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL5189274";"";"None";"516.65";"1";"4.83";"L10";"COc1cc(Nc2nc(CNCC3CCN(C)CC3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC";"IC50";"'='";"2.754";"nM";"8.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL1114";"THEOBROMINE";"3.0";"180.17";"0";"-1.04";"2";"Cn1cnc2c1c(=O)[nH]c(=O)n2C";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5223691";"Inhibition of human A3 adenosine receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223081";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL113";"CAFFEINE";"4.0";"194.19";"0";"-1.03";"Caffeine";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"'='";"13300.0";"nM";"4.88";"";"";"UO_0000065";"25.11";"0.48";"5.91";"7.89";"0";"CHEMBL5223691";"Inhibition of human A3 adenosine receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223081";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL2322924";"";"None";"359.39";"0";"3.38";"12a";"COc1ccc(C(=O)Nc2nc(C)nc3cn(-c4ccccc4)nc23)cc1";"IC50";"'='";"19.7";"nM";"7.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5126854";"Antagonist activity at human adenosine A3A receptor expressed in CHO cells assessed as inhibition of cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126505";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"ANTAGONIST";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.02291";"nM";"10.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322680";"Agonist activity at wild type human A3 receptor stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"3.802";"nM";"8.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322686";"Agonist activity at wild type human A3 receptor M174'5.35A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"M174A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.01445";"nM";"10.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322692";"Agonist activity at wild type human A3 receptor I253'6.58E mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"I253E";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL27";"PROPRANOLOL";"4.0";"259.35";"0";"2.58";"1";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"'>'";"5011.87";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3738125";"Antagonist activity at human wild-type A3 receptor expressed in CHO-K1 cells assessed as IB MECA-induced cAMP by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734721";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307512";"";"";""
"CHEMBL4439336";"";"None";"517.54";"1";"1.71";"17b; LUF7602";"CCCn1c(=O)c2c(nc3cc(OC)ccn32)n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"14.62";"0.29";"5.86";"5.66";"0";"CHEMBL4392071";"Displacement of [3H]PSB11 from human A3 adenosine receptor transiently expressed in CHOK1 cell membranes measured after 2 hrs by scintillation spectrometric method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4390672";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3962269";"";"None";"349.37";"0";"3.63";"BDBM214690";"Cc1cc(Nc2nc([C@H](O)c3ccc(F)cc3)nc3ccccc23)n[nH]1";"IC50";"'='";"28.0";"nM";"7.55";"";"312382";"UO_0000065";"21.62";"0.40";"3.92";"8.71";"0";"CHEMBL3887155";"Adenosine A3 Receptor Radioligand Binding Assay: .(R)- and (S)-(4-Fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol was tested in a radioligand binding assay, according to the procedure described in Olah et al., Mol. Pharmacol. 1994, 45, 978-982 and Salvatore et al., Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10365-10369, in human recombinant CHO-K1 cells expressing the human adenosine A3 receptor. Incubations of a range of concentration of each compound were carried out in duplicates for 1 h at 25° C. in 25 mM HEPES, pH 7.4, 5 mM MgCl2, 1 mM CaCl2, 0.1% BSA, in the presence of 0.5 nM [125I] AB-MECA. Non-specific binding was determined in the presence of 1 uM IB-MECA.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886191";"37";"BindingDB Database";"";"2016";"CHEMBL3307512";"";"";""
"CHEMBL1077943";"";"None";"381.49";"0";"4.03";"BDBM50310923";"CNc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1";"IC50";"'='";"22.9";"nM";"7.64";"";"323826";"UO_0000065";"";"";"";"";"0";"CHEMBL3887222";"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886219";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL5178658";"";"None";"302.28";"0";"2.37";"37";"O=c1[nH]cc(CSc2ccc(C(F)(F)F)cc2)[nH]c1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5166414";"Inhibition of recombinant human adenosine A3 GPCR incubated for 120 mins by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154896";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"";""
"CHEMBL1080421";"";"None";"395.51";"0";"4.42";"BDBM50310924";"CCNc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1";"IC50";"'='";"37.3";"nM";"7.43";"";"323828";"UO_0000065";"";"";"";"";"0";"CHEMBL3887222";"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886219";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3973260";"";"None";"378.48";"0";"4.63";"BDBM177998";"C=Cc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1";"IC50";"'='";"746.7";"nM";"6.13";"";"323830";"UO_0000065";"";"";"";"";"0";"CHEMBL3887222";"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886219";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL88147";"";"None";"403.83";"0";"4.37";"EUB0000397a";"O=C(Cc1ccccc1)Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12";"IC50";"'='";"0.09772";"nM";"10.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5185003";"";"None";"495.58";"1";"5.68";"L8";"COc1cc(Nc2nc(CNCc3ccccc3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC";"IC50";"'='";"7.244";"nM";"8.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL4074150";"";"None";"374.39";"0";"4.26";"14";"CCCn1c(Oc2ccc(F)c(F)c2)nc2nc(C3CCCC3)[nH]c2c1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3994395";"Displacement of [3H]HEMADO from human adenosine A3 receptor expressed in HEK293 cell membranes after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992564";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3307715";"";"";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"2; NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"1.148";"nM";"8.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322680";"Agonist activity at wild type human A3 receptor stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.005888";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322684";"Agonist activity at wild type human A3 receptor V169'5.30A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"V169A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL119709";"IB-MECA";"None";"510.29";"1";"0.41";"3; IB-MECA, CF101";"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.02138";"nM";"10.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322690";"Agonist activity at wild type human A3 receptor I249'6.54A mutant stably expressed in Flp-In CHO cells cotransfected with pOG44 assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by LANCE assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"P0DMS8";"I249A";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321810";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL5177023";"";"None";"681.81";"2";"6.20";"57";"Cc1c(C#Cc2ccc(CN3CCC(CO)CC3)cc2)cc(C(F)F)c2cn(C(C(=O)Nc3nccs3)c3ncn4c3CCC43CC3)nc12";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"9.83";"0.19";"0.50";"6.63";"0";"CHEMBL5120441";"Inhibition of adenosine A3 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113538";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4075640";"";"None";"390.45";"1";"5.32";"19c";"O=C(Nc1nc(-c2ccccc2)cn2cc(-c3ccccc3)nc12)c1ccccc1";"IC50";"'='";"235.0";"nM";"6.63";"";"";"UO_0000065";"16.98";"0.30";"1.31";"11.18";"0";"CHEMBL5126846";"Binding affinity to human adenosine A3A receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126505";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"ANTAGONIST";""
"CHEMBL4526845";"";"None";"317.14";"0";"3.93";"26g";"O=c1oc2c(O)cccc2cc1-c1ccc(Br)cc1";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5126877";"Antagonist activity at human adenosine A3A receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126505";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"ANTAGONIST";""
"CHEMBL4289256";"";"None";"331.44";"0";"4.08";"(S)-(-)-2";"CCCOc1cc(NC(C)=O)nc(S[C@@H](C)c2ccccc2)n1";"IC50";"'='";"428.2";"nM";"6.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4263216";"Antagonist activity at recombinant human adenosine A3 receptor expressed in CHO cells assessed as reduction in Cl-IB-MECA-induced inhibition of forskolin-stimulated [3H]cAMP accumulation preincubated for 10 mins followed by Cl-IB-MECA addition measured after 30 mins by liquid scintillation counting method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261564";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL5180268";"";"None";"311.35";"0";"4.24";"L4";"N#Cc1cc2c(-c3ccccc3)n[nH]c2c(Nc2ccccc2)n1";"IC50";"'='";"60.26";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5189470";"";"None";"496.57";"1";"5.08";"L9";"COc1cc(Nc2nc(CNCc3cccnc3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC";"IC50";"'='";"8.913";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5174600";"";"None";"364.45";"0";"4.36";"L21";"Cn1nc(NC(=O)Nc2ccccc2)c2ccnc(NC3CCCCC3)c21";"IC50";"'='";"4.266";"nM";"8.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5173159";"";"None";"367.41";"0";"3.72";"L3";"COc1cc(Nc2nc(C#N)cc3c(C(C)C)n[nH]c23)cc(OC)c1OC";"IC50";"'='";"3.802";"nM";"8.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL3929143";"";"None";"376.42";"0";"4.39";"L6";"COc1cc(Nc2nccc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC";"IC50";"'='";"5.129";"nM";"8.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5187501";"";"None";"325.33";"0";"2.60";"A15";"COc1cc(Nc2nc(C#N)cc3cn[nH]c23)cc(OC)c1OC";"IC50";"'='";"1.95";"nM";"8.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL464859";"NECA";"None";"308.30";"0";"-1.84";"NECA";"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"0.9333";"nM";"9.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL3929812";"";"None";"410.86";"1";"5.05";"L5";"COc1cc(Nc2nc(Cl)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC";"IC50";"'='";"12.3";"nM";"7.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL4565447";"";"None";"280.32";"0";"4.17";"2";"CCOc1cccc2cc(-c3ccc(C)cc3)c(=O)oc12";"IC50";"'='";"18400.0";"nM";"4.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4379763";"Antagonist activity at human adenosine receptor A3 expressed in CHO cells assessed as suppression of NECA-induced decrease of cAMP accumulation by Glo-sensor cAMP assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376839";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL5201810";"";"None";"358.41";"0";"3.75";"L12";"O=C(CNc1ccccc1)Nc1n[nH]c2cnc(Nc3ccccc3)cc12";"IC50";"'='";"3.02";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL4069012";"";"None";"391.43";"0";"4.71";"19d";"O=C(Nc1nc(-c2ccccc2)cn2cc(-c3ccccc3)nc12)c1cccnc1";"IC50";"'='";"172.0";"nM";"6.76";"";"";"UO_0000065";"17.28";"0.31";"2.05";"9.37";"0";"CHEMBL5126846";"Binding affinity to human adenosine A3A receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126505";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"ANTAGONIST";""
"CHEMBL5180010";"";"None";"372.43";"0";"3.76";"A26";"Cn1nc(NC(=O)CNc2ccccc2)c2cc(Nc3ccccc3)ncc21";"IC50";"'='";"12.3";"nM";"7.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5191702";"";"None";"284.29";"0";"2.29";"42";"O=c1[nH]cc(CSc2ccc(C(F)F)cc2)[nH]c1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5166414";"Inhibition of recombinant human adenosine A3 GPCR incubated for 120 mins by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154896";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"";""
"CHEMBL4070079";"";"None";"418.46";"0";"4.88";"19b";"O=C(c1ccccc1)N(C(=O)c1ccccc1)c1nccn2cc(-c3ccccc3)nc12";"IC50";"'='";"187.0";"nM";"6.73";"";"";"UO_0000065";"16.08";"0.29";"1.85";"9.96";"0";"CHEMBL5126846";"Binding affinity to human adenosine A3A receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126505";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"ANTAGONIST";""
"CHEMBL4448899";"BAY-876";"None";"496.42";"0";"4.17";"EUB0000307b";"Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1";"IC50";"'='";"1140.0";"nM";"5.94";"";"";"UO_0000065";"11.97";"0.23";"1.77";"4.69";"0";"CHEMBL5214526";"Selectivity interaction (Eurofins-Panlabs radioligand binding assay ) EUB0000307b ADORA3";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: GPCR";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"2023";"None";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 68.0 None | Selectivity Remarks: In-vitro potency | Selectivity Source Knowledge: https://doi.org/10.1002/cmdc.201600276, https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-876";"";""
"CHEMBL5186062";"";"None";"343.39";"0";"3.96";"L15";"Cn1nc(NC(=O)c2ccccc2)c2cc(Nc3ccccc3)ncc21";"IC50";"'='";"6.761";"nM";"8.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5111994";"Antagonist activity at wild type A3R (unknown origin) expressed in Flp-In-CHO cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Flp-In-CHO";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108055";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL4780673";"";"None";"537.62";"1";"3.02";"EUB0000253b";"Cc1c(Nc2ccc(S(=O)(=O)N3CCN(C)CC3)cc2F)nc2ccc(-c3cnn(C4CC4)c3)cn2c1=O";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"9.88";"0.19";"2.29";"5.06";"0";"CHEMBL5214201";"Selectivity interaction (NIBR principial panel (12 GPCRs, 3 nuclear receptors, 3 transporters, and 7 other enzymes)) EUB0000253b ADORA3";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: GPCR";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"2023";"None";"Selectivity number of off-targets = 3.0 None | Selectivity number of targets = 25.0 None | Selectivity Remarks: In-vitro potency (selective, other targets IC50 >30 µM, with exception of D3 and H3) | Selectivity Source Knowledge: https://www.thesgc.org/chemical-probes/NVS-BPTF-1";"";""
"CHEMBL4092103";"";"None";"314.35";"0";"3.65";"19a";"O=C(Nc1nccn2cc(-c3ccccc3)nc12)c1ccccc1";"IC50";"'='";"163.0";"nM";"6.79";"";"";"UO_0000065";"21.59";"0.39";"3.14";"11.45";"0";"CHEMBL5126846";"Binding affinity to human adenosine A3A receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126505";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"ANTAGONIST";""
